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  Abstract   
 
 
 
 
 
 
Abstract 
 
 
Detecting and quantifying biomolecules is an important tool in biological research. Ideal dyes 
have to have a number of characteristics i.e. low toxicity and limited autofluorescence. The 
properties of near infrared dyes make these ideal for cell and tissue imaging. 
 
The work within this thesis focuses on the development of three families of NIR dyes (linear, 
rigid and substituted polymethine) and these are actively compared against the clinical standard 
Indocyanine Green (ICG) and its structural derivative New Indocyanine Green (IR-820). The 
ultimate aim being to identify dyes which can be used alongside the clinical standards. 
 
The compounds developed within this thesis are structurally based on the NIR heptamethine 
cyanine (Cy7) dyes. To expand, variations fall into three categories, linear, rigid and polymethine 
substituted, each being synthesised using either existing methodology or through the development 
of a novel cascade reaction. The photophysical properties of each dye have been evaluated 
experimentally, focusing on absorption and emission wavelengths, fluorescence quantum yields 
and Stokes shifts. It is noted that most dyes synthesised within this thesis, show comparable 
Stokes shift but increased fluorescence quantum yields when compared against ICG and IR-820. 
All dyes absorb and emit within the NIR region based on excitation at 785 nm. 
 
The growth inhibition characteristic is an important criterion which determines the practical use of 
the dyes in living cells. Most of the dyes which showed no growth inhibition were the dyes 
bearing the sulfonic acid group, suggesting the sulfonic acid limited cellular uptake as a result of 
decreased membrane permeability. Dyes possessing growth inhibitory characteristics all contain 
linear N-alkyl moieties. It is thus postulated that the increased lipophilicity of these molecules 
result in increased lipid distortion and subsequent toxicity. 
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  CHAPTER ONE  
 
 
General Introduction: 
Molecular probes 
 
 
 
 
 
1.0 Introduction 
 
 
The work presented in this thesis seeks to develop three different families of Cy7 dyes 
(linear, rigid and polymethine substituted) and compare their photophysical and growth 
inhibition characteristics against two classical near infrared (NIR) dyes: Indocyanine Green 
(ICG) and New Indocyanine Green (IR-820). 
 
 
 
 
 
 
ICG 
 
IR-820 
 
- - - - 
 
 
Figure 1.1: Structures of ICG and IR-820 
 
 
 
ICG in particular, has been approved by the United States Food and Drug Administration for 
use in clinical applications, in particular, evaluating blood flow and clearance [1]. ICG 
derivatives  also  have  the  potential  as  a  tool  for  fluorescence-guided  management  and 
treatment of cancer [1]. The impact of this research is timely, as illustrated by a recent article 
in Nature Methods [appendix] which highlighted the need for novel probes for biological 
imaging. The thesis focuses on the development of cost-effective molecular probes with 
enhanced photo-physical and low toxicity characteristics, when compared against the current 
clinical standard, ICG.  The in situ cascade reaction also developed in this project provides an 
2 
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- 
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elegant approach to the substituted polymethine linear dyes which can be tailored to develop 
more structurally sophisticated cyanine dyes. 
The research within this thesis is divided into three areas: 
 
 
1. The synthesis of the NIR dyes; 
 
2. The photophysical characterisation of the NIR dyes and 
 
3. Growth inhibition studies of the NIR dyes. 
 
Figure 1.2 shows the three different structures of the NIR dyes developed during this work 
with Table 1.1 showing the different array of functionalities attached to these dyes. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.2: Structures of developed NIR dyes. 
 
 
 
 
X X- R1 R2 R3 R4 
S I- Me Cl Br Ph 
(CH3)2 Br- Et NHPh Cl 
n-Pr Me 
n-Bu 
Bn 
CH2(CH2)2SO3 
CH2(CH2)3SO3 
Table 1.1: Structures of developed NIR dyes. 
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1.1 Molecular Imaging 
 
 
Molecular imaging, also known as optical imaging is a rapidly developing area of research 
aimed at enhancing visualisation of cellular and molecular events in a non-invasive manner 
[1].  These  cellular  or  molecular  events  could  be  in  the  form   of  simply  locating 
specific population of cells, or an indication of the levels of a given protein receptor on the 
surface  of  cells.  Molecular  imaging  allows  evaluation  and  characterisation  of  gene  and 
protein function, protein-protein interaction, and profiling of signal transduction pathways of 
human diseases such as cancer in order to gain more understanding into the molecular 
pathology of such diseases [2]. It also facilitates observation of cellular process at genetic or 
molecular level in vivo [3]. The reasons for observing or monitoring various cellular targets 
include: 
 
• Characterisation of certain disease processes that might  correlate with  the 
concentrations of one or more of the molecular targets. For example, the 
manifestation of comparatively high levels of somatostatin receptor type 2 
(located on cell membranes) in the lungs of a patient or subject may be 
suggestive of the presence of cancer cells in the lungs. This may in turn help 
guide and facilitate the medical management of the patient or subject in which 
such a molecular target is detected [4]. 
• It also assists in revealing complex  underlying biology. For instance,  one 
might be able to investigate the migration of a specific subset of T- 
lymphocytes (T-cells) into a tumour and subsequent activation of the cells by a 
T-cell receptor. This enables a better understanding of the details of interaction 
between the tumour and the immune system [4]. 
• Another important reason for observation of the cellular targets is to help in 
the process of drug discovery and validation, as well as in predicting and 
evaluating response to various types of therapy [4]. 
 
Molecular imaging instruments are simpler and less expensive to handle than those required 
for other imaging technologies such as magnetic resonance imaging (MRI), radiography, 
hence, facilitating their integration in less specialised medical applications. In order to obtain 
suitable images, optical contrasts need to be generated by the attachment of unique 
visualisation labels or contrast agents to the cellular target. Presently, there are three major 
Molecular Probes 
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types of molecular probes or labels used in imaging applications namely: bioluminescence, 
fluorescent  proteins  and  fluorescent  dyes  [5].  Whilst  bioluminescence  and  fluorescent 
proteins require engineering cell lines or transgenic animals that carry suitable genes, 
fluorescent dyes do not. This unique feature coupled with its ease of handling and cost 
effectiveness makes fluorescent dyes a prospective candidate for rapid translation to clinical 
applications over methods which require genetic engineering [1-5]. 
 
Light is produced in molecular imaging by the excitation of a fluorescent molecule with a 
laser or light source resulting in emitted light of lower energy or longer wavelength that can 
be employed for imaging applications [6]. Molecular imaging techniques are attractive since 
they are highly sensitive and capable of detecting picomoles of light-emitting fluorophores in 
heterogeneous media [5]. 
 
 
 
 
 
1.2 Molecular Imaging Probes 
 
 
Molecular imaging probes have attracted significant interest in recent years due, in large part, 
to their important application in clinical and biomedical research for the visualisation of cells 
and tissues both in vitro and in vivo [7-12]. The advantages of using molecular imaging 
probes include: 
• High contrast i.e. good signal-to-noise ratio is usually obtained: since only 
the target and not the background is visible because different wavelengths 
are used for excitation and recording. 
• High sensitivity. 
 
• Several potential imaging modes can be obtained, most of which are unique. 
 
• Easy to use and handle: very similar to classical staining. 
 
• Cost efficient: the computing and optical instrumentation required are quite 
simple and inexpensive [13]. 
 
Most molecular imaging probes exhibit absorption and emission in the ultraviolet-visible 
(UV/Vis) wavelength region. This makes them difficult for applications relating to 
investigation of in vivo molecular imaging activities, due to the high absorption and 
autofluorescence of biomolecules in the UV/Vis region [14-16]. Also, light sources within 
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this wavelength region are easily dispersed and absorbed by biomolecules (e.g. melanin, 
haemoglobin and oxy-haemoglobin) and hence reduce the efficacy of tissue penetration 
(Figure 1.3). Furthermore, the autofluorescence from the biomolecules stimulates high 
background noise which causes a low signal-to-noise ratio [17]. 
 
In contrast, molecular imaging probes possessing absorption and emission in the NIR region 
(700-900 nm) can be efficiently utilised to investigate in vivo molecular targets because most 
tissues generate little NIR fluorescence, deep tissues penetration and minimal photodamage 
to biological sample [18]. In addition, molecular imaging probes operating in the NIR region 
result in improved signal-to-noise ratios, since they are spectrally isolated from the 
autofluorescence of tissue components such as collagen and fluorescence signals arising from 
other body absorbers [19]. The NIR probes could be used for visualisation and tracking of 
biomolecules such as melanin and haemoglobin (Figure 1.3) in their intrinsic location and in 
a non-invasive manner [20]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.3: Spectra for endogenous visible absorbers [24]. 
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At present, the general paradigm for designing fluorescent imaging probes can be categorised 
into non-targeting and targeting molecular probes. The non-targeting probes which include a 
number of NIR fluorescent cyanine dyes such as ICG are currently being used in clinical 
applications for evaluating blood flow and clearance [21]. A NIR fluorescent dye makes use 
of the NIR spectrum, facilitating deeper tissue penetration of light. The NIR light can achieve 
a depth of 5-10 mm, but this usually depends on the tissue type involved [23, 24]. The 
targeting probes are mostly used for functional imaging of tumour tissues, as cancer cells 
often overexpress certain surface receptors. This approach involves conjugating the 
fluorophore to a ligand that binds to a specific molecular target [22]. The targeting probes 
bind to the target and are retained at the target site, whereas the unbound probes are cleared 
from the circulation. The targeting probes are further divided into active and activatable 
probes [22-24]. 
 
 
 
 
 
1.3 Organic Dyes 
 
 
In  order  to  understand  the  concept  of  using  non-targeted  NIR  heptamethine  cyanine 
molecular probes for biomedical applications, it is imperative to grasp the background from 
which they developed, as this may provide some logical explanation on cell staining and bio- 
molecular interaction. A significant part of the literature focuses on the synthesis and 
applications of non-targeting heptamethine cyanine dyes as molecular probes for potential 
imaging applications. It is widely accepted that many imaging agents e.g. Fluorecein-5- 
isothiocyanate, Methylene blue etc (Figure 1.4) has been derived from dyes [25]. 
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Methylene blue 
 
 
 
 
 
 
 
Fluorescein-5-isothiocyanate 
 
 
 
Figure 1.4: Examples of imaging and staining agents derived from dyes. 
 
 
 
 
Dye chemistry has been investigated for over a century [26]. Whilst the developers of modern 
therapeutics have been inclined to avoid the use of coloured compounds due to their tendency 
to stain, it is precisely this characteristic which modern biomedicine has come to rely on [27]. 
There are two major areas of application for dyes in today’s medicine, as molecular probes in 
the field of surgical oncology, and as photosensitizer in Photodynamic Therapy (PDT). 
Molecular probes are molecules or agents which absorb in the visible or NIR region, enabling 
them to be used as indicators to visualise and study the in vivo molecular properties of certain 
cells, molecules, enzymes or a biological state of cells [28]. PDT is where the dye is 
concentrated in a specific site, i.e. a tumour, and the correct wavelength of light is shone on 
the dye to release reactive oxygen species or redox radicals which are highly toxic to cells. 
Both these applications are related in that they both require a selective uptake of the dye by 
the cells [24]. Organic dyes are the most widely developed NIR molecular probes used for in 
vivo imaging investigations. Some of the first organic dyes to receive extensive biomedical 
application include trimethine cyanine (Cy3), pentamethine cyanine (Cy5) and heptamethine 
cyanine (Cy7) dyes, which are all based on the polymethine platform [29, 30]. 
 
 
 
 
 
1.4 Polymethine Dyes 
 
 
Polymethine dyes (trimethine, pentamethine and heptamethine) (Figure 1.5) have been well 
known since the early 1920s. They have attracted a lot of interest due to their unrivalled 
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ability to be utilised extensively in various areas of biomedical research activities [31]. They 
are dyes containing the π-electron conjugated system bearing an electron acceptor terminal 
group (ETG1), electron donor terminal group (ETG2), and the methine chain (MC) joining the 
two terminal groups. 
 
 
 
 
 
 
 
 
.. 
 
 
 
 
ETG1 MC ETG2 
 
 
Figure 1.5: Polymethine dye. 
 
 
 
 
 
The  electron  acceptor  terminal  group  usually  contains  a  highly  electronegative  atom 
adjoining to a double bond such as N+=. The carbon atom =C integrated into the heterocyclic 
system is normally a monovalent residue. The electron donor terminal group contains an 
atom having a lone pair of electrons such as O, N, S joined to a divalent carbon atom. The 
polymethine chain is made up of sp2- hybridised carbon atoms forming the π-electron 
conjugated system. The unsaturated nature of this part of the molecule allows electron 
movement  between  the  heterocyclic  termini,  and  for  a  given  pairing,  the  maximum 
wavelength of absorption can be related to the length of the methine chain due to the fact that 
the vinylene shift amounts to about 100 nm [32]. Variation in the length of the polymethine 
chain and the identity of the terminal group allows for the alteration of the absorption and 
emission spectra throughout the visible and NIR regions of the electromagnetic spectrum. 
The  conjugation  between  the  electron  donor  terminal  group  and  the  electron  acceptor 
terminal group results in the delocalisation of π-electron and bond order equalisation of the 
chromophore. Depending on the chemical constitution of the terminal end group, the 
polymethine dye can be categorised as being either symmetric or asymmetric. If the terminal 
end group possess the same chemical constitution, the polymethine dye is called symmetric. 
Figure 1.6 shows an example of symmetric trimethine (Cy3) polymethine dye called 
pinacyanol. 
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Figure 1.6:  Symmetrical Cy3 dye (pinacyanol). 
 
 
 
 
 
The electron density distribution within the chromophore system of such a dye is also 
symmetrical. Alternatively, if the terminal end groups differ in their chemical composition, 
the polymethine dye is called asymmetric. Figure 1.7 shows an example of an asymmetric 
polymethine dye called merocyanine 540 (MC 540). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.7:  Asymmetrical polymethine (MC 540). 
 
 
 
 
 
Amongst the different kinds of polymethine dye molecules e.g. squaraine derivatives (Figure 
 
1.8), the cyanine family possess the greatest potential for being used in biomedical 
applications due to their excellent biocompatibility, superior photophysical and bio- 
distribution properties [33]. They also possess large molar extinction coefficients, moderate- 
to-high fluorescence quantum yields and a broad wavelength range that is chemically 
adjustable [33]. 
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Figure 1.8:  Squaraine derivative. 
 
 
 
 
 
The name cyanine dyes was derived from the Latin word cyanos, meaning blue,  which 
represent a unique class of charged π-electron organic compounds which generically consist 
of two heterocycles joined by an electron deficient conjugated methine chain [24, 34]. 
Cyanine dyes are among the oldest class of synthetic dyes commonly used today. They were 
first discovered by Williams in 1856 who obtained “corn flour” blue cyanine by treating 
quinolinium salts with amyl iodide followed by treatment with a base [35]. Since their 
discovery, they have been used extensively in numerous technical applications including their 
use as non-optical materials and photographic sensitisers. More recently they have been used 
as fluorescent probes for in-vivo molecular imaging activities due to their ability to emit light, 
i.e. fluoresce [36, 37]. 
 
The typical cyanine dye molecule (Figure 1.9) can be defined as being made up of two 
nitrogen-containing heterocyclic ring systems, in one of which the nitrogen atom is trivalent 
and in the other it is tetravalent; the two nitrogen atoms are joined by a conjugated chain of 
an uneven number of carbon atoms. In the early days, both the two heterocyclic rings were 
derived from quinolone; but nowadays they are also derived from pyridine, indole, 
benzothiazole, benzoselenazole and other heterocycles [38]. 
 
 
 
 
 
n 
 
 
 
Figure 1.9:  Generic cyanine dye. 
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The naming of cyanine dyes directly corresponds to the number of methine groups located in 
the  methine  chain  joining  the  two  heterocycles.  Dyes  having  n  =  0,  1,  2,  and  3,  are 
categorised as mono-, tri- (Cy3), penta- (Cy5) and hepta- (Cy7) methine cyanine dyes [39- 
41]. The structural versatility of cyanine dyes is such that analogue formation is relatively 
straight forward e.g. via variation in heteroatom, length of polymethine chain or N-alkylation. 
This has led to the synthesis of large number of various types of cyanine dyes over the last 
century. There are three main types of cyanine dyes (Figure 1.10) namely; streptocyanine, 
hemicyanine, and closed chain cyanine dyes [42]. 
 
 
 
 
X- 
 
 
Streptocyanines 
 
 
 
 
 
 
 
X- 
 
 
Hemicyanines 
 
 
 
 
 
 
 
X- 
 
 
Closed-chain cyanines 
 
 
Figure 1.10: Types of cyanine dyes. 
 
 
 
 
 
Cyanine dyes are usually associated with intense colour, which is a result of the resonance 
interaction between the nitrogen atoms at the terminal ends of the conjugated methine chain, 
involving  the  movement  of  cationic  charge  [43].  The  colour  of  cyanine  dyes  can  be 
understood by considering the structural components of the dyes such as terminal groups, 
chromophoric systems and the sensitivity of the dyes to specific solvents [39, 40]. Generally, 
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cyanine dyes all have a sterochemical trans-geometry in their stable form although they do 
occasionally undergo photoisomerisation, a major route for deactivation of cyanine dyes [38]. 
They also show absorption and fluorescence that are a function of their molecular structure. 
 
Generally, visible light absorption by a dye molecule depends on the possession of a 
conjugated π-system with the wavelength of the absorbed light depending on the charge 
distribution within the system. The λmax  for a given heptamethine dye can be increased by 
lengthening the polymethine chain [44]. However, this may result in photoisomerisation, a 
major deactivation pathway for most cyanine dyes. This deactivation process could lead to 
formation of singlet oxygen species [44]. Singlet oxygen has been proven to kill both healthy 
and  tumour  cells.  Furthermore,  increasing  the  polymethine  chain  length  often  leads  to 
reduced solubility of the dye. Therefore, careful consideration and balance of these factors is 
needed when designing potential candidates for biomedical applications. 
 
 
 
 
 
1.5 Chromophoric System of Cyanine Dyes 
 
 
Resonance theories such as Pariser-Parr-Pole (PPP) Molecular Orbital (MO) theory have 
been applied in predicting the colour and other colour-related properties of the cyanine dyes 
in terms of the energy levels of the frontier orbitals and the π-electron density changes 
accompanying the first transition [45-47]. The absorption maximum of cyanine dyes usually 
exhibits a bathochromic shift of about 100 nm due to the presence of each extra vinylene 
conjugating unit. The effects of a heteroaromatic ring R on the λmax of cyanine dyes depends 
on its structure as shown in Figure 1.11. A bathochromic shift can be gained by increasing the 
basicity of heteroatoms and enlarging the π- conjugated systems. 
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R=CH-(CH=CH)3-R 
 
 
 
 
 
 
 
 
 
920 nm 
 
818 nm 
 
X = Se 
 
790 nm 
  X = S 
X = CMe2 
X = O 
763 nm 
741 nm 
695 nm 
Figure 1.11: Structures of heteroaromatic ring R. 
 
 
 
 
 
1.6 Synthesis of Cyanine Dyes 
 
 
The base catalysed aldol type reaction is one of the major methods used to synthesise NIR 
fluorescent cyanine dyes due to its high level of stereo-selectivity and hence formation of 
stereo-controlled products [28]. Classical synthesis of cyanine dyes usually involves a 
heteroaromatic compound such as the quaternary pyridine derivative with a methyl group at 
position 2, 4 or 6 as the starting material. The electron-withdrawing nature of the quaternary 
nitrogen enhances the acidity the methyl proton, which then loses a proton. The proton 
abstraction step could also be promoted by the use of a base such as sodium acetate, pyridine 
or triethylamine to form the nucleophile or carbanion (Scheme 1.1). The nucleophile then 
attacks the dialdehyde or ketone through a nucleophile attack followed by subsequent 
dehydration to form the basic cyanine-type molecule. 
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-H2O 
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X- 
 
 
 
 
 
Scheme 1.1: General mechanism for cyanine dye synthesis [28]. 
 
 
 
 
 
1.7 Monomethine Cyanine Dyes 
 
 
Deligeorgiev and co-workers developed a novel method for the preparation of symmetrical 
and asymmetrical monomethine cyanine dyes (Scheme 1.2) [48]. The novel synthetic method 
developed  involves  the  reaction  of  quaternary  salts  of  a  heterocyclic  2-  or  4-methyl 
compound and N-heterocyclic 2- or 4-sulfobetainic compounds by simply melting or boiling 
them in common polar solvents or solvent mixtures in the absence of a basic agent. The 
applicability of this method is highly dependent on the melting points of the starting materials 
and their thermostability [48]. 
 
 
 
 
-SO2, H2O 
 
ethanol  X- 
X- 
R 
R 
 
 
 
 
 
-SO2, H2O 
 
ethanol 
 
 
Scheme 1.2: Deligeorgiev novel method for the preparation of symmetrical and asymmetrical 
monomethine cyanine dyes [48]. 
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1.8 Trimethine Cyanine Dyes (Cy3 Dyes) 
 
 
Peng and co-workers have utilised the classical orthoester synthetic approach to synthesise a 
range  of  novel  trimethine  cyanine  dyes.  The  approach  involves  the  condensation  of 
orthoesters with quaternary heterocyclic salts substituted with an activated methyl group 
under basic conditions (Scheme 1.3) [49]. 
 
 
 
 
 
CH(OC2H5)3 
X- X
- 
 
 
 
Pyridine 
Et3N 
 
 
 
 
 
 
 
 
X- 
 
 
 
Scheme 1.3: Pengs synthetic route to yield trimethine cyanine dyes [49]. 
 
 
 
 
 
The synthetic route involves a condensation reaction using triethyl orthoformate with 
appropriately substituted 2-methyl-3H-indolium salts in the presence of triethylamine. The 
route was developed by successful optimisation of the reaction conditions, from a ratio of 2- 
methyl-3H-indolium : ortho ester : triethylamine  of 2 : 3 : 4, the reaction mixture was then 
refluxed for 1 h at 120 °C in pyridine solution. 
 
Using similar synthetic transformations, a central one-carbon constituent of the trimethine 
bridge can be derived from N,N’-diphenylformamidine [50, 51] or iodoform. The 
diphenylformamidine protocol allows for the synthesis of asymmetric dyes bearing two 
diverse  end-heterocyclic  subunits  or  two  different  N-subunits  on  the  same  heterocyclic 
systems [52]. The central methine group of the trimethine chain in dyes A and B can also be 
Molecular Probes 
16 
 
 
 
 
made  using  a  novel  Vilsmeier-type  reagent  obtained  from  N,N’-dimethylformamide  and 
hydrogen bromide (Scheme 1.4) [53]. 
 
 
 
 
 
DMF, reflux 
HBr 
 
 
 
 
 
 
HBr 
 
Δ 
 
 
 
 
 
 
 
 
 
 
A (30%) B (52%) 
 
 
Scheme 1.4: Synthetic route to yield trimethine cyanine dyes using dimethylformamide 
protocol [53]. 
 
 
 
 
Post synthetic modifications can be carried out at the meso postion of a meso-methyl- 
substituted trimethine dye (Scheme 1.5) by condensation with an aldehyde to yield dye C. An 
ethyl analogue can also undergo the same condensation at the α-position of the ethyl group 
[54]. 
 
 
 
 
 
 
 
 
 
 
 
TsO- 
1. piperidine, ethanol 
2. NaI, methanol 
 
C 
 
Scheme 1.5: Post synthetic modification to yield dye C [54]. 
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1.9 Pentamethine Cyanine Dyes (Cy5 dyes) 
 
 
One of the main synthetic routes to yield this class of polymethine dyes is the condensation of 
cationic heterocyclic compounds containing an activated methyl group with derivatives of 
malondialdehyde. Waggoner and co-workers have recently developed a novel synthetic 
method to yield a water soluble pentamethine cyanine dye D (Scheme 1.6) [55]. 
 
 
 
 
 
 
 
 
MeO-CH=CH-CH(OMe)3 
pyridine, 80 °C 
 
 
 
 
 
 
 
D 
Scheme 1.6: Waggoner synthesis of water soluble pentamethine cyanine dye 16 [55]. 
 
 
Renard  and  co-workers  have  developed  a  new  synthetic  route  (Scheme  1.7)  for  the 
preparation of a range of novel water soluble pentamethine cyanine dyes, using an effective 
acylation reaction with an original trisulfonated linker [56]. The structure of the intermediates 
were designed to create a scaffold bearing the two orthogonal reactive amino and carboxylic 
acid groups, which can be modified easily and selectively to yield pentamethine cyanine dye 
E bearing two different N-substituents [56]. Purification of pentamethine cyanine dye E is 
usually very difficult and challenging, due to their high level of polarity. Crystallisation 
rarely produces pure compounds and large amounts of the dye are irreversibly adsorbed by 
using the normal silica gel chromatography method. The most effective purification method 
for such highly polar dyes is reverse-phase chromatography utilising a commercial C18 
adsorbent [50]. 
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1. AcOH, pyridine 
2. H2NNH2, MeOH, CH2Cl2 
3. reverse-phase chromatography 
 
 
 
 
 
 
 
CF3COO- 
 
 
 
 
E 
 
 
 
Scheme 1.7: Renard synthesis of pentamethine cyanine based amino acid [56]. 
 
 
 
 
 
1.10 Heptamethine Cyanine Dyes 
 
 
Currently, there is a huge amount of interest in the chemistry of heptamethine cyanine dyes 
due to their application as fluorescence biomarkers in biomedical sciences [57-62]. A large 
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amount of these dyes possess a six-membered cyclohexene subsystem as part of the 
heptamethine chain e.g. compound F (Scheme 1.8). One of the advantages of this structural 
feature is that it helps to increase the rigidity of the compound, hence give an increase in the 
quantum yield of the molecule. Due to steric factors, the cyclohexene subsystem also 
decreases the level of dye aggregation in solution. The first series of heptamethine cyanine 
dyes were synthesised in 1977 by Makin and co-workers [60]. The synthesis involved the 
condensation of Vilsmeier-Haack intermediate (VH1) obtained from cyclohexanone and a 
heterocyclic salt bearing an activated methyl group (MG1) in the presence of base (Scheme 
1.8). 
 
 
 
 
 
N Me 
 
 
 
ethanol 
MG1 N 
 
 
VH1 F 
 
R1 = H, 
R2 = MeI 
 
 
Scheme 1.8: Makins synthesis of heptamethine cyanine dye [60]. 
 
 
 
 
 
1.11 Application of Cyanine Dyes 
 
 
Due to the recent advancement of specialised innovative or functionalised dyes, there has 
been increasing interest in the application of cyanine dyes. The biological and photophysical 
properties of cyanine dyes within different types of media have led to their use over a vast 
range of applications such as photorefractive materials [63], industrial paints, for trapping 
solar energy, as sensitisers for solar cells [64], in optical disk for recording media [65-67], as 
laser materials [68-72], as inorganic large band-gap semiconductor materials [73-78] and 
most recently as targeted and non-targeted probes for in-vivo imaging activities [79-86]. 
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1.12 Sensitisers for solar cells 
 
 
Much emphasis has been placed on the investigation of dye-sensitised solar cells due to the 
advent of green technology using solar energy [87]. Though an array of organic dyes such as 
merocyanine [88], polyenes [89] and coumarins [90] have been reported to show excellent 
solar-light to electricity conversion efficiency, little has been reported on near-infrared 
sensitisers [91]. Some heptamethine cyanine dyes are usually very stable under UV- 
irradaition as they contain the rigid cyclohexene moiety, and this makes them very interesting 
and attractive compounds for application as sensitisers for solar cells [91, 92]. 
 
Jianli and co-workers have designed and synthesised new fluoranthene-based asymmetric 
cyanine dye G1 and G2 (Figure 1.12) bearing a ethynyl unit for comparison purposes as 
sensitisers  for  applications  in  Dye-Sensitized  Solar  Cells  (DSSC)  [93].  The  absorption 
spectra,  electrochemical  and  photovoltaic  properties  of  the  dyes  (G1  and  G2)  were 
extensively investigated and reported. The DSSC based on the fluoranthene dye G1 displayed 
the superior photovoltaic performance: a maximum monochromatic PCE of 67%, a short- 
circuit photocurrent density (Jsc) of 7.83 mAcm−2, an open-circuit photovoltage (Voc) of 
 
0.476 V, and a fill factor (ff) of 0.63, conforming to an overall conversion efficiency of 
 
2.34% under simulated AM 1.5G solar light conditions in comparison to cyanine dye G2. 
Also investigated were the effects of ChenoDeoxyCholic Acid (CDCA) in a solution as a co- 
adsorbate on the photovoltaic performance of DSSCs based on cyanine dyes. The presence of 
CDCA for 30 mins was reported to increase both the photovoltage and photocurrent of the 
DSSC in combination with G1, in which the photovoltage and photocurrent increase 9.3% 
and 20%, respectively. The above photovoltaic results indicate that co-adsorption of suitable 
amount of CDCA is effective in improving solar cell performance [88]. 
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G1 
 
 
 
 
 
 
 
 
 
G2 
 
Figure 1.12: Molecular structures of cyanine-based dyes G1 and G2 [88]. 
 
 
 
 
 
1.13 Ion Sensors 
 
 
A range of novel NIR ketocyanine dyes have been designed and synthesised by Julian and 
co-workers [94]. The dyes were evaluated as potential pH fluoroionophores to be utilised for 
the development of new Integrated Waveguide Fluorescence Optodes (IWFO). The 
ketocyanines (H1) upon protonation were transformed to meso hydroxyl substituted 
carbocyanine dyes (H2) (Scheme 1.9) and this process was accompanied by a large 
bathochromic shift (in the range of 200 nm) of the absorption band along with a considerable 
decrease in fluorescence intensity. 
 
 
 
 
 
 
 
H1 H+ 
 
 
 
 
 
X- 
 
H2 
 
X, Y = CMe2, S; R1, R2 = H, OH, COOEt, NH2, NHAC 
 
Scheme 1.9: Protonation of ketocyanine dyes [94]. 
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The ketocyanine dyes also demonstrated their suitability for application as acidochromic 
fluoroionophores in bulk optodes for the design and development of IWFO. They show high 
fluorescence intensities in the far-visible region, an optimum pH sensitivity and sufficient 
photostability [89, 95]. 
 
 
 
 
 
1.14 Non-Linear Optics 
 
 
With  the  increasing  demand  for  optically  non-linear  organic  chromophores  and 
photorefractive materials [96, 97], a great deal of research has focused upon the molecular 
engineering requirements to improve the optical non-linearities in push-pull compounds [98, 
99]. Non-linear optics is concerned with studies of the non-linear interactions of 
electromagnetic radiation and the media. The non-linear interaction indicates that matter 
reacts in a non-linear manner to the incident radiation fields. This gives the media the ability 
to change the wavelength, or the frequency of the incident electromagnetic waves. In general, 
this non-linear interaction is only observed when the incoming light is of high intensity 
(electric field) [100]. Boxer and co-workers have reported results of Stark and Electric-Field- 
Induced-Second-Harmonic  (EFISH)  measurements  for  a  series  of  donor/acceptor 
merocyanine dyes which differ in their electron acceptor end group (Figure 1.13). These 
demonstrate  the  correlation  between  optical  non-linearities  along  with  a  large  solvent 
dependence of their electronic structure [101]. 
 
 
 
 
 
Het 
 
 
 
 
Het = ; 
; ;
 
 
 
 
 
Figure 1.13: Merocyanine dyes synthesised by Boxer and co-workers [101]. 
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Merocyanines have been known to show non-linear optical properties both in a polymer 
matrix and as crystals. However, most non-linear optical chromophores are usually difficult 
to crystallise [102]. Tsuboi and co-workers have utilised the Second-Harmonic Generation 
(SHG) to study the non-linear optical responses of a Self-Assembled Monolayer (SAM) 
bearing merocyanine chromophore (Figure 1.14) on gold in water and ethanol [103]. The pH 
dependence of the SHG clearly indicated a solvatochromic modification of the merocyanine 
from a protonated form to a zwitterionic form [103]. 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.14: Merocyanine dye synthesisd by Tsuboi and co-workers [103]. 
 
 
 
 
 
1.15 Cyanine Dyes for Photodynamic Therapy (PDT) 
 
 
Photodynamic Therapy (PDT) involves the use of a photosensitising agent and near-visible 
light to kill cancer cells [104]. After administration into the body, within a short period of 
time, the photosensitiser localises in the tumour in high concentrations, and then the treated 
area is irradiated with a light source. The light causes the photosensitising agent to react with 
molecular oxygen producing singlet oxygen, a powerful oxidant and a cytotoxic agent, that 
kills the cancer cells. PDT may also work by damaging the blood vessels that feed the cancer 
cells and by informing the immune system to attack the cancer [28]. The effectiveness of the 
photosensitiser depends on the initial singlet electronic excited state of the molecule 
possessing sufficient longevity to give enhanced intersystem crossing and electron spin 
inversion to yield the triplet excited state. This stimulate the interaction with the surrounding 
environment through either electron transfer (Type I photosensitisation) or energy transfer 
and singlet oxygen generation (Type II photosensitisation) (Scheme 1.10) [28]. Also, the 
absorption maximum and the wavelength of the laser source are important parameters that 
determine the strength of photodynamic action on malignant tissues. PDT possesses several 
advantages over some of the traditional cancer treatments like chemotherapy, radiation and 
hormone therapy. It can target specific cells and can be repeated several times at the same site 
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if the need arises. The treatment is less invasive and cancer patients treated with PDT have 
less, if any, long term side-effects. PDT has been approved by the Medicines and Healthcare 
products Regulatory Agency (MHRA) and United States Food Drug Administration (FDA) 
and is utilised worldwide for the treatment of lung cancer, obstructive oesophageal cancer 
and age-related macular degeneration [105-108]. 
 
 
 
 
 
Inter-system 
crossing 
 
 
Triplet excited state T1 
 
 
 
Phosphorescence 
 
Type  1 Photosensitisation 
(Redox reactions) 
 
 
 
 
 
Type  2 Photosensitisation 
(Singlet oxygen production) 
 
 
 
 
 
 
 
Scheme 1.10: Jablonski diagram showing the various stages involved in 
photosensitisation process [24]. 
 
 
 
Cyanine dyes such as merocyanines and ketocyanines have been studied extensively as 
potential PDT tools for the treatment of solid tumours [102, 109]. They have also been 
utilised as radiation sensitizers for treatment of cancerous cells [110]. Harrimann and co- 
workers have proposed merocyanine as a reagent for both diagnosis and treatment of early 
stages of leukaemia by PDT as it has shown the potential for selective recognition of the 
leukaemia cells [110]. The intracellular merocyanine dye I1-I7 (Figure 1.15) acts as a 
phototoxin to destroy the host cells under irradiation due to the long-lived triplet excited state 
of the dyes which plays an important role in the overall process [111]. 
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I1: X = O, Y = S (MC 540) 
I2: X = C(CH3)2, Y = S 
I3: X = S, Y = S 
I4: X = Se, Y = S 
I5: X = Se, Y = O 
I6: X = Se, Y = Se 
I7: X = O, Y = O 
 
Figure 1.15: Intracellular merocyanine dye for PDT [111]. 
 
 
 
The photo-process involves isomerisation from the singlet excited state progressing from an 
all-trans configuration to a long-lived cis-isomer. Thus for merocyanine dye derivatives to be 
clinically useful, it is essential that: 
a)  The photoisomerisation is inhibited, since it competes with intersystem crossing 
and radiative deactivation. 
b)  Highly  fluorescent  dyes  are  photobleached  in  cellular  media  to  recognise 
leukaemia cells [105]. 
 
 
 
The photobleaching process occurs via an oxidative attack of the singlet oxygen produced 
from the long-lived triplet excited state on the polymethine chain [112]. Therefore, a group of 
merocyanine dyes giving no triplet state, are hence suitable for detection purposes, and other 
analogues of such dyes displaying high triplet yield, are consequently useful as phototoxins, 
both of which are required. 
 
It has also been observed that for a series of merocyanine dye derivatives, the presence of 
heavy atoms increases the triplet yield by spin-orbital coupling and alters the rate and yield of 
isomerisation [113]. Amongst the derivatives, merocyanine I6, containing Se, was shown to 
be a potent sensitiser. The lipophilicity also increases by the attachment of heavy atoms. It 
possesses high toxicity towards leukaemia cells due to high intracellular solubilisation, and 
also a faster rate of uptake into infected cells which improves its biological activity [114]. 
Molecular Probes 
26 
 
 
 
 
1.16 Protein Labelling 
 
 
Protein labelling also known as probe technology involves the conjugation or attachment of a 
chromophore   to   a   protein   either   covalently   or   non-covalently.   The   technology   is 
advantageous because it allows for higher sensitivity and better detection limits since the 
detection of the extrinsic chromophore possess a higher molar absorptivity than the protein’s 
intrinsic chromophore. Greater sensitivity is achieved when studies are carried out in the NIR 
region of the electromagnetic spectrum. Covalent and non-covalent labelling techniques can 
be used to study both quantitative and qualitative analysis [115-117]. 
 
The majority of covalent labels employed for biological applications are usually synthesised. 
Primary amines and thiols are typically the reactive moieties on the proteins that are targeted 
by dyes for conjugation by the reaction with functionalised dyes [118]. Hydrazide or amine 
groups on dyes have been used for the attachment to carboxylic acid groups on proteins. Dyes 
derived with iodoacetamide or maleimide can be reacted with protein thiols. In addition, dyes 
functionalised with an isothiocyanate (SCN) group or N-hydroxysuccinimidyl (NHS) ester 
have been widely used to target lysine moieties. Figure 1.16 illustrates the reactive pathways 
of some commonly available labelling reagents [50]. 
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Figure 1.16: Covalent labelling of amine and thiol groups of proteins R2NH2 and R2SH. 
 
 
 
Reactions involving lysine functionalities of proteins occur readily under neat conditions with 
a variety of commercially available reagents. Covalently labelled complexes are generally 
very specific and stable, and the possibility for nonspecific interactions is significantly 
minimised [119]. Due to their excellent specificity, covalent labelling is often employed in 
quantitative analysis, where it is used to determine the number of reactive sites or degree of 
substitution. This particular characteristic of covalent labelling is suitable for determining the 
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number of functional groups (e.g. amines) present on the surface of a protein of interest 
[119]. Some fluorescent covalent labelling agents have shown excellent water solubility, 
good photostability, and favourable photophysical properties. Figure 1.17 shows a range of 
selected NIR reagents for labelling of proteins at the amino group [119]. 
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Figure 1.17: NIR cyanine dyes for covalent labelling of proteins at an amino group. 
 
 
 
Frangioni and co-workers have investigated intraoperative NIR fluorescence imaging systems 
for small-animal surgery [120]. They labelled Human Serum Albumin (HSA) covalently with 
an IRDye78 to produce an HSA-dye conjugate (Figure 1.18) as a fluorescent lymph tracer 
[120, 121]. The tracer is suitable for use in intraoperative NIR fluorescence imaging studies 
since it is non-toxic and the excitation light source used is safe for animals. The tracer was 
reported to exhibit clearly resolved images. The properties of the NIR probe were also 
compared with that of Quantum Dots (QDs). It was discovered that the NIR probes possessed 
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superior properties such as high emission wavelengths and quantum yield indicating their 
better suitability for in vivo imaging applications. 
 
 
 
 
 
 
 
 
 
 
SO3Na 
 
 
 
 
 
 
 
 
 
SO - 
 
Figure 1.18: IRDye78-NHS. 
 
 
 
 
 
1.17 Tumour Targeting and Imaging 
 
 
Amongst the available NIR dyes, cyanine dyes have demonstrated promising potential for 
tumour targeting and imaging. A vast amount of research has focused on increasing the 
tumour-targeted  specificity of  cyanine  dyes  by  conjugating  them  to  targeting  molecules 
known to bind to certain receptors having high expression in tumour cells [122]. Also, 
multifunctional  dyes  with  Magnetic  Resonance  Imaging  (MRI)  and  optical  imaging 
properties are being developed. In a bid to develop tumour targeting specific fluorescent 
agents, Achilefu and co-workers conjugated NIR cyanine dye to small peptides for targeting 
Somatotatin (SST) receptors [123]. In their approach to prepare the tumour targeting agent 
J3, the NIR cyanine dye J1 was conjugated to the C- terminus of a cyclic SST receptor avid 
octapeptide J2 (Scheme 1.11). The absorption and fluorescence emission properties of the 
fluorescent probe J3 were similar to that of the precursor NIR cyanine dye J1. 
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Scheme 1.11: NIR cyanine dye peptide conjugate. 
 
 
 
In a similar study Licha and co-workers  reported the synthesis and characterisation of SST 
receptor-specific peptide H2N-(d-Phe)-cyclo[Cys-Phe-(d-Trp)-Lys-Thr-Cys]-Thr-OH, which 
was labelled with a carboxylated indodiacarbo and an indotriacarbocyanine NIR cyanine dye 
at the N-terminal amino group. The imaging agent was prepared by using automated solid- 
phase synthesis, with subsequent attachment of the cyanine dye and cleavage of the whole 
conjugate  from  the  resin  (Scheme  1.12)  [124].  The  resulting  peptide-dye  conjugates 
displayed high absorbance at 792 nm and emission at 811 nm, which are typical for cyanine 
dyes. Hence, these dyes are suitable receptor-targeted contrast agents for tumour targeting 
and imaging. The ability of the peptide-dye conjugates to target the SST receptor was 
demonstrated by flow cytometry in vitro, in which the indotricarbocyanine conjugate led to 
elevated cell-associated fluorescence on SST receptor-expressing tumour cells. While in 
contrast, the linear analogue of the sequence H2N-(D-Phe)-Met-Phe-(D-Trp)-Lys-Thr-Met- 
Thr-OH produced only minimal cell fluorescence, thus confirming the specificity of the 
cyclic SST derivative [117]. 
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Scheme 1.12: Preparation of monocarboxylated indodicarbo (K1) and indiotricarbocyanine 
 
(K2), and the structures of the resulting peptide conjugates K3-K6. 
 
 
 
Glunde and co-workers have reported the synthesis and development of two novel NIR 
cyanine dye fluorescent probes by linking a carbocyanine fluorophore and glucosamine 
through diverse linkers (Scheme 1.13) [125]. The probes demonstrated a high quantum yield, 
low cytotoxicity, reversible pH-dependent fluorescence in the physiological pH range, and a 
decreased aggregation tendency in aqueous solutions. Results from the in vitro NIR optical 
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imaging studies showed cellular uptake and strong intracellular NIR fluorescence for the two 
probes in four breast epithelial cell lines [125]. 
 
 
 
 
 
 
 
 
 
 
 
L1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
L2 L3 
 
 
 
Scheme 1.13: Glucosamine fluorescent dye probes. 
 
 
 
Kimura and co-workers have successfully coupled a NIR fluorescent ICG dye molecule to a 
nanocarrier for tumour imaging application [126]. A murine model for human liver cancer 
was established by injecting human hepatocellular carcinoma cells expressing luciferase into 
mice. The ICG coupled nanocarrier was then delivered parenterally. The ICG NIR 
fluorescence distribution pattern was reported to overlap with the luciferin bioluminescence, 
indicating the potential of the NIR fluorescent dye-coupled nanocarrier as a prospective 
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tumour imaging candidate [126]. In another approach, a NIR cyanine dye (Cy5.5) in 
conjugation with NHS with a potent Prostate-Specific Membrane Antigen (PSMA) inhibitor 
was utilised [127]. The probe was reported to display high potency against PSMA and 
demonstrated successful application for precisely labelling PSMA-positive prostate cancer 
cells in two and three dimensional cell culture conditions. The results indicated that a NIR 
Cy5.5-PSMA inhibitor conjugate (Figure 1.19) could be utilised for detection of prostate 
tumour cells by in vivo optical imaging [127]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.19: NIRF Conjugate Cy5.5-PSMA. 
 
 
 
 
 
1.18 Click Chemistry 
 
 
Improving and advancing the field of molecular imaging agents will require new chemistry 
techniques. Because imaging agents are often developed by the coupling of molecular entities 
with different but complementary functionality, the use of more refined and reliable covalent 
coupling  reactions  is  necessitated  [128].  Recently,  a  unique  class  of  coupling  reactions 
termed  “click  chemistry”  has  attracted  tremendous  amount  of  interest  in  the  field  of 
chemistry. Click chemistry was first fully introduced by Sharpless et al, and it can be defined 
as an integrated technique that utilises only the most feasible and consistent chemical 
transformations [129]. Its usage is often found in all aspects of drug discovery, starting from 
lead discovery through combinatorial chemistry to proteomics and DNA research, utilising 
bioconjugation reactions [130]. Click chemistry is predominantly used as a powerful linking 
reaction, due to its high level of specificity, dependability, and the complete bio-compatibility 
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of the reactants. The reactions are usually associated with high yields, with minimal side 
products that are easily removed by non-chromatographic techniques such as distillation or 
crystallisation. The reactions are also easy to perform being non sensitive to oxygen and 
water and utilise solvents that are easily removed or benign like water [130]. Though usually 
mistaken with a single reaction, 1,3-dipolar cycloaddition (CuAAC), “click chemistry” refers 
to a concept of how to do chemistry [131]. Numerous reactions including CuAAC, Diels- 
Alder reactions, nucleophilic substitution chemistry (such as the ring-opening chemistry of 
epoxides),  carbonyl  chemistry  (such  as  thiourea  formation),  and  oxidative  additions  to 
carbon-carbon multiple bonds (such as expoxidations) [132, 133] were identified to fulfil the 
click chemistry criteria such as minimal side products and hence can be categorised as click 
chemistry [126-131]. 
 
With the increasing interest in developing new synthetic approaches to construct chemically 
modified DNA for use in biological applications, it has quickly become apparent to 
researchers in the synthetic biology field that the Cu(I) catalysed [3+2] azides-alkyne 
cycloaddition reactions possess enormous potential [134]. The characteristics of click ligation 
reaction that are potentially useful for synthetic biology include: 
 
• Azides and alkynes can be readily attached to nucleic acids without disturbing or 
changing their biophysical properties [132]. 
• The resulting triazole unit is particularly stable, being resistant to both hydrolysis and 
redox reactions [135]. 
• Azides and unactivated alkynes are almost totally unreactive towards the functional 
groups  encountered  in  nature;  they  react  only  with  each  other.  Figure  1.20  and 
Scheme 1.14 show the basic CuAAC click reaction and the Cu(I) catalysed click 
reaction cycle  [132]. 
 
 
 
Cu(I) 
Ligand 
 
 
 
 
Scheme 1.14: The CuAAC reaction between an azide and a terminal alkyne to 
produce a 1,4-triazole [132]. 
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The Cu(I) are usually introduced by the reduction of Cu(II) salts by sodium ascorbate or 
ascorbic acid (5-10 mol%). The Cu(II) salts are reasonably cheap making this synthetic route 
preferable [136]. 
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Figure 1.20: Proposed mechanism for Cu(l) catalysed click reaction between an azide and a 
terminal alkyne [136]. 
 
 
 
 
The reaction mechanism is divided into two pathways. The first pathway is the direct [2+3] 
cycloaddition  and  the  second  pathway  is  the  stepwise  progression  (B1-B2-B3).  Most 
recently, click chemistry has been used to incorporate alkyne functions into oligonucleotides 
and label them with dye azides. One strategy of carrying out this reaction is to introduce the 
fluorophore post-synthetically by reacting an alkyne-labelled DNA oligonucleotide with an 
azide derivative of a fluorescent dye, since the alkynes and azides are very stable functional 
groups except when reacting with each other. Wagnenknecht and co-workers have recently 
utilised this strategy, incorporating an alkyne moiety into oligonucleotides and labelling them 
with dye azides to give fluorescent dye oligonucleotide conjugate M1 (blue) and M2 (red) 
[137] (Scheme 1.15). 
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Scheme 1.15: Dye labelling at 2-position of ribose in DNA oligonucleotide using the CuAAC 
 
reaction [137]. 
 
 
 
 
 
Recent research has also shown that the CuAAC is a direct and robust method to couple a 
large variety of imaging agents to other functional entities [138]. Such entities include azide 
and  alkyne–containing  analogues  of  metabolic  precursors  such  as  monosaccharides  and 
amino acids [138-140]. It is envisaged that in the future, there will be more novel molecular 
imaging applications of “click chemistry” and these applications will in turn help fuel the 
development of new and sophisticated molecular targeting imaging agents. 
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2.0 Near-Infrared Absorbing Heptamethine Cyanine Dyes 
 
 
Near-infrared fluorescent dyes are molecules that absorb in the NIR region, 700-1000 nm. 
They can be efficiently used to visualise and study in vivo molecular targets because most 
tissues produce little autofluorescence in the NIR region [141]. NIR fluorescent dyes 
developed for in vivo imaging of cellular targets offer new opportunities in the field of 
molecular imaging [142]. The NIR fluorescent dyes have a highly conjugated molecular 
structural system with the energy gap between the ground and the excited state being lower 
than the dyes which absorbs in the visible region [141]. Currently, there are four main types 
of NIR fluorescent dyes commonly used in optical imaging, namely: cyanine dyes, squaraine 
dyes, thiazine and oxazine dyes [143-146]. The fluorescence mechanism of NIR fluorescent 
dyes  relies  on  the  transition  of  electrons  between  molecular  electronic  states.  When  an 
electron absorbs a photon from a radiation source of the right wavelength, the electron is 
promoted from its singlet ground state to its singlet excited state and the electron can return to 
its original state (singlet ground state) either directly or via molecular vibration. A photon is 
usually emitted when the electron returns directly to the singlet ground state and this is 
known as fluorescence. However, no radiation is produced when the electron returns by 
molecular vibration (Figure 2.1). In addition, energy is usually released when the electron 
returns to the singlet ground state. The energy change of excitation (∆Eex) is generally larger 
than the energy change of emission (∆Eem) thereby, generating a longer wavelength for the 
emission radiation than the excitation [147]. 
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Figure 2.1: Jablonski diagram showing Electronic transition energy level [148]. 
 
 
 
 
 
2.1 NIR fluorescent cyanine dye characteristics 
 
 
Indocyanine Green (Figure 2.2) has attracted a great deal of attention in the industrial and 
academic world. ICG is a typical non-targeting tricarbocyanine dye showing long-wavelength 
absorption  around  800  nm  and  830  nm  emission  maxima.  It  was  first  introduced  into 
medicine in 1957 by Fox and co-workers [149] and its first application was in measuring 
cardiac output [150]. ICG was later adopted as a method of measuring hepatic blood flow and 
function [151]. When dissolved in blood, ICG has shown affinity for proteins such as Human 
Serum Albumin (HSA) and lipoproteins. Although ICG is a non-specific agent that is rapidly 
cleared from the blood, it frequently accumulates in regions of dense vascularity through 
extravasation [151]. 
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Figure 2.2: Indocyanine Green (ICG). 
 
 
 
 
 
ICG and its analogues  have also been  explored as imaging agents in various aspect of 
surgical medicine [13, 152, 153]. For example, it has been applied for decades in 
ophthalmology for imaging retinal blood vessels, i.e. in retinal angiography [154, 155], for 
imaging sentinel node mapping in gastric cancer [156] and for evaluation of breast lymphatic 
pathways in patients with breast cancer [157]. Tumour targeting by fluorescence imaging is a 
result of a series of events occurring at the molecular level. The overall outcome is that a 
fluorescent molecule absorbs light within a molecular-specific absorption band and then 
emits light isotropically at a longer wavelength. The wavelength shift accompanying the 
fluorescence emission together with the isotropic nature of the emission facilitates 
discrimination between excited and emitted light in fluorescence imaging [158]. ICG has 
been used clinically for over 20 years with some drawbacks such as its cytotoxicity, non- 
specific binding and low fluorescence quantum yields (of 0.01) [159, 160]. Therefore, the 
development of new fluorescent dyes is important for medical research. Non-targeting NIR 
fluorescent heptamethine cyanine probe used for biomedical applications need to comply 
with several important criteria, as follows: 
 
1) Wavelength: All potential NIR fluorescent dyes should be designed to absorb at 
wavelengths between 700-900 nm (diagnostic window) where there is enhanced tissue 
penetration (of approximately 5-10 mm) and less interference from other endogenous 
absorbers such as oxy and deoxyhaemoglobin, lipids and water. Below 700 nm, light does not 
penetrate to the maximum distance through tissues because of scattering and the presence of 
other endogenous absorbers. Above 900 nm water absorbs and therefore reduces the light 
penetration efficiency of the dye [161]. 
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2) Quantum yield: Fluorescence quantum yield (ɸ) is one of the most important 
characteristics of a NIR fluorescent dye and having a high quantum yield is a major 
characteristic that the dye must possess. Fluorescence quantum yield can be defined as the 
level of effectiveness with which absorbed light creates the desired effect. It can also be 
defined as the percentage of photons emitted to those which are absorbed. The maximum 
fluorescence quantum yield is 1.0 (100%) indicating all photons emitted are absorbed [162]. 
 
3) Toxicity and Clearance: The safety of NIR fluorescent dyes is of paramount importance. 
It is critical to ensure that the imaging probe does not significantly interfere with the living 
subject in an acutely or chronically toxic manner. An optimal dye for biomedical application 
should have no toxic effects on cells and should clear rapidly, since uncleared free dye will 
interfere with the background light and hence affect its performance. Another important 
factor to be considered when designing tumour imaging dyes is the half-life of the dye in the 
human system. This is normally governed by the lipophilic or hydrophilic character of the 
dye. It is a well-established fact that hydrophilic dyes are rapidly cleared from the biological 
system but the lipophilic dyes are usually metabolised in order to generate more hydrophilic 
derivatives. This implies that a more lipophilic dye will remain for longer periods within the 
system, consequently increasing the chances of a deleterious event such as killing of normal 
cells [18, 159]. 
 
4) Solubility: NIR fluorescent dyes must have a high level of aqueous solubility before being 
administered into tissues for tumour visualization. A good level of solubility reduces the 
tendency of aggregates to form. One way of increasing the aqueous solubility of a dye is by 
the attachment of a sulfonic acid group on the dye structure [18, 199, 202]. 
 
5) Photobleaching: An ideal NIR fluorescent dye should be chemically stable under various 
conditions. Photobleaching, also known as fading, is a phenomenon which occurs when a dye 
loses its ability to fluoresce as a result of photon induced chemical damage. It results in a 
dramatic loss of the fluorescence emission intensity of most dyes [18, 197, 198]. 
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2.2 Fission Yeast 
 
 
To a test a number of the properties required by NIR dyes, non-targeting molecular probes 
can be tested in vitro (with extracts of cells) and in vivo using intact cells in cell assays. 
Testing the non-targeting probes with intact cells helps to determine some of the biological 
effects of the probes, such as toxicity. These techniques, in combination with modern 
molecular biology methods allows for a better understanding of the interactions between the 
molecular probes and the living subject [163]. 
 
In biology, the word yeast is usually used when referring to a wide variety of different single- 
celled  fungi.  Fission  yeast  (Figure  2.3)  also  known  as  Schizosaccharomyces  pombe  (S. 
pombe) is a species of yeast which has been extensively employed as a model organism in 
molecular and cell biology for investigating the fundamental processes significant to all 
living organisms [164]. There is a high degree of similarity between the cellular processes in 
yeast and those of human cells [164], which has resulted in the successful application of 
fission   yeast   as   a   model   organism   for   mammalian   diseases   and   pathways.   These 
characteristics of yeast are considered in combination with its technical advantages, such as 
low cost, ease of growth and maintenance, reproducibility and the drive towards a reduction 
in the use of animal models in research. Fission yeast also gives the advantage of testing cell 
permeability and toxicity at the same time [165]. 
 
Yeast-based assays have been extensively used for measuring the activity of proteins and for 
detecting and characterising novel compounds with molecular interactions [166]. The easy 
genetic  manipulation  of  yeast  makes  it  an  ideal  system  for  investigating  the  effects  of 
multiple mutations on cellular proliferation. These assays can immediately select against 
compounds that are cytotoxic and can also provide information on cell stability, permeability 
and solubility of the inhibitor [166]. Measurement of the reduction in cell proliferation has 
been used to characterise growth inhibition of established and new chemical entities such as 
chemical probes, which preferentially target proliferating cells [167]. 
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Figure 2.3: The electron tomogram of a complete S. pombe yeast cell [168]. 
 
 
 
 
 
2.3 Recent Developments in Heptamethine Cyanine Dyes for Tumour Imaging 
 
 
Amongst the available NIR dyes, heptamethine cyanine dyes have shown great potential for 
tumour imaging, due to their excellent biocompatibility and photophysical properties [169]. 
A vast amount of research is currently focused on increasing their tumour-targeted specificity 
by conjugating the fluorophores to targeting molecules known to bind to certain cell surface 
receptors that are expressed in tumour cells [171]. Also, on-going efforts are being made to 
develop targeted tumour photosensitisers conjugated to heptamethine cyanine dyes. The 
resulting bifunctional agents will be used for tumour imaging and photodynamic therapy. 
Such compounds which can be applied for imaging and therapeutic purposes would create a 
new paradigm for tumour diagnosis and therapy [191]. In this section, a perspective on the 
synthesis, photophysical characteristics, imaging and therapeutic potential of selected cyanine 
dyes will be briefly discussed. 
 
Recent studies have focused on the design and development of new NIR fluorescent dyes 
with improved photophysical properties for in vivo imaging applications. For example in 
2002, Tung and co-workers reported the synthesis of four new highly stable NIR dyes (Figure 
 
2.4) with the aim of improving their photophysical and photochemical properties. The dyes 
were designed with a monoreactive carboxyl end group for labelling purposes [169]. 
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Figure 2.4: NIR dyes synthesised by Tung and co-workers [169]. 
 
 
 
 
 
The NIR dyes (Figure 2.4) contain multiple hydrophilic groups and were synthesised as 
monohydroxyl succinimide esters for binding to biomolecules such as proteins, metabolites 
and other affinity ligands. The synthesised dyes were characterised to be highly stable, 
possessing high quantum yields and excellent water solubility. In another report, Cheng and 
co-workers synthesised a series of novel NIR 3H-indocyanine dyes with varying N- 
substituents (Figure 2.5). The dyes were synthesised and tested to investigate the relationship 
between structures and photophysical properties in order to develop potential NIR dyes with 
excellent photostability for fluorescent imaging applications [170]. 
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Figure 2.5: Structures of novel NIR cyanine dyes synthesised by Cheng and co-workers 
 
[170]. 
 
 
 
 
 
The NIR dyes which had an electron-donating group on the N-atom of the 3H-indolenine ring 
were reported to be effective in attaining greater resistance to photobleaching than those with 
electron-withdrawing groups. The NIR dyes showed absorption and emission maxima at 782- 
786 nm and 807-814 nm and fluorescence quantum yields ɸ within the range of 0.10-0.15 in 
methanol. The effects of varying the substitution pattern on the photostability for different 
substituents on the N-position was reported to decrease within the series from O5> 
O2>O3>O1>O6>O4  [170].  Nagao  and  co-workers  have  described  the  synthesis  and 
reactivity of a novel NIR fluorescent labeling reagent, ICG amide derivative of 1,3- 
thiazolidine-2-thione (ICG-ATT) possessing 3-acyl-1,3-thiazolidine-2-thione (ATT) (Figure 
2.6) [171]. 
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Figure 2.6: Novel NIR fluorescent labelling reagent synthesised by Nagao and co-workers 
 
[171]. 
 
 
 
 
 
It was concluded that ICG-labelled proteins can be utilised for tumor imaging applications 
due to their excellent fluorescence [171]. Recently, Aibin and Liping synthesised a 
heptamethine cyanine-based sensor. The sensor was designed by integrating a heptamethine 
cyanine fluorophore and methylpiperazine (Figure 2.7) [172]. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.7: Heptamethine cyanine dye sensor synthesised by Aibin and Liping [172]. 
 
 
 
 
 
The sensor was reported to exhibit excellent responses to changes in pH levels (Scheme 2.1) 
and Stoke shift value of around 100 nm. Fluorescent imaging experiments were also 
performed in living cells to demonstrate the potential of the sensor for in vivo applications in 
biological systems [172]. 
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Scheme 2.1: Proposed binding mode between NIR sensor and H+ [172]. 
 
 
 
 
 
The experiments in living cells were carried out using V79 379A Chinese hamster cells. The 
results obtained from the experiments indicated that the sensor penetrated the cell membrane 
and could be used for imaging of H+ and detecting changes in H+ concentration in biological 
systems [172]. The synthesis of a range of structurally diverse NIR absorbing dyes has been 
reported by Samuel Achilefu and co-workers [173]. Studies were carried out to primarily 
determine the effects of structural changes on the Fluorescent Life Times (FLT) of the dyes. 
Figure 2.8 shows the diverse range of dyes synthesised [173, 174]. The report indicated that 
the comparative FLT analysis based on solvent showed that the FLT of the polymethine dyes 
increased from polar to non-polar solvents. Also, analysis based on the heterocyclic structural 
system and modification of the methine chain length indicated that dye P1 exhibited longer 
FLT than P3 and this effect could be attributed to the influence of both the heterocyclic 
system and the short polymethine chain [145]. Nucleophilic substitution on the meso-chlorine 
atom in IR 820 with a phenyl carboxyl to give compound P1 was also reported to increase 
the FLT from 0.48 to 0.98 nm in dimethyl sulfoxide (DMSO). This result demonstrated that 
not only the presence of the heavy-atom mediated intersystem crossing but a combination of 
different criteria can also play a role in determining the FLTs of NIR dyes. It was also 
observed that the presence of a bulky ring system in dye P1 gave shorter FLT than in dye P4, 
indicating the presence of the bulky phenyl group in P1 destabilises the excited state in 
comparison to dye P4 which has no phenyl group. The effect of different substituents at 
heterocyclic  ring  system  of  the  NIR  dyes  was  also  investigated.  The  results  obtained 
indicated that the presence of a heavy-atom plays an important role in the FLT of the NIR 
dyes, since the substitution of carbon with sulfur or selenium in P5 and P6 gave an increased 
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FLT. It was then concluded that the presence of heavy-atoms in the ring system facilitated 
 
inter system crossing [145]. 
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Figure 2.8: Structures of NIR fluorescent dyes synthesised by Achilefu and co-workers 
 
[173]. 
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Patonay and co-workers have synthesised and investigated the effect of varying the alkyl 
group length substituted on the indole nitrogens on the spectroscopic properties of cyanine 
dyes [175]. The molar absorptivities (ε) were determined by the Beer-Lambert law and 
fluorescence quantum yields were calculated using the relative method [175]. Two diverse 
classes of cyanine dyes were investigated:  pentamethine cyanine dyes and the ring-stabilised 
heptamethine cyanine dyes (Figure 2.9). The two classes of cyanine dyes with different 
“backbones” which differed mainly in terms of the substitution and length of the polymethine 
chain were selected as models to ensure that the observed results were broadly applicable to a 
variety of cyanine dyes. 
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Figure 2.9: Structure of pentamethine and heptamethine cyanine dyes studied by Patonay and 
co-workers [175]. 
 
 
 
 
Based on the results obtained, the authors generalised that increasing the chain length of the 
R substituents on the heterocyclic indole nitrogen has little or no effect on the quantum yields 
and the molar absorptivities of the cyanine dyes. Likewise, the addition of sulfonate groups to 
the ends the alkyl N-substituents does not alter the quantum yield. The lack of influence on 
quantum yield may be attributed to the fact that the N-substituents are not directly conjugated 
to the chromophore and hence have little or no influence on the internal conversion-type 
energy loss. Also, the short chain substituents do not provide enough steric hindrance to 
interfere with photoisomerisation to cis-cyanine. The effects of these results are significant to 
the development and synthesis of new cyanine dyes [175]. 
 
Reactive Oxygen Species (ROS) have been reported to operate as signalling molecules under 
a wide range of physiological conditions. The over production of ROS results in oxidative 
stress and is involved in the pathogenesis of many diseases such as cancer and neurological 
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disorders [176-178]. Hence, fluorescent probes for visualising ROS offer new opportunities 
for the investigation of molecular mechanisms of physiological and pathological process and 
might also be suitable for diagnosis. To this end, Nagano and co-workers have reported the 
synthesis of a novel fluorescent probe, FOSCY-1 (Figure 2.11) which operates in the 
physiologically favourable NIR region [179]. The probe consists of two cyanine dyes that 
react differentially with ROS connected by a linker. Reaction of the more labile dye with 
ROS results in intramolecular fluorescence quenching of the less labile dye. Firstly, they 
investigated  whether  cyanine  dyes  themselves  react  with  various  ROS  by  addition  of 
hydroxyl  radical  (•OH),  peroxynitrite  (ONOO-),  or  hypochlorite  (-OCl)  to  a  phosphate 
 
buffered solution of commercially available cyanine dyes, Cy5 and Cy7 (Figure 2.10). The 
absorption of the dyes in the NIR region was lost, whilst little absorption spectral change was 
observed in the presence of oxygen and hydrogen peroxide (H2O2), which are weaker 
oxidants. The reactivity of the cyanine dyes with ROS in terms of the percentage absorbance 
was also investigated. This was reported to decrease at the maximum wavelength after ROS 
addition. There was a clear difference of reactivity between Cy5 and Cy7 with Cy7 being 
more labile than Cy5. 
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Cy7COOH 
 
 
 
Figure 2.10: Structures of purchased or synthesised Cy5 derivatives and Cy7 derivatives by 
 
Nagano and co-workers [179]. 
 
 
 
 
 
The findings were also used to develop a novel NIR fluorescence probe. Emphasis focused 
on the differential reactivity of cyanine dyes using two linked cyanine dyes to obtain an 
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oxidative stress sensor (FOSCY-1) (Figure 2.11). Using this strategy, the two most suitable 
cyanine dyes with respect to reactivities were selected. IR786S and Cy5SO3H showed a 
large  difference  in  ROS  reactivity,  with  IR786S  reacting  favourably  with  ROS  in  the 
presence of equal amounts of the two dyes. Hence, the two dyes were adopted and linked 
together through a cyclohexanediamine linker, yielding the sensor FOSCY-1 [146,180]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.11: FOSCY-1 [180]. 
 
 
 
 
 
The absorption peaks were observed at 644 and 792 nm indicating the presence of Cy5SO3H 
and IR786S, respectively. The absorbance and fluorescence of FOSCY-1 were very stable 
with respect to pH change or photooxidation, showing that FOSCY-1 could detect ROS with 
high reliability in living cellular systems [179, 180]; thus, indicating its suitability for 
detection of ROS in chemical and enzymatic systems. The probe also demonstrated that it is 
suitable for detection of extracellular ROS as it appears to be almost membrane-impermeable 
[180]. Keli Han and co-workers have also developed a NIR reversible fluorescent probe 
bearing an organoselenium functional group that can be used for monitoring the highly 
sensitive  and  selective  peroxynitrite  oxidation  and  reduction  events  under  physiological 
conditions  [181].  ONOO-   is  controlled  by  a  cellular  antioxidant  defence  system,  the 
 
antioxidant enzyme glutathione peroxidase (GPx) in which selenium is a constituent of the 
active site [145, 182, 183]. GPx catalyses the reduction of ONOO- using glutathione (GSH) 
via a unique ping-pong mechanism [184]. A NIR fluorescent cyanine dye with a high 
extinction coefficient, was selected as a signal transducer, whilst 4-(phenylselenyl)aniline 
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(PSe) was selected as modulator since it usually responds selectively to ONOO- [185, 186]. 
Using the ping-pong mechanism, the authors designed and synthesised a new NIR reversible 
fluorescent probe (Cy-PSe) (Scheme 2.2) for detection of ONOO-  in living cells through a 
fast induced Photoinduced Electron Transfer (PET) process. 
 
 
 
 
 
 
 
ONOO- 
PET X 
GSH 
 
 
 
 
 
 
Cy-PSe Cy-PSeO 
Scheme 2.2: Cy-PSe [185]. 
 
 
 
 
 
The probe demonstrates little autofluorescence in biological systems and also shows minimal 
toxicity to cells. It can also be utilised for the real-time imaging of living cells. In summary, 
the results indicated that the Cy-PSe probe can be used to visualise intracellular peroxynitrite 
levels with insignificant amount of background fluorescence and cellular toxicity [181]. 
Recently, a series of unique heptamethine cyanine dyes (IR-783 and MHI-148) have been 
synthesised by Yang and co-workers (Figure 2.12a and b). The dyes were reported to be 
retained in cancer cells, and not normal cells, in tumour xenografts and transgenic mice 
[187]. They discovered that the dyes were localising in the mitochondria and lysosomes of 
cancer cells, possibly through Organic Anion Transporting Peptides (OATP), since the dye 
uptake and retention in cancer cells can be blocked totally by bromosulfophthalein (BSP). 
OATP are well established as routes for the transport of a wide range of substrates, including 
hormones, bile acids, xenobiotics, and their metabolites [188-191]. 
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IR-783 
Na+  
MHI-148 
 
 
Figure 2.12(a) and (b): IR-783 and MHI-148 [187]. 
 
 
 
 
 
Tan and co-workers recently reported the improved chemical synthesis (Scheme 2.3) and 
biological activity of an already existing heptamethine cyanine dye (IR-808). The dye was 
shown for first time to exhibit intrinsic preferential tumour accumulation, photosensitising 
activity and NIR imaging without the need for chemical conjugation [192]. The advantages of 
the dye include excellent optical properties and photostability in serum. This allows for clear 
visualisation of cancer cells and tissues, with negligible background fluorescence from the 
host tissue, achieving superb signal to background ratio. The dye also possesses good 
pharmacokinetic properties and can be rapidly cleared from the host without any toxicity 
issues. The unique tumour accumulation and superior photosensitising characteristics make 
the  dye  particularly  suited  for  targeting,  imaging  and  PDT  of  minor  tumours  at  their 
formation stage. 
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(1) DMF, POCl 3, 5 h 
 
(2) H2O, r.t. 
 
 
EtOH / NaOAc 
 
70 °C, 1 h 
 
Br(CH2)5COOH 
 
1,2-C6H4Cl2 
110 °C, 10 h 
 
 
IR-808 
 
 
 
 
 
 
Scheme 2.3: Synthesis of IR-808 by Tan and co-workers [192]. 
 
 
 
 
 
Maged and co-workers recently synthesised three heptamethine cyanine dyes using a facile 
one-pot synthetic methodology (Scheme 2.4) [193]. The reaction protocol yielded a mixture 
of three symmetric and asymmetric heptamethine cyanine dyes bearing various N-indolenine 
substituents, a dicarboxylic acid (DA), a monoester (ME), and a diester (DE). The dyes were 
isolated and purified using column chromatography [193]. The biological activities of the 
dyes were also investigated to determine their tumour cell toxicity and uptake selectivity. It 
was discovered that the esterified heptamethine cyanine dyes (monoester and diester) were 
selectively cytotoxic to cancer cells and not to normal fibroblast cells. This effect could be 
attributed to the fact that esters are more readily transported across cellular membranes [193]. 
The heptamethine cyanine dyes were also used in confocal fluorescence imaging to confirm 
the tumour cell targeting potentials of the dyes. 
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Br(CH2)5COOH 
(CH3CO)2O,  reflux 3 hr 
 
MeCN, 
reflux 18 hr 
 
2. MeOH 
 
 
 
 
R1OOC  
 
2 
 
 
[DE]: R1  = R2  = Me (15%) 
[ME]: R1  = H, R2  = Me (30%) 
[DA]: R1  = R2  = H (20%) 
COOR2 
 
 
Scheme 2.4: Synthetic protocol for the one pot synthesis of symmetrical and unsymmetrical 
heptamethine cyanine dyes (DE, ME and DA) [192]. 
 
 
 
 
At present, there is still many on-going research aimed at developing new NIR heptamethine 
cyanine dyes that require no conjugation to targeting molecules for their delivery [194 -196]. 
Furthermore, these new developments will go a long way to assist primary tumour resection 
and improve the chances of complete removal of all tumour tissues while sparing surrounding 
healthy tissues during surgical procedures. 
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2.4 Aims and Concept 
 
 
The aim of this project is to develop three different families of Cy7 dyes (linear, rigid and 
polymethine substituted) and experimentally compare their photophysical and growth 
inhibition characteristics against two classical NIR imaging dyes: The clinical standard ICG 
and IR-820.The focus will be on the dyes bearing sulfonic acids due to their close link with 
both ICG and IR-820. The project goal being to develop a range of non-targeted Cy7 imaging 
dyes which can be used alongside the clinical standards in biochemical research. 
 
For these dyes to be considered for clinical application, dye candidates must have: 
 
 
1.   An economical and simplistic synthetic route, delivering the Cy7 dyes in good yields 
with straightforward purification. 
2.   Display better fluorescence quantum yields and comparable Stokes shifts to ICG and 
 
IR-820. All dyes must absorb and emit in the NIR region (700-900 nm). 
 
3.   Show less or comparative growth inhibition on cells upon comparison with ICG and 
 
IR-820. 
 
With the above criterion in mind the specific objectives are: 
 
 
1.   The synthesis of linear, rigid and polymethine substituted heptamethine cyanine dyes. 
 
These synthesised dyes will contain a basic cyanine structure. Also, the dyes will also 
possess good leaving groups such as chlorine and bromine atoms making them 
potentially multifunctional agents for conjugation and functionalisation with 
biomolecules of interest. 
2. Experimental photophysical evaluation of each dye by absorption and emission 
wavelengths, fluorescence quantum yields and Stokes shifts. The photophysical 
properties of dyes are important characteristics which determine their effective use as 
molecular probes for clinical applications. 
3. Undertake    comparative    growth    inhibitory    studies,    performed    using 
Schizosaccharomyces pombe (S. pombe), a eukaryotic microorganism previously used 
for growth inhibitory screening and providing an important and valuable screening 
tool for determination of dye toxicity. 
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  CHAPTER THREE  
 
 
Synthesis and Characterisation. 
 
 
 
 
3.0 Results and Discussion 
 
 
This research project has been divided into three main sections which are outlined below: 
 
 
1.   Synthesis of non-targeted NIR heptamethine cyanine dyes. 
 
The rigid cyanine dyes were synthesised in accordance with published protocols [199, 
 
259, 260] along with methodology which has been developed during this project. To 
expand, the in-situ cascade reaction within this novel methodology is a modification 
of the Zincke reaction and provides an elegant approach to the linear cyanine dyes, 
which can be tailored to develop more structurally sophisticated cyanine dyes, an 
example of which can be seen in Figure 3.15. Purification has been performed using 
either  recrystallisation  or  column  chromatography.  Standard  analytical  techniques 
such as 1H, 13C NMR, ESI, HRMS, IR, UV and melting point analysis has been used 
 
for structural elucidation. 2D COSY NMR was also used to show coupling where 
required. One problem encountered with the characterisation part of this thesis was 
the difficulty in obtaining 13C NMR for the rigid and linear dyes. These difficulties 
could be attributed to solubility issues and formation of aggregates in solution by the 
rigid and linear dyes. 
 
2.   Photophysical characterisations of the non-targeted NIR dyes. 
 
Photophysical characterisation for each dye was based upon, absorption and emission 
(excitation at 785 nm), fluorescence quantum yield (ɸ) and Stoke shifts. Each of the 
dyes was analysed alongside ICG and IR-820 due to their structural similarities. 
 
 
3.   Growth inhibition screening of the non-targeted NIR dyes. 
 
Comparative growth inhibition studies was performed using Schizosaccharomyces 
pombe (S. pombe), a eukaryotic microorganism used for growth inhibition screening 
[164]. It provides an important and valuable screening tool for determination of dye 
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toxicity [165]. This is important, should these dyes show potential for clinical 
applications. Using S. pombe as a model for mammalian cells is advantageous as 
many cellular processes are highly conserved between the two [164, 165]. Cell 
permeability and growth inhibition can be tested simultaneously and S. pombe strains 
are low in cost, easy to grow and the results obtained are highly reproducible [165]. 
The photophysical and growth inhibition data for each dye synthesised will be 
evaluated in chapter four. 
 
 
The cyanines are N-substituted heterocyclic dyes with an extendable polymethine backbone 
which allows variations in their absorption profile; this is due to a bathochromic shift of 
approximately 100 nm per vinylene moiety (CH=CH) [38]. The heptamethine cyanine (Cy7) 
dyes in particular are among the most common NIR fluorescent dyes, showing high molar 
absorption coefficients and fluorescent quantum yields in organic solutions [40]. However, in 
aqueous solution many cyanine dyes suffer from poor photostability, low quantum yield, 
undesired aggregation and mild fluorescence [197]. Adapting these dyes to incorporate a 
rigid cyclohexenyl ring in the polymethine backbone increases their photostability and 
fluorescence quantum yield [39]. It has been recorded that addition of electron- 
donating/withdrawing groups on the nitrogen of 3H-indolenine affects the photostability of 
the cyanine dyes and by substituting the central chlorine atom on the cyclohexene ring for an 
electron-donor group such as amines can enhance the photostability of these dyes [198, 36, 
41]. 
 
 
To this end, three classes of heptamethine cyanine dyes (rigid, linear and substituted 
polymethine linear dyes) (Figure 3.1) have been synthesised and their suitability as non- 
targeting probes for imaging in biological systems is evaluated and presented. Three distinct 
variations can be seen (X, R1, R2) with a final variation being shown along the polymethine 
backbone (R3 – R4). The reasons for such are highlighted below: 
 
1. (X = S or 2 x C(CH3)2). It is well documented that sulfur moiety can exhibit a 
heavy atom effect and dramatically enhance intersystem crossing to the triplet 
state leading to alterations of the fluorescence quantum yield [145, 173]. It is 
also known that sulfur moiety can shift the absorption into the red by approx. 
20  nm  as  shown  in  Table  4.4.  The  gem-  dimethyl  functionality  on  the 
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indolenine   moiety   allow   comparisons   to   be   made   against   the   sulfur 
functionalities present in the benzothiazole moiety (Table 3.1) 
 
2. (R1). Extending the alkyl chain length on the tertiary nitrogen (n=1 to 10, 
where n= alkyl salts). It has been shown in Table 4.1 that above n=4 the alkyl 
chains tend to make these compounds cytotoxic and as such, only alkylation 
from n=1 to 4 have been accomplished on the dyes synthesised. Many 
hepatmethine cyanine dye molecules tend to form aggregates in aqueous 
solution, specifically when inorganic salts are present. These aggregates 
typically have absorption bands shifted to the blue and, usually have a weak 
fluorescence [199]. It has been reported that cyanine dyes with a sulfonate 
group attached to the heterocyclic ring system of the dye have a minimal 
tendency to form these aggregates [202]. The sulfonate groups attached to the 
alkyl moiety of the indolenine nuclei of the dyes have little or no effect on the 
chromophore, but have been reported to increase the photostability, and 
aqueous solubility [197, 199, 202]. 
 
3. (R2). The potential heavy atom effects will be observed if different functional 
groups (such as Cl) are attached at this position. 
 
4. Its well noted that altering the rigidification of the polymethine chain is an 
established approach for improving the chemical and photostability of NIR 
dyes [173, 175]. 
 
Each of the dyes prepared are structurally related to each other so direct comparisons can be 
made. 
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X- X- 
 
 
 
 
 
 
 
X- 
 
 
 
Figure 3.1: Structures of synthesised heptamethine cyanine dyes. 
See Table 1.1 for values of X and R 
 
 
 
3.1 N-Alkylation on the heterocyclic indole nitrogen 
 
 
3.1.1 N-Alkylation of 2,3,3-trimethylindolenine and 2-methylbenzothiazole 
 
 
The synthesis of the N-alkylated 2,3,3-trimethylindolenine (1 a-m) and 2- 
methylbenzothiazole (2 a-m) salts was straight forward and required no harsh or unusual 
methodology, as shown in Scheme 3.1. The salts were prepared by alkylation with the 
corresponding alkyl/benzyl halides or sultones, to afford the N-alkylated salts (bromides or 
iodides) in excellent to poor yields as shown in Table 3.1. For compounds with linear alkyl 
chains lengths less than n=4, the alkyl iodides (e.g. iodomethane) were used, whereas for 
chains greater than n=5, alkyl bromides (e.g. 1-bromopentane) were used [appendix]. It’s 
interesting to note that compounds 1 a-d and k-m precipitated from the reaction mixture and 
were isolated by vacuum filtration. This was also the case for all the N-alkylated 2- 
methylbenzothiazole  salts   (2   a-m).   Compounds   1   e-j  however,   show   an   increased 
hygroscopic nature which was attributed to the bromide counter ion. To counteract this 
problem, a counter ion exchange was performed based on the Finkelstein reaction to yield the 
iodide salts which are not as hygroscopic as the bromides; thus easier to handle and work 
with from a biological viewpoint. The counter ion exchange was straightforward and required 
refluxing the bromide salts with a stoichiometric amount of sodium iodide in acetone. 
Precipitation of sodium bromide followed, which was collected by filtration followed by 
evaporation of the liquor under reduced pressure yielded compounds 1 e-j as the iodide salt. 
The synthesis of the full set of compounds (1 a-m and 2 a-m) is shown in the experimental 
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section for clarity. The 1H NMR spectra were consistent with the literature report and all 
 
synthesised  compounds  displayed  downfield  shifted  signals  (range:  δ  3.90  –  4.05  ppm) 
 
corresponding to the CH2-N moiety. 
 
 
i 
 
Reflux X- 
 
1 a-m and 2 a-m 
 
i. Alkyl halides in MeCN or Toluene or neat 
 
 
Scheme 3.1: Synthetic route to yield N-alkylated salts (see Table 3.1 for values of X-, X and R). 
 
 
Number   
 
x- 
Number  
 
X- 
X- R % Yield X- R % Yield 
1a I- CH3 58 2a I- CH3 87 
1b I- CH2CH3 86 2b I- CH2CH3 41 
1c I- CH2CH2CH3 94 2c I- CH2CH2CH3 81 
1d I- CH2(CH2)2CH3 67 2d I- CH2(CH2)2CH3 33 
1e I- CH2(CH2)3CH3 38 (99) 2e I- CH2(CH2)3CH3 11 
1f I- CH2(CH2)4CH3 22 (99) 2f I- CH2(CH2)4CH3 7 
1g I- CH2(CH2)5CH3 19 (86) 2g I- CH2(CH2)5CH3 10 
1h I- CH2(CH2)6CH3 11 (40) 2h I- CH2(CH2)6CH3 15 
1i I- CH2(CH2)7CH3 20 (27) 2i I- CH2(CH2)7CH3 9 
1j I- CH2(CH2)8CH3 53 (99) 2j I- CH2(CH2)8CH3 6 
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1k Br- CH2C6H5 77 2k Br- CH2C6H5 7 
1l - - CH2CH2CH2SO3 63 2l - -
 CH2CH2CH2SO3 91 
1m - - CH2CH2CH2CH2SO3 50 2m - - CH2CH2CH2CH2SO3 51 
Table 3.1: Preparation of N-alkylated indolium/benzothiazole salts. 
 
*N akylated salts 1e-m ( C >5) data taken from allied project which has been 
published in Eur. J. Med .Chem which can be found in Appendix . 
 
 
 
 
 
 
3.1.2 N-Alkylation of 1,1,2-trimethylbenz[e]indole 
 
 
The synthesis of the N-alkylated 1,1,2-trimethylbenz[e]indole salts (3 a-g) was of strategic 
importance to the project, due to the fused benzene ring also being present in ICG and IR820. 
The synthetic route to these compounds is shown in Scheme 3.2 with Table 3.2 showing the 
% yields. Based on the cytotoxicity data collected (section 4.3) for the N-alkylated 2,3,3- 
trimethylindolenine (1 a-m) and 2-methylbenzothiazole (2 a-m) compounds, N-alkylation for 
these compounds was only to n=4. 
 
 
 
 
i 
 
Reflux X- 
 
3 a-g 
(see Table 3.2 for values of X- and R). 
 
i. Alkyl halides in MeCN or Toluene or neat 
 
 
Scheme 3.2: Synthetic route to yield N-alkylated 1,1,2-trimethylbenz[e]indole salts. 
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Number  
 
 
X- 
X- R % Yield 
3a I- CH3 91 
3b I- CH2CH3 89 
3c I- CH2CH2CH3 81 
3d I- CH2(CH2)2CH3 66 
3e Br- CH2C6H5 65 
3f - CH2CH2CH2SO3- 65 
3g - CH2CH2CH2CH2SO3- 28 
Table 3.2:  Preparation of 1,1,2-trimethylbenz[e]indole salts. 
 
 
 
 
 
 
 
3.1.3 N-Alkylation of 2-methylnaphtho[2,1-d]thiazole 
 
 
N-Alkylation of 2-methylnaphtho[2,1-d]thiazole (Figure 3.2) was attempted, however only 
alkylation with iodomethane was observed in low yield. This was accomplished under 
microwave conditions (heating at 150 °C for 1 h under neat conditions) using iodomethane. 
It should be noted that normal wet conditions were attempted, however, no product was 
isolated from the reaction mixture. It is postulated that the nucleophilic nature of the sulfur 
group has an effect in the N-alkylation of the tertiary nitrogen and thus the presence of the 
aromatic ring causes enhanced steric bulk resulting in only a basic methyl iodide methylation 
being accomplished. 
 
 
 
 
 
 
 
 
 
 
Figure 3.2: 2-Methylnaphtho[2,1-d]thiazole. 
 
 
 
 
 
3.2 Activation of indolium or benzothiazole salts 
 
For the rigid or linear heptamethine cyanine dyes to be synthesised, activation of the methyl 
group on position 2 of the indolium or benzothiazole salts must occur as shown in Scheme 
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3.3. This can be accomplished under Schotten-Baumann conditions, although this can also be 
 
done in-situ. Both conditions are explained further in 3.2.1 and 3.2.2 respectively. 
 
 
 
 
 
 
 
 
 
Scheme 3.3: Activation of the methyl group. 
 
 
 
 
 
 
 
3.2.1 The Schotten-Baumann Method. 
 
 
The Schotten-Baumann method is usually applied to the synthesis of amides as shown in 
Scheme 3.4. This historical method has been somewhat over-shadowed due to the potential 
problems of using an acid chloride in the presence of aqueous sodium hydroxide. 
 
 
 
 
NaOH H2O, 
CH2Cl2 
 
 
Scheme 3.4: Schotten-Baumann method of synthesis of amides. 
 
 
 
Activation of the methyl group in position 2 of the indolium or benzothiazole salts can also 
be accomplished using this method as it does not suffer the same problems as the 
aforementioned acid chloride. The mechanism is shown in Scheme 3.5 and works using a 
biphasic set-up of 2M NaOH and toluene. The indolium salt dissolves first into the basic 
aqueous phase and following deprotonation, the newly formed 1,3,3-trimethyl-2- 
methyleneindoline is driven into the organic toluene layer. Isolation of the toluene layer and 
concentration under reduced pressure yields activated methylene groups in high yield usually 
being deep red in colour. 
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Bas ic Aqueous Phas e Organic Phas e 
 
Scheme 3.5: Synthetic route to yield 2-methyleneindoline. :B = Base 
 
 
Problems do however exist with this method; the composition of the product is often very 
sticky and tar-like, thus leading to subsequent handling problems. 
 
 
 
 
 
3.2.2 The in situ method 
 
 
Alternatively, this reaction can be done in situ during the synthesis of the dye, with the base 
being added during reflux (for the rigid dyes) or at room temperature (for the linear or 
substituted polymethine). This is usually the best way of preparing these types of dyes and as 
such has been used during this project. One drawback of this method is that unlike the 
Schotten-Baumann method, the activation of the methyl group does not always go to 
completion, affording lower dye yields. 
 
 
 
3.3 Synthesis of the Rigid Heptamethine Cyanine Dyes 
 
 
Rigidification of the polymethine chain is accomplished by incorporating a rigid cyclohexane 
moiety, examples of which are shown in Table 3.3. In order for this to be done a Vilsmeier- 
Haack (VH1) intermediate must be synthesised as highlighted in section 3.3.1. 
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3.3.1 Synthesis of Vilsmeier-Haack intermediate (VH1) 
 
 
 
 
 
 
 
81% 
VH1 
 
i. POCl3 / DMF; ii. Aniline / EtOH; iii H2O / HCl 
 
 
Scheme 3.6: Synthetic route to yield VH1. 
 
 
 
 
 
The Vilsmeier-Haack intermediate (VH1) was synthesised using a previously reported 
procedure [199]. The Vilsemeier-Haack reagent is an iminium salt which possesses a weak 
electrophilic characteristic and is formed in the reaction between POCl3 and an amide as 
shown in Scheme 3.6. The Vilsemeier-Haack reagent is then added with cyclohexanone and 
aniline, followed by an acid workup affords VH1. The reaction as whole involves the drop 
wise addition of POCl3 (acid chloride) to a solution of anhydrous DMF and stirring them 
together at room temperature to form the reaction intermediate (Vilsmeier reagent) as a dark 
yellow solution. The next step is the addition of the cyclohexanone, followed by refluxing the 
combined mixture together to form a dark red mixture which is then allowed to cool down to 
room temperature. The final step is an exothermic reaction involving the drop wise addition 
of aniline in ethanol, followed by the acidic hydrolysis of the reaction mixture using dilute 
HCl and water to form the product in good yield of 81% (Scheme 3.6). The 1H NMR was 
 
consistent with the literature report and the NH peaks were noticed as broad singlet peaks at δ 
 
11.5 ppm. Further support for the structure was given by [M+H] peak in the ESIMS. 
 
 
The structures and codes of the dyes with the rigid cyclohexane moieties are shown in Table 
 
3.3 for clarity. 
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Code Structure Code Structure 
 
4 (a-g) 
 
 
 
X- 
 
7 (a-f) 
 
 
 
X- 
 
5 (a-g) 
 
 
 
X- 
 
8 (a-e) 
 
 
 
 
X- 
6 (a-g)  
 
 
 
X- 
 
Table 3.3: Structure of dyes with rigid cyclohexane moiety. 
X- = I- or Br- 
 
 
 
 
 
3.3.2 Synthesis of rigid dyes 4 a-g 
 
The rigid cyanine dyes (4 a-g) were synthesised using an aldol-like condensation reaction as 
shown in Scheme 3.7. 
 
 
 
i 
 
X- 
 
i. VH1, NaOAc, EtOH  
(4 a-g) 
 
 
Scheme 3.7: Synthesis of the rigid meso-chloro indolium heptamethine cyanine dyes (4 a-g). 
X- = I- or Br- 
 
 
 
The crude dyes were purified by crystallisation from hexane or using flash chromatography 
to afford the dyes all in solid forms (Table 3.4). 
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Code  
 
 
X- 
 
 
4 a-g 
X- R % Yield 
4a I- CH3 36 
4b I- CH2CH3 64 
4c I- CH2CH2CH3 54 
4d I- CH2(CH2)2CH3 25 
4e Br- CH2C6H5 14 
4f - CH2CH2CH2SO3- 69 
4g - CH2CH2CH2CH2SO3- 46 
Table 3.4:  Preparation of rigid indolium heptamethine cyanine dyes (4 a-g). 
 
 
 
 
 
This reaction involves refluxing 4 a-g with VH1, in ethanol in the presence of sodium acetate 
as shown in Scheme 3.7. Sodium acetate acts as a base catalyst forcing the deprotonation or 
proton abstraction of the methyl proton in the indolium salts to form the nucleophile. This 
step was accompanied by a colour change (yellow to red) during the reaction, indicating the 
formation  of  the  nucleophile,  which  attacks  the  Vilsmeier-Haack  salt  acting  as  the 
electrophile in the reaction to form the crude heptamethine cyanine dye. During the 
nucleophilic attack step, the reaction mixture changed colour to a green solution indicating 
the slow formation of the dye. It should also be noted that the electron-withdrawing effect of 
the quaternary nitrogen plays a significant role in the deprotonation step and this is evident 
from the proposed mechanism for 4a (Scheme 3.8). 
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Scheme 3.8: Proposed mechanism for formation of heptamethine cyanine dye. 
 
 
It is apparent from the reaction mechanism, the reaction for dye production will proceed in a 
 
2 (quaternary ammonium salt) to 1 (VH1) stoichiometric ratio, to obtain the heptamethine 
cyanine dyes (4 a-g). The 1H NMR splitting pattern shown for each dye in this family (4 a-g) 
is very precise (due to its symmetrical nature), each showing the expected 4H protons present 
on the polymethine backbone as doublets, each with a trans-coupling constant of 12 - 15 Hz. 
Also shown, is the 12H proton integral (4 x CH3) as a large singlet between 1.5 - 1.8 ppm and 
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the 6H protons for rigid cyclohexene moiety, often observed as multiplets around 1.8 - 3.0 
ppm. Each member of this family differs only in the N-alkylation substituents attached onto 
the quaternary nitrogen. To visually expand on this, Figure 3.3 shows the 1H NMR spectrum 
of compound 4f. Due to solubility issues, all the dyes within this thesis have been analysed 
using d6-DMSO as solvent. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3: 1H NMR spectra of 4f in d6-DMSO. 
 
 
 
 
 
To  expand  further  on  the  1H  NMR  of  compound  4f,  the  protons  in  the  conjugated 
polymethine chain, gives two unique separate doublets at 6.49 ppm (J = 14.0 Hz) and 8.22 
ppm (J = 14.0 Hz). The degree of the vicinal coupling constant indicates the all-trans 
characteristics of the polymethine chain. The large difference in the chemical shifts of the 
polymethine protons is due to the variation of charge along the conjugated cationic π-electron 
system. The N-alkylated side chain defines each dye within this family with 4f having a linear 
propyl sulfonic acid side chain. Due to the molecular symmetry, the linear chain shows a 
well-defined set of signals when looking at the 1H NMR with the N-CH2 signals. 
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3.3.3 Synthesis of rigid dyes 5 a-g 
 
The synthesis of the rigid benzothiazole cyanine dyes (5 a-g) was accomplished using the 
same reaction methodology and stoichiometry as for compounds 4 a-g and is shown in 
Scheme 3.9. 
 
 
i 
 
X- 
 
i. VH1, NaOAc, EtOH  
(5 a-g) 
 
 
Scheme 3.9: Synthesis of the rigid meso-chloro benzothiazolium heptamethine cyanine dyes 
(5 a-g), X- = I- or Br-. 
 
Purification either by recrystallisation or flash chromatography yielded the pure dyes in 
moderate to low yields (Table 3.5). This reaction proceeded faster in comparison to the 
indolenine dyes as noted by the rapid colour change of the reaction mixture from pale red to 
dark green. A possible explanation of this could be down to the nucleophilic character of the 
sulfur group. 
 
The benzothiazole heptamethine cyanine dyes featuring two benzothiazole rings linked by a 
polymethine chain, possess the greatest potential for use in visualisation of cellular changes 
occurring in-vivo due to their excellent biocompatibility [200]. Patonay and coworkers have 
previously reported that heptamethine cyanine dyes bearing sulfur atoms within their 
heterocyclic ring system bind preferentially to human serum albumin (HSA) binding sites and 
furthermore, the sulfur atom on the heterocyclic ring system could enhance the specificity of 
the dye molecule [201]. Waggoner and coworkers have also reported that the presence of 
sulfonate groups on the aromatic rings of the dyes helps to increase aqueous solubility and 
thereby reduces aggregation [202]. 
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Number   
X- R % Yield 
5a I- CH3 51 
5b I- CH2CH3 60 
5c I- CH2CH2CH3 63 
5d I- CH2(CH2)2CH3 38 
5e Br- CH2C6H5 54 
5f - CH2CH2CH2SO3- 15 
5g - CH2CH2CH2CH2SO3- 42 
Table 3.5: Prepartion of rigid benzothiazolium heptamethine cyanine 
dyes (5 a-g). 
 
 
 
 
Upon comparing the 1H NMR of 5e to 4f it is clear to see differences in their structrual 
features. Noteably the 12H proton integral (4 x CH3) as a large singlet between 1.5 - 1.8 ppm 
in 4f is now absent in 5e owing to the replacement of the sulfur moiety. It is also notable that 
the 6H cyclohexane protons which were shown as non-defined multiplets in 4f are now 
shown as very prominent multiplets. The main difference comes from the 10H proton integral 
from the aromatic N-benzyl moiety off the benzothiazole ring. The Ph-CH2-N protons in the 
1H NMR spectra of 5e are equivalent and appear as a prominent singlet at δ 5.74 ppm, while 
 
the aliphatic region only indicates the presence of the cyclohexane protons confirming the 
presence of the benzothiazole dye. 5e was further subjected to 2D COSY NMR analysis 
(Figure 3.4) to show further confirmation of the structure. Accurate mass analysis (HRMS) 
was also performed on 5e to further emphasise on the purity of the compound. Figure 3.4b 
shows the accurate mass spectra for 5e 
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Figure 3.4: 2D COSY spectra of 5e in d6-DMSO. 
 
 
 
 
 
Figure 3.4b: Accurate mass spectra of 5e. 
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3.3.4 Synthesis of rigid dyes 6 a-g 
 
 
The synthesis of the benz[e]indolium heptamethine cyanine dyes was carried out by heating 
various N-substituted 2,3,3-trimethyl benz[e]indolium salts (3 a-g) with VH1 in the presence 
of sodium acetate and ethanol under reflux (Scheme 3.10). The crude dyes were purified by 
silica gel column chromatography to afford the dyes all in solid forms (Table 3.6). 
 
 
 
 
 
i 
 
X- 
 
i. VH1, NaOAc, EtOH  
(6 a-g) 
 
 
Scheme 3.10: Synthetic route to yield benz[e] indolium heptamethine cyanine dyes (6 a-g). 
X- = I- or Br- 
 
 
 
Number  
 
 
 
 
X- 
 
6 a-g 
X- R % Yield 
6a I- CH3 29 
6b I- CH2CH3 58 
6c I- CH2CH2CH3 72 
6d I- CH2(CH2)2CH3 45 
6e Br- CH2C6H5 20 
6f - CH2CH2CH2SO3- 70 
6g - CH2CH2CH2CH2SO3- 79 
Table 3.6: Preparation of Benz[e] indolium heptamethine cyanine dyes (6 a-g). 
 
 
 
 
 
The benz[e]indolium based heptamethine cyanine dyes have been reported to increase the 
extent of π-electron conjugation of the heptamethine scaffold [173]. The increase in 
conjugation shifts the absorption wavelength of the dyes to the longer wavelength region 
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[175]. The presence of the extra phenyl ring on the dye molecule increases the planarity of 
the  molecule,  which  reduces  the  chances  of  aggregation  and  in  turn  decreases  the 
fluorescence excited state of the dye. As previously mentioned these dyes were strategically 
made as these structurally mimic IR-820 due to the fused benzene ring. The fused benzene 
ring leads to an increased bathochromic shift by approximately 20 nm into the red when 
compared to 4 a-g. 
 
The 1H NMR spectra indicates the presence of extra aromatic protons belonging to the 
benz[e]indolium aromatic moiety (see Chapter 6). 
 
 
 
 
3.3.5 Synthesis of rigid functionalised dyes 7 a-g 
 
 
Previously Peng and co-workers had reported that tricarbocyanine dyes bearing an amine 
group at the central position of the polymethine bridge possess larger Stokes shifts than the 
non-substituted tricarbocyanines, owing to intramolecular charge transfer (ICT) [203, 204]. 
The large Stokes shift characteristic of the amine-substituted cyanine dyes renders them 
useful as NIR platforms for the development of a wide range of non-targeting fluorescent 
probes [203]. This will be discussed further in Section 4.4.4. It was envisaged that the 
presence of secondary nitrogen at the meso-position would improve the spectral properties 
and also have an effect on the growth inhibition properties of the synthesised dyes. The 
heptamethine cyanine dye structures are frequently modified at the meso-position to enhance 
and improve their cellular uptake, binding interactions, pH sensitivity and solubility [204]. 
Understanding the chemistry of how these modifications may impact the activity and spectral 
properties of the dyes is an important criterion for designing novel compounds with specific 
functional and binding properties. 
 
The synthesis of dyes with the aniline moiety in place of the chlorine atom, involves the 
treatment of the heptamethine cyanine dyes 4 a-g in anhydrous DMF under an atmosphere of 
nitrogen with ten equivalents of aniline (Scheme 3.11). A polar aprotic solvent such as DMF 
is suitable for this reaction since it helps in increasing the rate of the reaction. 
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Aniline 
 
DMF, 85 °C 
X- X- 
 
 
 
Scheme 3.11: Synthetic route to yield meso-anilino derivatives of indolium based 
heptamethine cyanine dyes (7 a-f), X- = I- or Br-. 
 
 
 
The crude dyes were purified by flash chromatography to afford the dyes all in solid forms 
with moderate to poor yields (Table 3.7) and in high purity. 
 
 
 
 
 
Number   
 
X- 
X- R % Yield 
7a I- CH3 30% 
7b I- CH2CH3 35% 
7c I- CH2CH2CH3 43% 
7d Br- CH2C6H5 17% 
7e - CH2CH2CH2SO3- 33% 
7f - CH2CH2CH2CH2SO3- 40% 
Table 3.7: Preparation of meso-anilino derivatives of indolium based heptamethine cyanine 
dyes (7 a-f). 
 
 
 
 
Upon the addition of aniline to the dye, the reaction mixture was heated under reflux at 85 ⁰C 
overnight to afford the crude product. The progress of the reaction was monitored 
continuously by TLC and visual appraisal due to a hypsochromic (shortwave) colour shift 
from green to blue as the electron-withdrawing chloro group is being replaced by an electron- 
donating amino group (Figure 3.5). The crude product was purified by column 
chromatography on silica gel to give the product with yields in the range of 17% to 43%. The 
conjugate dyes were stable at room temperature. The 1H NMR data (Figure 3.6) supports the 
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presence of a bound aniline molecule, which is best exemplified by the Ph-NH signal 
appearing at 8.62 ppm as a broad singlet peak (see Chapter 6). Inspection of the IR spectra of 
7a-f shows N-H stretches at 2920 - 2928 cm-1 appearing in form of a shoulder band. The C-N 
 
stretch appears at around 1232 - 1240 cm-1 rather than at lower wave numbers due to the 
presence of the bound aniline molecule. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.5: Colour change accompanying the substitution process. 
 
 
The proposed mechanism for the reaction (Scheme 3.12) proceeds by the direct addition of 
the nucleophile to the cationic π-system followed by the subsequent elimination of the 
chlorine ion. The reaction occurs slowly upon gradual heating and prolonged reaction time. 
 
 
Ph-N..H2 
 
.. + 
 
 
 
-HCl 
 
 
 
 
 
 
 
 
 
Scheme 3.12: Proposed mechanism to yield meso-anilino derivatives of indolium based 
heptamethine cyanine dyes. 
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3.3.6    Synthesis of rigid functionalised dyes 8 a-g 
 
 
The meso-chlorine atom on the heptamethine scaffold of the benz[e]indolium heptamethine 
cyanine dye was treated with aniline in the presence of DMF to furnish the resulting anilio 
derived  benz[e]indolinium  heptamethine cyanine dyes  (8  a-e)  (Scheme  3.13).  The butyl 
iodide and propanesultone derived meso-anilino dyes were unable to be synthesised due to 
solubility and purification issues. The crude products were purified by column 
chromatography on silica gel (chloroform/methanol 90:10) to give the pure products (Table 
3.8). All the synthesised dye conjugates were stable at room temperature. 
 
 
 
 
 
 
 
 
Aniline 
 
DMF, 85 °C 
 
 
 
 
Scheme 3.13: Synthetic route to yield meso-anilino derived benz[e]indolinium heptamethine 
 
cyanine dyes (8 a-e), X- = I- or Br-. 
 
 
Number  
 
 
 
X- 
X- R % Yield 
8a I- CH3 44% 
8b I- CH2CH3 34% 
8c I- CH2CH2CH3 38% 
8d Br- CH2C6H5 38% 
8e - CH2CH2CH2CH2SO3- 40% 
Table 3.8: Preparation of meso-anilino derivatives of benz[e]indolinium heptamethine 
cyanine dyes (8 a-e). 
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The 1H NMR spectra (Figure 3.6) shows the presence additional aromatic proton and Ph-NH 
 
signal belonging to the aniline moiety. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.6: 1H NMR spectra of 8e in DMSO. 
 
 
 
 
 
3.3.7 Attempted synthesis of meso-anilino derivatives of benzothiazole based 
heptamethine cyanine dyes. 
 
Several attempts to synthesise the meso-anilino derivatives of the benzothiazole based 
heptamethine cyanine dyes (Scheme 3.14) failed. It is postulated that this effect could be 
due the nucleophilic nature of the sulfur atom in the heterocyclic ring system. The synthesis 
of the derivative was therefore discontinued. 
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DMF, 85 °C 
 
 
Aniline 
X- 
 
10 
Scheme 3.14: Attempted synthesis of meso-anilino derivatives of benzothiazole based 
heptamethine cyanine dyes. 
 
 
 
 
3.4 Synthesis of the linear heptamethine cyanine Dyes. 
 
 
The linear or straight chain polymethine dyes are widely used in a large range of applications 
due to their excellent photophysical properties and low toxicity [205]. ICG (Figure 3.7) is a 
commercially available symmetrical Cy7 dye approved by the Medicines and Healthcare 
Products Regulatory Agency and the United States Food and Drug Administration. It is used 
in clinical applications, in particular, evaluating blood flow [205-207] and clearance [1]. 
Although  it  also  has  the  potential  as  a  tool  for  fluorescence-guided  management  and 
treatment of cancer [208, 209]. 
 
 
 
 
 
 
 
 
 
ICG 
 
 
 
 
- - Na+ 
 
Figure 3.7: ICG 
 
 
 
Symmetrical Cy7 dyes are usually prepared using a one-step condensation reaction with the 
appropriate indolium salt containing an activated methyl group in the 2-position in the 
presence of glutaconaldehyde dianil monohydrochloride  (Figure 3.8). 
81 
Synthesis and Characterisation  
 
 
 
 
 
 
 
 
 
 
Figure 3.8: Glutaconaldehyde dianil monohydrochloride 
 
 
 
The glutaconaldehyde dianil monohydrochloride is usually purchased as the trans isomer. In 
the presence of the indolium salts (2 molar stoichiometric ratio) under basic conditions yields 
the symmetrical Cy7. Scheme 3.15 shows the synthetic route to yield ICG. 
 
 
 
 
 
Toluene Base/Ethanol  
ICG 
 
 
 
- 
 
Scheme 3.15: Synthetic route to yield ICG. 
- Na+ 
 
 
 
Asymmetrical Cy7 dyes on the other hand require a modification to their synthesis. Such 
dyes are generally synthesised in accordance with Scheme 3.16 below, as per the literature 
methodology (step 1) [210], (step 2) [211], (step 3) [212]. The asymmetric Cy7 dyes require a 
slightly different synthetic approach, requiring two condensation reactions as shown in 
Scheme 3.16. The first step is straight forward and requires activation of the indolium salt 
using base catalysis to yield the activated methyl group in position 2. This is usually 
accomplished using Schotten-Baumann conditions as previously discussed, which 
subsequently  reacts  with  glutaconaldehyde  dianil  monohydrochloride  in  the  presence  of 
acetic acid and acetic anhydride to yield intermediate IO (Scheme 3.16). It should be noted 
that asymmetric dyes are useful labelling agents (usually via a Azide-Alkyne Huisgen 
Cycloaddition) due to the large amount of selectivity which can be obtained. 
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Toluene AcOH/Ac2O 
 
Step 1 Step 2 
IO 
 
 
 
Step 3 Ethanol / Base 
 
 
 
 
 
 
 
 
 
 
 
Scheme 3.16: Synthetic route to yield asymmetrical Cy7 dyes. 
 
 
 
 
3.4.1 Linear cyanine dyes via an in-situ cascade reaction 
 
 
The Cy7 dyes are very expensive to buy/produce, partly owing to the high cost of the 
glutaconaldehyde dianil monohydrochloride. There has long been a need for an improved 
synthetic methodology to reduce the costs of manufacturing such dyes. In particular, current 
synthetic methodologies to develop the Cy7 dyes suffer from the following drawbacks: 
 
• Low yields of the final dye compounds. 
 
 
• Low purity of the final dye compounds. 
 
 
• Prevalence of the less desirable cis-isomer (Z-isomer) of the dye compound. 
 
 
• Purification   difficulties   with   respect   to   both   the   glutaconaldehyde   dianil 
monohydrochloride and the dye compound. 
 
• Complexities of isolating intermediates. 
 
 
• Difficulties and inconsistencies on scale-up. 
 
 
• Laborious and complex processing. 
 
 
• Large energy input required (e.g. heating at reflux in Step 2). 
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• Long reaction times. 
 
 
Having mentioned all these limitations, there is need for the development of a new and 
improved synthetic methodology to solve the aforementioned problems. As a result, the 
inspiration to develop a more efficient synthesis has led us to the development of a cascade 
reaction based on the Zincke reaction [218, 219] (Scheme 3.17). 
 
 
 
 
 
NaOAc 
 
Ethanol 
 
 
 
 
Scheme 3.17: Novel synthetic route to linear or straight chain heptamethine cyanine dye. 
X- = I- or Br-. 
 
 
 
The cascade reaction provides a one-pot process, in which the reactive intermediate is formed 
in situ, which in turn reacts in situ with the activated alkylated salts. The pyridinium salt ring 
opens to give the activated Zincke salt. This produces the linear heptamethine cyanine dyes 
(Table 3.10) in moderate yields, and in a manner which avoids undesirable by-product 
formation. 
 
The new synthetic methodology takes place in a protic solvent system such as ethanol. Also, 
the reaction according to the newly developed synthetic protocol is base catalysed (Scheme 
3.17). The base increases the reactivity between the alkylated salts and the pyridinium salt (or 
reactive intermediates derived there from e.g. Zincke-type intermediates). The base is 
preferably a weak base (i.e. sodium acetate). The reaction takes place substantially at ambient 
room temperature. This is significantly advantageous over existing methodologies, which 
require a significant amount of heat to effect the reaction between the alkylated salts and a 
Zincke-type intermediate. This method was used during the synthesis of all the linear dyes 
reported in this thesis. 
 
The newly developed synthetic methodology is also a cheap and efficient route to producing 
the linear heptamethine cyanine dyes which are otherwise very expensive to produce or 
purchase commercially. It is envisaged that the newly developed synthetic methodology will 
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help fuel further research in the development of distinct heptamethine cyanine molecular 
probes. The solution to the drawbacks of the existing synthetic methodologies essentially 
involves combining Steps 1, 2 and 3 (shown in Scheme 3.15) into a single one-pot process. 
Scheme  3.21  illustrates  the  postulated  mechanism  for  the  newly  developed  synthetic 
methodology. The success of this “one-pot” procedure was particularly surprising given that 
multiple by-products were expected. 
The newly developed synthetic methodology advantageously provides: 
 
• Compounds in moderate yield (over the three steps). 
 
• Compounds in high purity. 
 
• Compounds which are easier to purify to produce a product specification suitable for 
use in medical applications due to the versatility of the synthetic protocol. 
• Resource efficient and simple processing. 
 
• A process which requires no burdensome isolation of intermediates. 
 
• A low energy route to the yield the linear heptamethine cyanine dyes (e.g. which 
requires no heat input). 
• A very fast process, since reaction times are very fast (4 – 10 h). 
 
Another excellent characteristic of this cascade reaction is that the polymethine chain can be 
functionalised by using a wide range of commercially available pyridines (Schemes 3.18, 
3.19 and 3.20). 
 
 
 
 
 
 
 
 
 
 
 
NaOAc 
 
Ethanol 
 
 
 
 
Scheme 3.18: Synthetic route to yield distinct novel Cy7 dye bearing a phenyl ring on the 
polymethine chain. 
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NaOAc 
 
Ethanol 
 
 
 
 
Scheme 3.19: Synthetic route to yield distinct novel Cy7 dye bearing a chloro group on the 
polymethine chain. 
 
 
 
 
 
 
 
 
 
NaOAc 
 
Ethanol 
 
 
 
Scheme 3.20: Synthetic route to yield distinct novel Cy7 dye bearing a methyl group on the 
polymethine chain. 
 
 
 
 
Until now regioselective functionalisation was not possible on the polymethine backbone. 
There are of course limitations to these reactions. Nucelophilic functional groups (amines, 
hydroxyl and thiols) cannot be used during this reaction, also due to the nature of the Zincke 
reaction, carbonyls also cannot be used. However this can be overcome by functional group 
protection. This allows scope to accomplish the addition of carbohydrates since cancer cells 
need more energy to divide and thus take in sugar to create this energy. Furthermore, DNA 
aptamers and antibodies could also be added to the polymethine backbone. 
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Scheme 3.21: Proposed mechanism for formation of linear heptamethine cyanine dye (9a). 
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3.4.2    Pyridine Salt formation 
 
 
Pyridinium salts are versatile class of compounds utilised as cationic surfactants [213], 
initiators of cationic polymerisation [214], antimicrobials [215], acylating agents [216] and 
precursors to the formation of Zincke salts used in the synthesis of NIR dyes [217-219]. The 
Zincke salts are valuable group of conjugated dienes, derived from the ring opening reaction 
of pyridinium salts [220]. The ring-opening reaction itself dates back to more than a century 
to the pioneering work of Zincke and Konig [217-219]. The pyridinium salts resulting from 
the ring-opening reaction have proven to be useful synthetic building block and versatile 
precursor to many biologically active compounds. The Zincke reaction (Scheme 3.22) is 
overall an amine exchange process that converts pyridinium salts to the Zincke salts upon 
treatment with aniline [220]. It should be noted at this point that the glutaconaldehyde dianil 
monohydrochloride can be synthesised using the pyridinium salt as shown in Scheme 3.22 in 
the presence aniline in 80% aqueous ethanol. However this reaction is problematic and if not 
controlled carefully, leads to the unwanted bi-product 2,4-dinitroaniline usually after ten 
minutes of adding the aniline. Our method removes the use of aniline and as mentioned 
previously allows the pyridine to be further functionalised. 
 
 
 
 
.. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Zincke salt 
 
Scheme 3.22: Zincke reaction. 
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The formation of the pyrdinium salts (Scheme 3.23) is straightforward and high yielding as 
indicated by the synthesis of (2,4-dinitrophenyl)pyridinium chloride. The salts precipitated 
directly from the reaction mixture in high purity, in this instance, 76%. 
 
 
 
 
 
 
Acetone / Reflux 
 
 
 
Scheme 3.23: Synthetic route to yield pyrdinium salts 
 
 
 
 
To highlight the versatility of this reaction, a small selection of polymethine substituted 
cyanine dyes were prepared. These are highlighted in Section 3.4.7. Table 3.9 highlights the 
structures and yields of the pyridinium salts used to making the linear Cy7 dyes. 
 
 
 
 
 
Number  
R1 R2 % Yield 
PY1 H H 76% 
PY2 Me H 69% 
PY3 Br H 79% 
PY4 Cl H 79% 
PY5 H Ph 81% 
Table 3.9: Pyridinium salts. 
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The cyanine dyes formed from the functionalised pyridinium salts (PY1-PY5) were N- 
alkylated with alkyl sulfonic acids in order for photophysical and biological comparisons to 
be made between the synthesised Cy7 dyes and ICG. A typical structure for these types of 
dyes is shown in Figure 3.9 below and highlights the use of PY3 in the reaction. 
 
 
 
 
 
 
 
 
 
 
 
 
Na+ 
 
 
Figure 3.9: Substituted Polymethine linear Cy7 dye (13). 
 
 
 
 
 
3.4.3 Synthesis of linear dyes 9 a-g 
 
 
The structures and codes of the linear Cy7 dyes are shown in Table 3.10 for clarity. See 
 
Tables 3.11, 3.12 and 3.13 for values of R. 
 
 
 
Code Structure 
 
9 (a-g) 
 
 
 
X- 
 
10 (a-g) 
 
 
 
X- 
 
11 (a-g) 
 
 
 
 
X- 
Table 3.10: Synthesised linear Cy7 dyes. 
X- = I- or Br-. 
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The dyes were synthesised and purified by silica gel column chromatography to afford the 
 
dyes in good to moderate yields as shown Table 3.11 
 
 
Number  
 
 
X- 
X- R % Yield 
9a I- CH3 28% 
9b I- CH2CH3 47% 
9c I- CH2CH2CH3 66% 
9d I- CH2(CH2)2CH3 31% 
9e Br- CH2C6H5 21% 
9f - CH2CH2CH2SO3- 60% 
9g - CH2CH2CH2CH2SO3- 73% 
Table 3.11: Synthesised linear indolium heptamethine Cy7 dyes. 
 
 
The 1H NMR spectra of 9a is shown in Figure 3.10 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.10: 1H NMR spectra of 9a in d6-DMSO. 
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The molecular structures of 9 a-g are closely related and will be discussed together. In 
regards to the 1H NMR spectrum of 9a, the molecular symmetry of the structure is highly 
evident from the coupling patterns of the protons within the molecule. The signals of the 
alkyl hydrogen moiety are easily recognised, N-CH3 protons (s, 6H) at 3.58 and gemdimethyl 
(s, 12H) at 1.62 ppm. The signals shown for the polymethine backbone exhibited trans 
coupling constants indicating that the electronic charges are distributed alternately on the 
conjugated on the polymethine chain. Further views of 9a are depicted in 2D COSY NMR 
(Figure 3.11) indicating the coupling patterns of the molecule. 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.11: 2D COSY spectra of 9a in d6-DMSO. 
 
 
 
 
 
3.4.4    Synthesis of linear dyes 10 a-g 
 
 
The linear cyanine dyes (10 a-g) were synthesised once again using the Zincke type cascade 
reaction as shown in Scheme 3.24. The reactions progressed more rapidly in comparison to 
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dyes 9 a-g and this can possibly be attributed to the nucleophilic nature of the sulfur in the 
 
benzothiazole subunit. 
 
 
 
 
 
NaOAc, EtOH 
 
 
(10 a-g) 
 
 
 
Scheme 3.24: Synthetic route to yield linear benzothiazole heptamethine cyanine dyes. 
 
The dyes were synthesised and purified by silica gel column chromatography to afford the 
dyes in good to moderate yields as shown Table 3.12 
 
 
Number  
X- R % Yield 
10a I- CH3 78% 
10b I- CH2CH3 46% 
10c I- CH2CH2CH3 66% 
10d I- CH2(CH2)2CH3 44% 
10e Br- CH2C6H5 60% 
10f - CH2CH2CH2SO3- 46% 
10g - CH2CH2CH2CH2SO3- 47% 
Table 3.12: Synthesised linear benzothiazole Cy7 dyes. 
 
 
 
 
 
The 1H NMR spectra data (Figure 3.12) was consistent with the structure of the linear 
benzothiazole heptamethine cyanine dye. 
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Figure 3.12: 1H NMR spectra of 10e in d6-DMSO. 
 
 
 
 
 
3.4.5 Synthesis of linear dyes 11a-g 
 
 
 
 
 
 
NaOAc 
 
Ethanol 
 
 
 
 
Scheme 3.25: Synthetic route to yield benz[e]indolium heptamethine cyanine dyes. 
 
 
 
 
 
The synthesis of the linear benz[e]indolium heptamethine cyanine dyes (11 a-g) was 
accomplished using the various N-substituted 2,3,3-trimethyl benz[e]indolenine salts (3 a-g) 
with the pyridinium chloride salt in the presence of sodium acetate and ethanol at room 
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temperature. The crude dyes were purified by silica gel column chromatography to afford the 
 
dyes all in solid forms with moderate to poor yields as shown in Table 3.13. 
 
 
Number  
X- R % Yield 
11a I- CH3 37% 
11b I- CH2CH3 19% 
11c I- CH2CH2CH3 20% 
11d I- CH2(CH2)2CH3 28% 
11e Br- CH2C6H5 17% 
11f - CH2CH2CH2SO3- 32% 
11g - CH2CH2CH2CH2SO3- 28% 
Table 3.13: Synthesised linear benz[e]indolium Cy7 dyes (11 a-g). 
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The 1H NMR spectra (Figure 3.13) confirms the presence of extra aromatic protons belonging 
to the benz[e]indolium aromatic moiety. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.13: 1H NMR spectra of 11a in d6-DMSO. 
 
 
 
 
The IR spectra of the linear dyes are quite similar and therefore they will be discussed 
together. Although the IR spectra of heptamethine cyanine dyes have been reported to be 
complex [222], the characteristic functional absorption bands can be relatively assigned. The 
aromatic absorption appears at 1620-1590, 1580-1520, (ѵC=C) and 860-800 (ѵC=H), 770- 
730. In addition, the resonance-conjugated unsaturated stretching modes in the chromophore 
 
appear at 1520-1480 and 1440-1420 cm-1. The chromophoric CH out-of-plane bending (ѵ- 
CH=CH-) appears around 980-920 cm-1. 
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3.4.6 Substituting across the polymethine backbone 
 
 
Additional compounds bearing substituents on the polymethine backbone were also 
synthesised to further illustrate the applicability of the novel one pot synthetic methodology 
as highlighted in Section 3.4.1. 
 
The synthetic route is shown in Scheme 3.26 and has the potential to allow a great deal of 
new dyes to be synthesised. As already discussed, there are limitations to this method, 
however these could be dealt with using functional group protection. 
 
 
 
 
 
 
NaOAc 
 
Ethanol 
 
 
 
Scheme 3.26: Synthetic route to yield substituted heptamethine cyanine dye bearing methyl 
group on the polymethine chain. 
 
 
 
 
Table 3.13 shows the structure of some of the diverse dyes synthesised. Emphasis was placed 
on altering the nature of the substituting group on the polymethine chain, but keeping the N- 
alkyl chains as sulfonic acids. This allowed direct comparisons to be made against ICG. It 
was anticipated that having different electron donating and electron withdrawing groups on 
the polymethine chain would affect the photophysical and growth inhibitory properties of the 
dyes. It is was envisaged that these new dyes would possess better spectral properties than the 
currently available commercial dye (ICG), thereby leading to the development of new non- 
targeting heptamethine cyanine molecular probes bearing various conjugation points for 
linking of targeting molecules. 
 
Although these novels dyes were synthesised, the reactions suffered from low yields as 
judged by Table 3.14. The synthesised dyes were all stable at room temperature and have 
been characterised using a combination of HRMS, IR, and NMR (1H and 13C) spectroscopy 
(see Chapter 6). The 1H NMR of 16 is shown in Figure 3.16. The methylene N-CH2 protons 
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in the 1H NMR spectra of 16 are inequivalent and appear as two distinct triplets at  4.47 and 
 
4.67 ppm indicating the unsymmetrical character of the dye molecule. 
 
 
Figure 3.14 shows the HRMS for cyanine dye 15 indicating the purity of the compound and 
the presence of an extra phenyl ring. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.14: HRMS for substituted heptamethine cyanine dye 15. 
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Code Structure Yields Code Structure Yields 
12  
 
 
 
 
Na+ 
19% 17  
 
 
 
 
 
Na+ 
22% 
13   
 
 
 
 
Na+ 
19% 18   
 
 
 
 
Na+ 
20% 
14  
 
 
 
 
Na+ 
18% 19  24% 
15    
 
 
 
 
Na+ 
20% 20  36% 
16  
 
 
 
Na+ 
18% 21  21% 
Table 3.14: Substituted heptamethine cyanine dyes. 
 
 
 
 
 
Using this methodology further sophisticated Cy7 dyes could be prepared for instance 
attachment of substituted isoalloxazine molecule as shown in Figure 3.15. This would be 
advantageous from a PDT viewpoint. 
 
 
 
 
 
 
 
 
 
 
 
 
Na+ 
 
 
Figure 3.15: Conjugate Cy7 dyes. 
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In  conclusion,  a  total  of  40  linear  and  substituted  heptamethine  cyanine  dyes  were 
synthesised using the novel one-pot synthetic method, which we believe offers a better 
alternative to the existing methods. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Na+ 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.16: 1H NMR spectra of 16 in d6-DMSO. 
 
 
 
 
 
3.4.7 Synthesis of linear specific dyes for Click Chemistry 
 
 
The in vitro and in vivo labelling of biomolecules by the use of fluorescent dyes represents a 
significant tool in order to study complex biological processes often via molecular or optical 
imaging [223]. One of the important characteristics of the fluorescent dye utilised for this 
purpose  is  their  high  sensitivity.  The  conjugation  of  the  fluorescent  dye  relies  on  their 
selective and efficient reaction under aqueous conditions with functional groups available at 
the biomolecule of interest [209]. Amongst the known ligation reactions, the click reaction 
Cu(I)-catalyzed  azide-alkyne  cycloaddition  (CuAAC)  is  the  most  concise  method  for 
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synthetically designing labelling biomolecules bearing alkyne and azide functional 
groups[224,   225]. The Huisgen’s 1,3-dipolar cycloaddition of alkynes and azides yielding 
triazoles is undeniably the foremost example of a click reaction. The Huisgen’s 1,3-dipolar 
cycloaddition offers several advantages such as the  easy preparation  of alkynes and azides, 
their ease of attachment to biomolecules. Also their inertness toward biological molecules 
and the reaction conditions within the living system makes it an ideal reaction for a wide 
range of in vitro and in vivo bio-conjugation applications [130, 131]. 
 
The recently discovered dramatic rate acceleration of the azide–alkyne coupling reaction 
using copper-(I) catalysis and the beneficial effects of water as the reaction solvent [130] has 
led to the utilisation of this unique connection process to design and synthesis variety of 
benzothiazole NIR heptamethine cyanine dye azide conjugates (Scheme 3.27). 
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MeCN  
Step 1 
 
 
 
 
 
2n 
 
MeCO2Na 
 
 
 
PY2 
 
MeCO2Na 
EtOH, 3 hr 
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MeCO2Na 
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Step 2 
 
 
 
 
 
 
24 22 23 
 
 
 
 
 
 
 
 
 
 
 
1. 2. CuSO4 
3. Sodium abscorbate 
4. Water/acetone 
 
Step 3 
Click reaction 
 
 
 
 
 
 
 
 
 
 
26 
27 25 
 
 
 
 
 
 
Scheme 3.27: Synthetic route to yield azide dye conjugates. 
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The first step in the above synthetic route (Scheme 3.27) was the synthesis of the 
benzothiazole salt (2n) bearing the alkyne functional group moiety. This strategy of 
incorporating the alkyne moiety at the first stage of the synthetic scheme was employed in 
order to avert the potential problems of steric interference and the tedious purification step 
encountered during the post synthetic modifications of cyanine dyes. The next step was the 
dye formation reaction between the benzothiazole salts and the corresponding pyridinium 
salts (PY2, PY1) and the iminium salt (VH1), in the presence of sodium acetate as the base 
to afford the crude dyes. These were purified by column chromatography to obtain the pure 
dyes (24, 22, 23) bearing the alkyne moiety. The 1H NMR spectra obtained were consistent 
 
with the expected structure. Figure 3.17 shows the 1H NMR spectrum of 22. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.17: 1H NMR spectra of 22 in d6-DMSO. 
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The final step in the synthetic scheme is the click reaction between the benzothiazole cyanine 
dyes (24, 22, 23) bearing the alkyne moiety with a benzyl azide bearing the azide functional 
group in the presence CuSO4. 5H2O, sodium ascorbate and a mixture of 80% water/acetone. 
The sodium ascorbate enhances the reduction of the CuII salts to CuI salts [225]. The crude 
 
dye azide conjugates obtained were purified by column chromatography to yield the pure 
product in solid forms. It is suggested that the above synthetic route (Scheme 3.27) will 
provide a blueprint for the future design and synthesis of symmetrical heptamethine cyanine 
dyes conjugated to biomolecules, since to our knowledge this is first time heptamethine 
cyanine dyes bearing the same conjugated group at the heterocyclic ring terminals has been 
synthesised.  Figure 3.18 shows the 1H NMR spectrum of 25. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.18: 1H NMR spectra of 25 in d6-DMSO. 
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The above 1H NMR spectra (Figure 3.18) confirms the formation of the dye azide conjugate 
when compared to the 1H NMR spectra of 22 (Figure 3.16) (dye bearing only the alkyne 
functional group). The protons in the triazole ring give a unique singlet at 8.34 ppm which is 
absent in Figure 3.17 (spectra of 22). The N-CH2 protons linked to the triazole ring and the 
phenyl ring both gives a prominent singlet peaks at 5.63 and 5.59 ppm respectively. Further 
evidence for the structure is illustrated by the presence of extra aromatic proton belonging to 
the phenyl rings linked to the triazole rings. 
 
The proposed catalytic cycle for the Cu(I) catalysed ligation process is shown below (Figure 
 
3.19) [136]. 
 
 
 
 
 
 
B-3 
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lV 
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B-2  
B-direct 
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R1   
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R1 = Benzothiazole heptamethine cyanine dye 
R2 = Benzyl azide 
Ln = Sodium asbcorbate 
 
 
 
Figure 3.19: Proposed catalytic cycle for CuI catalysed ligation. 
 
 
 
 
 
The reaction mechanism is divided into two pathways. The first pathway is the direct [2+3] 
cycloaddition and the second one is the stepwise progression (B1-B2-B3) pathway. The CuI 
are usually introduced by the reduction of CuII salts by sodium ascorbate or ascorbic acid (5- 
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10 mol%). The CuII salts are reasonably cheap, reliable and readily available making them a 
preferred choice for the process. The proposed reaction mechanism of the benzothiazole 
heptamethine cyanine dye with the benzyl azide in theory should provide a model for the 
design of future long-wavelength absorbing cyanine dyes azide conjugated absorbing 
biomolecule. 
 
Potential problems with the Huisgen’s 1,3-dipolar cycloaddition of alkynes and azides do 
exist upon scale-up and these are associated with the explosive nature of the azides in the 
presence of copper. 
 
Chapter four of this thesis will focus on the photophysical properties and growth inhibition 
studies using the newly synthesised Cy7 dyes. 
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  CHAPTER FOUR  
 
 
Photophysical and 
Growth Studies. 
 
 
 
 
 
 
 
4.0 Photophysical and Growth Studies. 
 
 
4.1 Photophysical properties of structurally diverse heptamethine cyanine dyes. 
 
 
Much attention has been focused on the photophysical properties of heptamethine cyanine 
dyes including their absorption and emission wavelengths, fluorescence quantum yields, 
Stokes shifts and effect of solvent polarity. Several strategies have been attempted to improve 
the overall photophysical properties of heptamethine cyanine dyes. It is well noted that 
rigidification of the polymethine chain is an established approach for improving the chemical 
and  photostability  of  NIR  dyes  [226].  Two  classical  NIR  probes  are  ICG  and  New 
Indocyanine Green IR-820 are currently being used for clinical applications [227, 228]. One 
of the main draw backs of ICG is its low fluorescence quantum yield [229-231]. IR-820 is 
structurally related to ICG except with the incorporation of a rigid cyclohexane moiety 
providing improved in vitro and in vivo stability. However, it is documented that IR-820 has 
a notably lower quantum yield than ICG [232]. 
 
With the increasing importance of NIR heptamethine cyanine dyes in biological imaging 
applications, dyes with unique structural features are being designed and synthesised to 
improve spectral properties. Inspired by this, the photophysical properties (absorption and 
fluorescence spectra, fluorescence quantum yields and Stokes shift) of the dyes synthesised in 
this project has been compared against those of the standard fluorophores ICG and IR-820. 
This comparison is based on structural similarities such as length and substitution pattern of 
the polymethine chain, nature of the substituting group on the nitrogen of the heterocyclic 
Photophysical and Growth Studies 
107 
 
 
 
 
ring system. As shown in figure 4.1, the established ICG (linear chain) and IR-820 (rigidified 
 
chain) dyes have terminal dimethyl-indolyl groups with an additional fused benzene ring. 
 
 
 
 
 
 
 
 
 
 
 
IR-820 
ICG 
 
 
- - Na+ - - Na+ 
 
Figure 4.1: The structures of IR-820 and ICG. 
 
 
 
 
 
The heterocyclic ring system and the polymethine chain linking the heterocyclic rings 
generally determine the spectral characteristics of heptamethine cyanine dyes. The 
photophysical properties of the heptamethine cyanine dyes synthesised in this project are 
summarised in Tables 4.3 - 4.14. 
 
 
 
 
4.2 Growth Inhibition Screening 
 
 
Apart from the photophysical properties of the dyes, the growth inhibition and lipophilicity 
properties are important characteristics which determine the practical use of the dyes in living 
cells. The LogP is an estimate of a compound's overall lipophilicity and it is usually linked to 
potency. It is envisaged that the vast structural diversity of the dyes synthesised in this project 
should play a major role in their solubility and growth inhibition characteristics. To this end, 
dyes synthesised were screened in order to identify and select the best set of dyes as potential 
candidates for clinical applications. For the experiment, we employed the eukaryotic, 
unicellular organism, fission yeast Schizosaccharomyce spombe (S. pombe), as a medium for 
establishing growth  inhibition  screening due to  a high  degree of similarity between  the 
cellular processes in yeast and those of human cells [164]. 
 
The growth inhibition screening procedure involved the inoculation of S. pombe wild-type 
cells (NJ2 h- ura4-D18 leu1-32 ade6-M210 his7-366) into 0.5% w/v yeast extract broth (YE), 
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3% w/v glucose, 0.025% w/v adenine, histidine, leucine, uracil+lysine, as previously reported 
[235]. The culture was then incubated overnight at 30 °C with shaking at 200 rpm. Stock 
solutions of the dyes were prepared in 20% DMSO and diluted in YE, resulting in a final 
concentration of 10% DMSO, a concentration known not to inhibit yeast growth. DMSO and 
YE were used as controls for the experiment. 3 x 104  yeast cells were transferred into the 
wells of a 96-well plate. A 1:2 serial dilution of the dyes was then performed (Figure 4.2). 
The well plates were visually inspected for growth after 24 h of incubation at 30 °C. Growth 
was indicated by full or partial appearance of yeast on the bottom of the wells. The minimum 
growth inhibition concentration of the dyes was estimated to be the concentration of the 
compound in the well before yeast growth was first seen. The experiment was repeated three 
times to ensure reproducibility of the results. For a number of dyes, no growth was observed 
at the lowest concentration tested. These are included in Tables 2.3.1-2.3.10, where the 
lowest concentration tested is indicated. In addition, a number of dyes had limited solubility; 
the  values  within  the  tables  indicate  the  highest  possible  concentration  tested.  Wells 
containing 10% DMSO and only YE showed 100% yeast growth. The effect on cell growth 
of the synthesised dyes was compared to available commercial dyes such as ICG, IR-820 and 
acridine orange (AO) (Figure 4.2). AO is a well-known commercially available toxic dye, 
possessing strong inhibitive actions by intercalation and hence was used as a negative control 
[233, 234]. The synthesised dyes were graded based on their Minimal Inhibitory Conentration 
(MIC) values alongside AO. MIC in the range of < 4 µM indicated by red bars exhibited high 
levels of inhibition against the S. pombe yeast strain. IR-820/ICG MIC in the range of greater 
>8 µM indicated by green bars show low levels of inhibition against the aforementioned 
strain. MIC values in the range of 4 - 8 µM are classified as intermediates and indicated by 
yellow bars which represent an intermediate level of inhibition (Figure 4.3 - 4.14). 
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AO 
 
 
Figure 4.2: Schematic diagram of growth inhibition process using 96 Well plates showing 
growth inhibitory effect of heptamethine cyanine dyes on yeast cells and structure of AO. 
 
 
 
 
4.3 N-Alkyled 2,3,3-trimethylindolenine and 2-methylbenzothiazole 
 
A major step during this work was to determine to what extent the alkyl chain length affected 
growth inhibition and to determine if the N-alkylated salts were toxic. It was necessary to 
investigate the growth inhibition effects of the N-alkylated salts since we cannot however, 
rule out the possibility of photodegradation of the dyes occurring in solution. Degradation of 
cyanine dyes in solution in the presence of light and air has been a recurrent problem over the 
years [236, 237]. Lepaja and co-worker have reported one major photoproduct in the 
degradation pathway of heptamethine cyanine dyes as 2,3,3-trimethylindolenine [237]. To 
this  end,  the  growth  inhibitive  effects  of  the  N-alkylated  salts  were  investigated.  To 
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understand this both 2,3,3-trimethylindolenine and 2-methylbenzothiazole were alkylated up 
to a chain length of C=10. Also both compounds were N-alkylated with benzyl bromide and 
1,3-propanesultone and 1,4-butanesultone. The growth inhibition was determined against S. 
pombe, fission yeast. Table 4.1 shows the MICs for the N-alkylated 2,3,3-trimethylindolenine 
and Table 4.2 for the N-alkylated 2-methylbenzothiazoles. It should be noted that the full 
MICs for N-Alkylations being C5-10 can be found in the Appendix (Eur. J. Med. Chem) 
 
 
 
 
Number  
 
X- 
MIC (µM) 
R X- % Yield LogP S. pombe 
1a CH3 I- 58 -0.691 500 
1b CH2CH3 I- 86 -0.315 500 
1c CH2CH2CH3 I- 85 0.188 250 
1d CH2(CH2)2CH3 I- 67 0.747 250 
1k CH2C6H5 Br- 77 0.904 1000 
1l - CH2CH2CH2SO3 - 58 -4.33 1000 
1m - CH2CH2CH2CH2SO3 - 50 -4.114 1000 
1n NA (control) - - 3.286 250 
Table 4.1: Growth Inhibition Evaluation for N-alkylated 2,3,3-trimethylindolenine. 
 
 
 
MIC of synthesised compounds tested in S. pombe. Cells were innoculated at a concentration 
of 3 x 104 cells. Culture media tested were in YE for S. pombe. Growth of yeast was 
determined visually after 24 hours incubation at 30 °C. The MICs of the compounds were 
determined to be the well before yeast growth was first seen. The experiments were repeated 
three times. 
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Number   
 
x- 
MIC (µM) 
R X- % Yield LogP S. pombe 
2a CH3 -
 I 87 -1.077 500 
2b CH2CH3 -
 I 41 -0.701 250 
2c CH2CH2CH3 -
 I 44 -0.199 250 
2d CH2(CH2)2CH3 -
 I 51 0.36 250 
2k CH2C6H5 -
 Br 90 0.517 1000 
2l - CH2CH2CH2SO3 - 50 -4.576 1000 
2m - CH2CH2CH2CH2SO3 - 7 -4.411 1000 
2n NA (control) - - 2.085 250 
Table 4.2: Growth Inhibition Evaluation for N-alkylated 2-methylbenzothiazoles 
 
 
 
MIC of synthesised compounds tested in S. pombe. Cells were innoculated at a concentration 
of 3 x 104 cells. Culture media tested were in YE for S. pombe. Growth of yeast was 
determined visually after 24 hours incubation at 30 °C. The MICs of the compounds were 
determined to be the well before yeast growth was first seen. The experiments were repeated 
three times. 
 
The quaternary N-alkylated derivatives of both 2-methylbenzothiazole and 2,3,3- 
trimethylindolenine salts show varying degrees of growth inhibitive actions with the longer 
chain substituents being more potent against S. pombe. As shown in Appendix 1. This is 
evident when comparing 1j (15.6 µM) to 1a (500 µM) and 2j (7.8 µM) to 2a (500 µM) and 
indeed these results were consistent throughout the experiment. It was suggested that the 
growth inhibition can be attributed to the charged N-alkylated compounds with the increasing 
linear chain  lengths.  We postulate that  these  compounds  are  attracted  to  the negatively 
charged yeast membrane, with the longer lipophilic chains being absorbed into and 
subsequently distorting the lipid membrane [238]. 
 
It is concluded from this data that only N-alkyl chains up to the length of C4 should be used 
for the growth inhibition evaluation of the dyes due to the high level of growth inhibitive 
activity shown by the compounds possessing N-alkyl chain lengths of >C5. It is also noted 
that the sulfonic acid salts of both the 2,3,3-trimethylindolenine and the 2- 
methylbenzothiazole (1 l-m & 2 l-m) showed no growth inhibition activity, it is assumed that 
the presence of the sulfonic acid groups tends to increase their solubility and reduce their 
growth inhibition characteristics, possibly through suppressing membrane permeability and 
cellular uptake. It is also noted that the benzyl substituent also showed no activity against S. 
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pombe and this could possibly be due to the molecule having little membrane permeability 
due to the sp2 hybridised ring system and steric factors. 
 
 
4.4.0 Rigid Heptamethine Cyanine 
 
 
Section 4.4 will focus on analysis of the photophysical and growth inhibition data for families 
of compounds 4 – 8. Each of these compounds will be compared against IR-820 due to the 
high level of their structural similarities (the presence of the rigid cyclohexene backbone on 
the polymethine chain). During these experiments AO has been used as a negative control 
since it’s a well-known commercially available toxic dye possessing strong inhibitive effect 
[233, 234]. 
 
 
 
 
4.4.1 Compounds 4 a-g 
 
 
 
 
 
X- 
 
 
 
Compounds Fluorescence Studies Growth 
Inhibition Studies 
Code R Absorption 
λmax (nm) 
Fluorescence 
Emission (nm) 
Fluorescence 
Quantum Yield 
(Ф) 
Stokes 
Shift 
(nm) 
Minimum 
Growth 
Inhibition 
(µM) 
Log P 
4a Me 775 793 0.073 18 0.64a 4.928 
4b Et 777 796 0.080 19 0.61a 5.680 
4c n-Pr 781 798 0.074 17 0.58a 6.686 
4d n-Bu 780 799 0.076 19 0.70a 7.804 
4e Bn 775 793 0.084 18 0.61a 7.922 
4f CH2(CH2)2SO3- 782 802 0.082 20 17.9b -0.364 
4g CH2(CH2)3SO3- 782 802 0.085 20 17.2b -0.178 
IR-820 Commercial 
Dye 
820 840 0.032 20 15.1b 1.441 
AO Commercial 
Dye 
- - - - <1.47a 3.321 
Table   4.3:   Photophysical   and   growth   inhibition   evaluation   for   indolium-based   rigid 
heptamethine cyanine dyes. 
Quantum yields ± 10%, λmax ± 1 nm. Relative to IR-820. 
Excitation at 785 nm. 
aIndicates no visible yeast growth observed at this concentration of dye. 
bIndicates highest possible concentration tested, visible yeast growth observed. 
X- = I- or Br- 
Photophysical and Growth Studies 
113 
 
 
 
 
The photophysical properties of compounds 4 a-g are summarised in Table 4.3.  It’s clear to 
see that the indolium-based rigid heptamethine cyanine dyes exhibited absorption spectra 
maxima all absorbing in the NIR region between 775 - 782 nm. Rigidification of the 
polymethine backbone shifts the absorption and fluorescence maxima approximately 30 - 40 
nm to the red when comparing 4a (775 and 793 nm respectively) with 9a (740 and 770 nm). 
The fused benzyl rings on IR-820 leads to an increased bathochromic shift by approximately 
30 - 50 nm into the red which can be seen when comparing 4g (782 nm) with IR-820 (820 
nm) and 4e with 6e (775 and 822 nm respectively). Furthermore the similarities in the 
absorbance wavelength of the dyes in Table 4.3 could be attributed to the fact that the N- 
donor and N-acceptor substituting groups are too far away from the chromophore and as such 
have very little influence on the spectroscopic properties of the dyes. 
 
An interesting observation is noted that compounds 4 a-g demonstrated an approximate 2.5 to 
 
3-fold increase in quantum yield when compared with IR-820. This result clearly indicates 
that presence of the extra phenyl group in IR-820 and dyes in Table 4.5 (6 a-g) destabilises 
the excited state of the NIR dyes relative to 4 a-g. We note the Stokes shifts for the rigid dyes 
4 a-g show comparable shifts when compared against IR-820 and are also relatively small (17 
 
– 20 nm). This indicates minor structural changes between the ground and excited states of 
the dyes. 
 
The growth inhibition data can also be viewed in Table 4.3 and shows that compound 4 a-d 
which possess linear alkyl chains give MIC values from 0.58 - 0.70 µM. When linked to the 
LogP its clear to see that higher degrees of lipophilicity are linked to cytotoxicity. However 
4f and 4g with the sulfonic acid groups give MIC values of approximately 18 µM, thus we 
postulate that the presence of the sulfonic acid group on the dyes tends to increase their 
solubility and reduce their growth inhibition characteristics, possibly through reduced 
membrane permeability and cellular uptake. The growth inhibition is also shown graphically 
in Figure 4.3. The results from Figure 4.3 indicate that the synthesised heptamethine cyanine 
dyes (4 a-g) have a growth inhibition effect at different concentrations. The dyes coloured in 
green were the dyes which showed no inhibitory effect on the growth of the yeast cell (i.e. 
non-toxic) at the concentration tested. The results obtained were comparable to the result 
obtained  for  IR-820,  a  well-known  commercially  available  non-toxic  dye.  Those  bars 
coloured in red showed inhibitory effect on the growth of the yeast cells (i.e. prevented the 
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growth of the cells) and the results were similar to results obtained for AO, a well-known 
 
commercially available toxic dye. 
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Figure 4.3: Growth inhibition evaluation of rigid heptamethine cyanine. Green bars indicate 
growth inhibition was comparable to IR-820. Red bars indicate growth was comparable to 
AO. 
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4.4.2 Compounds 5a - g 
 
 
 
 
 
 
 
 
 
 
Compounds Fluorescence Studies Growth 
Inhibition Studies 
Code R Absorption 
λmax (nm) 
Fluorescence 
Emission 
(nm) 
Fluorescence 
Quantum 
Yield (Ф) 
Stokes 
Shift 
(nm) 
Minimum 
Growth 
Inhibition 
(µM) 
Log P 
5a Me 796 812 0.087 16 0.66a 3.923 
5b Et 796 812 0.087 16 0.63a 4.675 
5c n-Pr 797 814 0.091 17 0.60a 5.68 
5d n-Bu 796 813 0.093 17 0.05a 6.799 
5e Bn 804 820 0.093 16 0.89a 9.176 
5f - CH2(CH2)2SO3 798 815 0.066 17 18.43b -2.422 
5g - CH2(CH2)3SO3 800 817 0.082 17 17.71b -1.883 
IR-820 Commercial 
Dye 
820 840 0.032 20 15.1b 1.441 
AO Commercial 
Dye 
- - - - <1.47a 3.321 
Table   4.4:   Photophysical   and   growth   inhibition   evaluation   for   rigid   benzothiazole 
heptamethine cyanine dyes. 
Quantum yields ± 10%, λmax ± 1 nm. Relative to IR-820. 
Excitation at 785 nm. 
aIndicates no visible yeast growth observed at this concentration of dye. 
bIndicates highest possible concentration tested, visible yeast growth observed. 
X- = I- or Br- 
 
 
 
 
The results in Table 4.4 indicates that the replacement of the 3,3-dimethylindolenine ring 
with a benzothiazole ring, shifts the absorption and fluorescence maxima deeper into the red 
as shown by comparing 5a (796 and 812 nm) with 4a (775 and 793 nm). Indeed, this 
comparison is seen throughout the series in Tables 4.4 and 4.4. This result suggests that the 
heavy atom effect plays an important role, since replacement of carbon with sulfur in the 
heterocyclic ring system facilitates the intersystem crossing resulting in increased shifts as 
previously reported [173]. Also the similarities in the absorbance and emission wavelength of 
the dyes in Table 4.4 could still be attributed to the fact that the N-donor and N-acceptor 
Photophysical and Growth Studies 
116 
 
 
 
 
substituting groups are too far away from the chromophore to have any influence on their 
spectral properties. 
 
Furthermore, it was noted that the dyes in Table 4.4 (5 a-g) demonstrated an approximate 2.5 
to 3-fold increase in quantum yield when compared with IR-820. This is also attributed to the 
heavy atom effect in the heterocyclic ring system increased the quantum yield and this is seen 
when comparing 5a (Φ = 0.087) and 4a (Φ = 0.073). The Stokes shifts values remained fairly 
consistent when comparing dyes in Table 4.4 (5 a-g) and dyes in Table 4.3 (4 a-g). This 
demonstrated that substituting the indolinium moiety with sulfur atom had no effect on the 
Stokes shifts of the dyes. 
 
The growth inhibition values show that compounds 5 a-e (bearing the sulfur moiety) (Table 
 
4.4) show similar MIC values upon comparison with compounds 4 a-e (bearing the indolium 
group) (Table 4.3). It’s interesting to note that compounds 5f and 5g show slightly higher 
MIC values.  This is evident when comparing 5f (18.43 µM) and 5g (17.71 µM) with 4f (17.9 
µM) and 4g (17.2 µM) respectively. Hence, it is therefore suggested that the observed effect 
could be attributed to the excellent biocompatibility characteristics of the benzothiazole 
moiety [200]. The results from Figure 4.4 indicate that the synthesised heptamethine cyanine 
dyes have different growth inhibitory effect at different concentration. The dyes coloured in 
green were the dyes which showed no inhibitory effect on the growth of the yeast cell (i.e. 
non-toxic) at the concentration tested. The results obtained indicated that 5f (18.43 µM) and 
5g (17.71 µM) showed better MIC values when compared to IR-820 (15.1 µM), indicating 
their  suitability  for  possible  clinical  applications.  Those  bars  coloured  in  red  showed 
inhibitory effect on the growth of the yeast cells (i.e. prevented the growth of the cells) and 
the results were similar to results obtained for AO. 
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Figure  4.4:  Growth  inhibition  evaluation  for  rigid  benzothiazole  heptamethine  cyanine. 
Green bars indicate growth inhibition was comparable to IR-820. Red bars indicate growth 
was comparable to AO. 
 
 
 
 
4.4.3 Compounds 6 a-g 
 
 
 
 
 
X- 
 
 
Compounds Fluorescence Studies Growth 
Inhibition Studies 
Code R Absorption 
λmax (nm) 
Fluorescence 
Emission 
(nm) 
Fluorescence 
Quantum 
Yield (Ф) 
Stokes 
Shift 
(nm) 
Minimum 
Growth 
Inhibition 
(µM) 
Log P 
6a Me 813 834 0.028 21 0.02a 7.247 
6b Et 815 833 0.035 18 0.05a 7.999 
6c n-Pr 818 838 0.029 20 0.02a 8.695 
6d n-Bu 838 818 0.032 20 0.03a 9.139 
6e Bn 822 845 0.029 23 3.06a 9.176 
6f - CH2(CH2)2SO3 820 841 0.032 21 b 15.6 0.9 
6g - CH2(CH2)3SO3 820 840 0.032 20 b 15.1 1.441 
IR-820 Commercial 
Dye 
820 840 0.032 20 15.1b 1.441 
AO Commercial 
Dye 
- - - - <1.47a 3.321 
Table 4.5:  Photophysical and growth inhibition evaluation evaluation for rigid benzo[e] 
heptamethine cyanine dyes. 
Quantum yields ± 10%, λmax ± 1 nm. Relative to IR-820. 
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Excitation at 785 nm. 
aIndicates no visible yeast growth observed at this concentration of dye. 
bIndicates highest possible concentration tested, visible yeast growth observed. 
X- = I- or Br- 
 
 
 
Perspective views of 6 a-g are depicted in Table 4.5. Table 4.5 outlines the spectral properties 
of the indolinum based heptamethine cyanine dyes bearing the extra phenyl ring. Regardless 
of the substituting groups attached to the indolinium nuclei, the fluorescence quantum yield 
and Stoke shifts of the dyes (6 a-g) were practically identical. However on comparing the 
absorption and emission wavelengths of 6a (813 nm and 834 nm) with 4a (775 nm and 793 
nm), it was noted that the presence of the extra fused phenyl ring on the heterocyclic system 
resulted in an increase shift of absorption and emission wavelength to red which is as a result 
of increase in conjugation in the π-electron system. Indeed this result is consistent when 
comparing the values in Table 4.3 (4 a-g) with Table 4.5 (6 a-g) respectively. Also it should 
be noted that the quantum yields are around the same value as for IR-820 highlighting the 
close structural relationship. 
 
The MIC and LogP values were consistent with the results obtained from the previous series 
of compounds due to their structural similarities, with dyes bearing the N-alkylated linear 
chain  possessing  higher  toxicity and  higher  degrees  of  lipophilicity.  It  is  interesting  to 
observe that the compound 6e which has the N-benzylic group shows a higher MIC value 
when compared with 4e and 5e this could be attributed to the extra fused phenyl moiety 
having an effect on its spatial arrangement between itself and the cell wall of the S. pombe. 
Figure 4.5 further illustrates the results obtained for the growth inhibition evaluation. 
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Figure 4.5: Growth inhibition evaluation of rigid benzo[e] heptamethine cyanine dyes. Green 
bars indicate growth inhibition was comparable to IR-820. Red bars indicate growth was 
comparable to AO. 
 
 
 
 
4.4.4    Compounds 7 a- f 
 
 
 
 
 
X- 
 
 
Compounds Fluorescence Studies Growth 
Inhibition Studies 
Code R Absorption 
λmax (nm) 
Fluorescence 
Emission 
(nm) 
Fluorescence 
Quantum Yield 
(Ф) 
Stokes 
Shift 
(nm) 
Minimum 
Growth 
Inhibition 
(µM) 
Log P 
7a Me 736 786 0.030 50 0.58a 6.185 
7b Et 735 786 0.027 51 0.56a 6.937 
7c n-Pr 746 795 0.054 49 0.54a 7.942 
7d Bn 736 794 0.015 58 0.80a 8.778 
7e - CH2(CH2)2SO3 745 793 0.045 48 b
 16.5 -0.162 
7f - CH2(CH2)3SO3 745 791 0.047 46 b
 15.9 0.379 
IR-820 Commercial 
Dye 
820 840 0.032 20 5.1b 1.441 
AO Commercial 
Dye 
- - - - <1.47a 3.321 
Table 4.6: Photophysical and growth inhibition evaluation for functionalised indolium-based 
rigid heptamethine cyanine dyes. 
Photophysical and Growth Studies 
120 
 
 
 
 
Quantum yields ± 10%, λmax ± 1 nm. Relative to IR-820. 
Excitation at 785 nm. 
aIndicates no visible yeast growth observed at this concentration of dye. 
bIndicates highest possible concentration tested, visible yeast growth observed. 
X- = I- or Br- 
 
 
 
Due to unusual synthetic problems, the n-butyl derivative of these dyes could not be made 
and this synthesis was abandoned. Thus the comparison with this compound with 4d was 
unable to take place. 
 
Addition of aniline to the rigid cyclo-hexene central subunit shows a profound effect on the 
photophysical activities and this can be seen when comparing 7 a-f with 4 a-f. To highlight 
this, comparisons between 4a and 7a, 4e and 7d and 4g with 7f have been made. It’s 
interesting to note that each of the three sets of compounds shows unusually high Stokes 
shifts (~50 nm). This is related to the decrease in absorption across the spectrum of 
compounds which can be highlighted when comparing 4a to 7a (775 nm to 736 nm), 4e to 7d 
(775 nm to 736 nm) and 4g to 7f (745 nm to 787 nm) respectively. Also there is no defined 
pattern for the quantum yields and it is noted that compounds 7a, b and d all show a decrease 
when compared to IR-820. It’s interesting to note that compounds 7 e-f show higher quantum 
yields to that of IR-820. The increase in Stoke shift is advantageous for this type of work 
since it renders the amine-substituted cyanine dyes useful as NIR platforms for the 
development of a wide range of non-targeting fluorescent probes [203]. 
 
The growth inhibition data once again shows the same trend in comparison with the other sets 
of compounds 4-6. Once again the compounds 7e and f show lower MIC values when 
compared to IR-820 which of course go hand in hand with a decrease in LogP for both 
compounds. And this is evident in Figure 4.6 
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Figure  4.6:  Growth  inhibition  evaluation  of  functionalised  indolium-based  rigid 
heptamethine cyanine dyes. Green bars indicate growth inhibition was comparable to ICG. 
Red bars indicate growth was comparable to acridine orange AO. 
 
 
 
 
 
 
 
4.4.5    Compounds 8 a-e 
 
 
 
 
 
 
 
X- 
 
 
 
 
Compounds Fluorescence Studies Growth 
Inhibition Studies 
Code R Absorption 
λmax (nm) 
Fluorescence 
Emission 
(nm) 
Fluorescence 
Quantum 
Yield 
(Ф) 
Stokes 
Shift 
(nm) 
Minimum 
Growth 
Inhibition 
(µM) 
Log P 
8a Me 780 818 0.049 38 0.10a 8.488 
8b Et 776 820 0.062 44 0.10a 8.813 
8c n-Pr 778 823 0.063 45 0.20a 9.182 
8d Bn 769 826 0.048 57 1.43a 9.503 
8e - CH2(CH2)3SO3 779 824 0.067 45 b 14.15 2.698 
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IR-820 Commercial 
Dye 
820 840 0.032 20 15.1b 1.441 
AO Commercial 
Dye 
- - - - <1.47a 3.321 
Table 4.7: Photophysical and growth inhibition evaluation for functionalised rigid benzo[e] 
heptamethine cyanine dyes. 
Quantum yields ± 10%, λmax ± 1 nm. Relative to IR-820. 
Excitation at 785 nm. 
aIndicates no visible yeast growth observed at this concentration of dye. 
bIndicates highest possible concentration tested, visible yeast growth observed. 
X- = I- or Br- 
 
 
 
 
 
The structural and spectral characteristics of dyes in Table 4.6 (7 a-f) and Table 4.7 (8 a-e) 
are closely related and can also be discussed together. The dyes in Tables 4.6 and 4.7 are 
similar in terms of their structural features which differ most noticeably with presence of the 
extra phenyl ring on dyes 8 a-e. As can be seen in Tables 4.6 and 4.7, the Stoke shifts values 
of rigid heptamethine cyanine dyes 7 a-f and 8 a-e range from 38 to 57 nm and this is quite 
high and this increase is evident when comparing 7d (58 nm) with 4e (18 nm) and 8d (57 nm) 
with 6e (23 nm). Indeed, this comparison is seen throughout the series in Tables 4.3, 4.5, 4.6 
and 4.7. And it is postulated that the observed increase could be as a result of the substitution 
of the meso-chlorine atom with an aromatic moiety, indicating a large structural change 
between the ground and the excited singlet state of the dyes owing to an intramolecular 
charge transfer (ICT) effect. Figure 4.7 indicates the structures of the compared rigid 
heptamethine cyanines dyes for the Stokes shift studies. 
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Figure 4.7: Structures of heptamethine cyanine dyes. 
 
 
 
 
 
The MIC values remained fairly consistent with N-sulfonic acid dyes showing MIC values in 
the range of 14.1 to 16.5 µM. Also the values were parallel to results obtained for IR-820. 
While the N-linear alkyl chains gave MIC values from 0.10 - 0.80 µM relating to their LogP 
values and the values were corresponding to results obtained for 1AO. This is illustrated in 
Figure 4.8 
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Figure 4.8: Growth inhibition evaluation for functionalised rigid benzo[e] heptamethine 
cyanine dyes. Green bars indicate growth inhibition was comparable to IR-820. Red bars 
indicate growth was comparable to AO. 
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4.5.0 Linear Heptamethine Cyanine 
 
 
Section 4.5 will focus on analysis of the photophysical and growth inhibition data for families 
of compounds 9 – 11. Each of these compounds will be compared against ICG due to the 
high  level  of  their  structural  similarities  such  as  the  absence  of  the  rigid  cyclohexene 
backbone on the polymethine chain. During these experiments, AO has been used as a 
negative control [234]. 
 
 
 
 
4.5.1    Compounds 9 a-g 
 
 
 
 
 
 
 
X- 
 
Compounds Fluorescence Studies Growth 
Inhibition Studies 
Code R Absorption 
λmax (nm) 
Fluorescence 
Emission 
(nm) 
Fluorescence 
Quantum 
Yield (Ф) 
Stokes 
Shift 
(nm) 
Minimum 
Growth 
Inhibition 
(µM) 
Log P 
9a Me 740 770 0.09 30 0.58a 3.810 
9b Et 742 770 0.11 28 0.55a 4.562 
9c n-Pr 746 776 0.13 30 0.52a 5.567 
9d n-Bu 746 776 0.13 30 0.76a 6.686 
9e Bn 748 776 0.15 28 0.48a 6.804 
9f - CH2(CH2)2SO3 747 773 0.13 26 b 16.0 -2.537 
9g - CH2(CH2)3SO3 747 775 0.13 28 b 15.3 -1.995 
ICG Commercial 
Dye 
785 814 0.072 29 16.6b 1.591 
AO Commercial 
Dye 
- - - - <1.47a 3.321 
Table 4.8: Photophysical and growth inhibition evaluation for indolium-based linear 
heptamethine cyanine dyes. 
Quantum yields ± 10%, λmax ± 1 nm. Relative to ICG. 
Excitation at 785 nm. 
aIndicates no visible yeast growth observed at this concentration of dye. 
bIndicates highest possible concentration tested, visible yeast growth observed. 
X- = I- or Br- 
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Due to the remarkable and distinct variations between compounds 9 a-g and 10 a-g which 
include the replacement of 2,3,3-trimethylindolenine with a benzothiazole moiety, 
comparisons between both sets will be made on the next page. 
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Figure 4.9: Growth inhibition evaluation for linear indolium based heptamethine cyanine 
dyes. Green bars indicate growth inhibition was comparable to ICG. Red bars indicate growth 
was comparable to AO. 
 
 
 
 
4.5.2 Compound 10 a-g 
 
 
 
 
 
 
 
 
Compounds Fluorescence Studies Growth 
Inhibition Studies 
Code R Absorption 
λmax (nm) 
Fluorescence 
Emission 
(nm) 
Fluorescence 
Quantum 
Yield (Ф) 
Stokes 
Shift 
(nm) 
Minimum 
Growth 
Inhibition 
(µM) 
Log P 
10a Me 756 783 0.165 27 1.21a 2.805 
10b Et 759 785 0.161 26 0.57a 3.557 
10c n-Pr 761 786 0.176 25 0.54a 4.562 
10d n-Bu 761 787 0.181 26 0.06a 5.681 
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10e Bn 765 791 0.229 26 4.62b 5.994 
10f - CH2(CH2)2SO3 762 789 0.146 27 b 16.58 -3.542 
10g - CH2(CH2)3SO3 762 789 0.166 27 b 15.85 -3.001 
ICG Commercial 
Dye 
785 814 0.072 29 6.6b 1.591 
AO Commercial 
Dye 
- - - - <1.47a 3.321 
Table  4.9:  Photophysical  and   growth  inhibition  evaluation  for  linear  benzothiazole 
heptamethine cyanine dyes. 
Quantum yields ± 10%, λmax ± 1 nm. Relative to ICG. 
Excitation at 785 nm. 
aIndicates no visible yeast growth observed at this concentration of dye. 
bIndicates highest possible concentration tested, visible yeast growth observed. 
X- = I- or Br- 
 
 
 
 
 
The molecular structural backbone of dyes 9 a-g and 10 a-g are very similar with the only 
difference being the replacement of the 3,3-dimethylindolenine ring with a benzothiazole ring. 
The spectral properties collected for the dyes are summarised in Tables 4.8 and 4.9. It is noted 
that the benzothiazole ring shifts the absorption and fluorescence maxima deeper into the red as 
shown by comparing 9e (748 nm and 776 nm) with 10e (765 nm and 791 nm), however the 
Stokes  shift  remains  constant  for  both  at  28  nm  and  26  nm  respectively.  An  interesting 
observation is that the linear benzothiazole heptamethine cyanine dyes (10 a-g) show a 2-fold 
increase in quantum yield when compared with ICG. It was also discovered, that rigidification of 
the polymethine chain reduces the quantum yields by approximately 50%, as shown by comparing 
10a (Φ = 0.165) with  5a (Φ = 0.087). This  reduction in quantum  yield is also seen when 
comparing ICG (Φ = 0.072) with IR-820 (Φ = 0.032) and also when comparing dyes (9 a-g) with 
dyes (4 a-g). This finding is in contrast to the typical observations that rigidifying chromophore 
systems in organic molecules is an established strategy to stabilise and optimise the spectral 
properties of fluorescent dyes [239]. Also it was observed that the linear dyes (10 a-g) bearing the 
benzothiazole moiety showed higher quantum yield values when compared with the linear dyes (9 
a-g) bearing the 3,3-dimethylindolenine moiety. Based on the results obtained from this 
comparison, it could be suggested that a combination of different factors all play a role in the 
quantum yield of the dyes rather than just the presence of the rigid cyclo-hexene ring. And such 
factors include the substitution pattern of the indolium ring system and length of polymethine 
chain. Furthermore, large Stokes shift values were noticed when comparing the linear dyes (9 a-g, 
10 a-g) with Stokes shift values in the range 25-30 nm to the dyes (4 a-g, 5 a-g) bearing the rigid 
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cyclohexene moiety with Stokes shift values in the range of 16-20 nm. This characteristic is not 
unusual and could be attributed to the replacement of the rigid cyclohexene unit with the linear 
chain indicating a major structural change, which in turn affects the ground state and the excited 
singlet states of the dyes. 
 
The growth inhibition data can also be viewed in Table 4.8 and 4.9 and the results indicate that 
the dyes (9 a-d, 10 a-d) bearing the linear alkyl chains on the nitrogen of the indolenine nuclei 
gave MIC values from 0.06-0.76 µM. While the dyes (9 f-g, 10 f-g) bearing the sulfonic acid 
group gave MIC values from 15.3-16.58 µM. When considered against the LogP values its clear 
to see that higher degrees of lipophilicity are linked to toxicity and vice versa. Furthermore, the 
results  in  Figure  4.10  indicate  that  the  synthesised  linear  heptamethine  cyanine  dyes  have 
different growth inhibition effect at different concentration. The dyes coloured in green were the 
dyes which showed no inhibition effect on the growth of the yeast cell (i.e. non-toxic) at the 
concentration tested and the results obtained were corresponding to result obtained for ICG. 
Those  bars  coloured  in  red  showed  inhibitory  effect  on  the  growth  of  the  yeast  cells  (i.e. 
prevented the growth of the cells) and the results were parallel to results obtained for AO. 
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Figure 4.10: Growth inhibition evaluation for linear benzothiazoleheptamethine cyanine 
dyes. Green bars indicate growth inhibition was comparable to ICG. Red bars indicate growth 
was comparable to AO. Yellow bar indicate growth in the intermediate range. 
 
 
 
 
 
 
4.5.3 Compound 11 a-g 
 
 
 
 
 
 
 
 
 
X- 
 
 
 
Compounds Fluorescence Studies Growth 
Inhibition Studies 
Code R Absorption 
λmax (nm) 
Fluorescence 
Emission 
(nm) 
Fluorescence 
Quantum 
Yield (Ф) 
Stokes 
Shift 
(nm) 
Minimum 
Growth 
Inhibition 
(µM) 
Log P 
11a Me 778 807 0.064 29 0.007a 6.129 
11b Et 781 809 0.072 28 0.029a 6.881 
11c n-Pr 782 811 0.071 29 0.028a 7.881 
11d n-Bu 783 811 0.075 28 0.027a 8.696 
11e Bn 786 814 0.076 28 6.74b 8.753 
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11f - CH2(CH2)2SO3 784 812 0.073 28 b 17.2 -0.218 
11g - CH2(CH2)3SO3 785 814 0.072 29 b 16.6 0.323 
ICG Commercial 
Dye 
785 814 0.072 29 16.6b 1.591 
AO Commercial 
Dye 
- - - - <1.47a 3.321 
Table 4.10: Photophysical and growth inhibition evaluation for linear benzo[e] heptamethine 
cyanine dyes. 
Quantum yields ± 10%, λmax ± 1 nm. Relative to ICG. 
Excitation at 785 nm. 
aIndicates no visible yeast growth observed at this concentration of dye. 
bIndicates highest possible concentration tested, visible yeast growth observed. 
X- = I- or Br- 
 
 
 
The photophysical and growth inhibition characteristics for the linear benzo[e] heptamethine 
cyanine dyes are summarised in Table 4.10 above. The properties studied and data collected are 
similar  to  previous   results  obtained  and  discussed  for  dyes   having  similar  structural 
characteristics. 
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Figure 4.11: Growth inhibition evaluation for linear benzo[e] heptamethine cyanine dyes. 
Green bars indicate growth inhibition was comparable to ICG. Red bars indicate growth was 
comparable to AO. The yellow bar indicates growth in the intermediate range. 
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4.6       Substituted Polymethine Linear Heptamethine Cyanine 
 
 
Section 4.6 will focus the analysis of the photophysical and growth inhibition data for 
compounds 12 - 20. Because of the linear nature of these dyes comparisons will be made 
against ICG rather than IR-820. During these experiments AO has been used as a negative 
control. 
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X- 
 
 
 
 
Compounds Fluorescence Studies Growth 
Inhibition Studies 
Code R Absorption 
λmax (nm) 
Fluorescence 
Emission 
(nm) 
Fluorescence 
Quantum Yield 
(Ф) 
Stokes Shift 
(nm) 
Minimum 
Growth 
Inhibition 
(µM) 
Log 
P 
12    
 
 
 
 
 
 
 
Na+ 
784 814 0.072 30 9.39b 0.361 
13    
 
 
 
 
 
 
 
Na+ 
743 769 0.091 26 8.54b 0.279 
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14    
 
 
 
 
 
 
Na+ 
747 774 0.116 27 9.09b 0.148 
15  
 
 
 
 
 
 
 
 
Na+ 
758 782 0.144 24 17.1b 1.15 
16  
 
 
 
 
 
Na+ 
753 779 0.129 26 9.16b -1.267 
17  
 
 
 
 
 
Na+ 
758 783 0.158 25 9.81b -1.398 
18  
 
 
 
 
 
Na+ 
61 784 0.148 23 10.1b -1.185 
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19  737 764 0.071 27 1.01a 4.276 
20  752 777 0.154 25 1.13a 3.139 
ICG Commercial 
Dye 
785 814 0.072 29 16.6b 1.591 
AO Commercial 
Dye 
- - - - <1.47a 3.321 
Table 4.11: Photophysical and Growth Inhibition evaluation for substituted linear heptamethine cyanine dyes. 
*1  Quantum yields ± 10%, λmax ± 1 nm. Relative to ICG. 
*2 Excitation at 785 nm. 
aIndicates no visible yeast growth observed at this concentration of dye. 
bIndicates highest possible concentration tested, visible yeast growth observed. 
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The spectral and growth inhibition characteristics for the diverse range of heptamethine 
cyanine dyes (12 – 20) are summarised in Table 4.11 above. It’s clear to see that all dyes 
exhibited absorption spectra maxima in the NIR region between 743 - 784 nm. They also 
demonstrated higher fluorescence quantum yields than ICG. The fluorescence quantum yield 
for the dyes bearing the 3,3-dimethylindolenine ring increased in the order Cl>Br>CH3.While 
that of the dyes bearing the benzothiazole ring increased in the order Cl>CH3>Br. The results 
collected indicates that the dyes (17 and 20) bearing the benzothiazole ring with their linear 
polymethine chain linked to a chlorine atom showed the highest quantum yield 20 (Φ = 
0.154), 17 (Φ = 0.158). It is uncertain as to the mechanism or exact reason for the observed 
effect. Previous reports in the literature have suggested that the fluorescence life times and 
quantum yields of organic dyes increased with increasing molecular weight of the 
intramolecular heavy atom modifications [240]. It would therefore seem plausible that the 
presence of the chlorine, sulfur atom and substitution pattern of the polymethine chain may 
all have contributed to the increased quantum yields. We cannot however, rule out the 
possibility that heavy atom modification did increase the efficiency of crossing into the triplet 
state, since heavy atoms show larger rate of intersystem crossing. The growth inhibition data 
shows that the substituted linear heptamethine cyanine dyes demonstrated MIC values from 
1.01 - 17.1 µM based on their structural characteristics. Due to the intense colour of the dyes, 
it  was  difficult  to  accurately  judge  the  growth  of  yeast.  Therefore,  the  assay  for  the 
substituted linear heptamethine cyanine dyes may under estimate the MIC values. The dyes 
may not be growth inhibitive as the data suggests, since the MIC values were calculated from 
the second wells in which growth was more visible. The dyes bearing the alkyl chains on the 
nitrogen of the indolenine nuclei gave MIC values comparable to AO (Table 4.11 and Figure 
4.12). While the dyes bearing the sulfonic acid group gave MIC values comparable to ICG 
(Table 4.11 and Figure 4.12). Also when the MIC values are related to the LogP it’s clear to 
see  that  higher  degrees  of  lipophilicity  are  linked  to  toxicity.  Due  to  these  interesting 
quantum yields and MIC values, the diverse range of synthesised heptamethine cyanine dyes 
show potential for clinical applications when compared with the clinical standard ICG. 
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Figure 4.12: Growth inhibition evaluation for substituted linear heptamethine cyanine dyes. Green bars indicate growth inhibition was 
comparable to ICG. Red bars indicate growth was comparable to AO. 
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Compounds Fluorescence Studies Growth Inhibition 
Studies 
Code R Absorption 
λmax (nm) 
Fluorescence 
Emission 
(nm) 
Fluorescence 
Quantum Yield 
(Ф) 
Stokes Shift 
(nm) 
Minimum 
Growth Inhibition 
(µM) 
Log P 
22  758 786 0.17 28 4.83b 3.124 
23  800 818 0.09 18 1.05a 4.242 
24  759 782 0.15 23 4.70b 3.672 
ICG Commercial 
Dye 
785 814 0.072 29 16.6b 1.591 
AO Commercial 
Dye 
- - - - <1.47a 3.321 
Table 4.12: Photophysical and Growth Inhibition evaluation for click intermediate dyes. 
 
Quantum yields ± 10%, λmax ± 1 nm. Relative to ICG. 
Excitation at 785 nm. 
aIndicates no visible yeast growth observed at this concentration of dye. 
bIndicates highest possible concentration tested, visible yeast growth observed. 
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Figure 4.13: Growth inhibition evaluation for click intermediate cyanine dyes. Green bars indicate growth inhibition was comparable to ICG. 
Red bars indicate growth was comparable to AO. Yellow bar indicate growth in the intermediate range. 
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Compounds Fluorescence Studies Growth Inhibition 
Studies 
Code R Absorption 
λmax (nm) 
Fluorescence 
Emission 
(nm) 
Fluorescence 
Quantum Yield 
(Ф) 
Stokes Shift 
(nm) 
Minimum 
Growth Inhibition 
(µM) 
Log P 
25  764 791 0.17 27 6.38b 5.493 
26  804 821 0.09 17 2.91a 6.611 
27  759 786 0.12 27 6.27b 6.041 
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ICG Commercial 
Dye 
785 814 0.072 29 16.6b 1.591 
AO Commercial 
Dye 
- - - - <1.47a 3.321 
Table 4.13: Photophysicaldatas for heptamethine cyanine dye-azide conjugates. 
 
Quantum yields ± 10%, λmax ± 1 nm. Relative to ICG. 
Excitation at 785 nm. 
aIndicates no visible yeast growth observed at this concentration of dye. 
bIndicates highest possible concentration tested, visible yeast growth observed. 
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The spectral characteristics of the cyanine dye triazole conjugates (25 - 27) and alkyne 
intermediates (22 – 24) will be discussed together. The spectral properties collected are 
summarised in Table 4.12 and 4.13. It is worth noting that the click intermediates compounds and 
the cyanine dye azide conjugates showed higher fluorescence quantum yield when compared ICG 
and   IR-820   indicating   their   suitability  as   potential   labelling   agents.   Also   the   spectral 
characteristics of the intermediate cyanine dyes and the cyanine dye azide conjugates are similar 
because the modification occurs at the nitrogen of the benzothiazole, which is too far away from 
the chromophore to exert any influence on the spectral characteristics of the compounds. 
 
The growth inhibition data is interesting denoting that the trizaoles are less cytotoxic towards S. 
pombe in comparison to the linear alkyl chains and this seen when comparing  25 (6.38 µM) with 
23 (1.05 µM) and  27 (6.27 µM) with 27 (4.70 µM) respectively (Tables 4.12, 4.13 and Figures 
4.13, 4.14). This in part is understandable as the linear alkyl chains have the ability to penetrate 
and subsequently disrupt the lipid membrane [241]. 
 
 
 
Growth inhibition evaluation for cyanine dye azide conjugates 
18 
 
16 
 
14 
 
12 25 
10 26 
 
8 24 
6 ICG 
AO 
4 
 
2 
 
0 
25 26 24 ICG AO 
cyanine dye azide conjugates 
 
 
 
Figure 4.14: Growth inhibition evaluation for cyanine dye azide conjugates. Green bars 
indicate growth inhibition was comparable to ICG. Red bars indicate growth was comparable 
to AO. Yellow bar indicate growth in the intermediate range. 
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Figure 4.15:7b in MeOH excited at 785 nm showing absorption and emission spectra with 
 
Stokes fluorescence. 
 
 
 
 
 
Finally the dependence of the spectral properties of these dyes on various solvents was also 
investigated in  order to  investigate their performances  in  different  solvent  environments 
(Table 4.14). 
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7a 
 
 
 
 
 
Dye 
 
 
 
Solvent 
 
 
 
Absorption 
λAmax (nm) 
 
 
 
Fluorescence 
Emission 
λAmax (nm) 
 
 
 
Fluorescence 
quantum 
yield 
Ф 
 
 
 
Stoke Shift 
(nm) 
7a Methanol 736 786 0.030 50 
7a DMSO 757 799 0.023 42 
7a Propan-1-ol 739 791 0.053 52 
7a Chloroform 754 799 0.156 45 
7a Dichloromethane 757 798 0.184 41 
Table 4.14: 7a in various solvent. 
 
 
 
 
 
Based on the results (Table 4.14) obtained from the analysis, it is difficult to determine which 
of the solvent properties such as polarity, viscosity and hydrogen bonding has the most 
dominant effect on the spectral properties of the dye. Several conflicting results on the effects 
of different solvent on the spectral properties of heptamine cyanine dyes have already been 
reported in the literature [242, 240]. The most consistent data from the results obtained from 
this experiment indicates that the quantum yield of the dyes increased from polar solvents to 
non-polar solvents in the order DMSO<methanol<propan-1-ol<chloroform<dichloromethane. 
It should be noted that the values of ICG and IR-820 can be found in the Appendix (Journal 
of sulfur chemistry). 
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  CHAPTER FIVE  
 
 
Conclusion and 
Future work. 
 
 
 
The  use  of  molecular  probes  for  detecting  and  quantifying  biomolecules  is  an  area  of 
emerging interest and importance [1]. Using dyes which fluoresce in the visible region for 
this type of research can be challenging and can cause considerable problems, such as auto- 
fluorescence of a sample matrix [81]. The use of near-infrared (NIR) probes (700 – 1000 nm) 
has generated a vast array of interest, as these can be efficiently used to visualise and 
investigate in-vivo molecular targets as most tissues generate little NIR fluorescence [23]. 
Also probes operating in the NIR region offer deeper tissue penetration and low toxicity, 
which is beneficial for cell and tissue imaging [23]. Furthermore, the instrumentation 
techniques used for NIR Imaging is compact and relatively inexpensive; this is advantageous 
in terms of clinical applications [13]. 
 
Motivated  by this,  the  synthesis,  photophysical  properties  and  growth  inhibition 
characteristics of a series of structurally related non-targeting NIR heptamethine cyanine dyes 
have been investigated. The study first began with the synthesis of a series of heptamethine 
cyanine dyes (rigid and linear heptamethine cyanine dyes). The synthesised dyes were 
characterised by 1H, 13C NMR, ESI, HRMS, IR, UV and melting point analysis.   The rigid 
indolium heptamethine cyanine dyes (4 a-g and 6 a-g) were further functionalised by 
substitution of their meso-chlorine atom with an aniline molecule with the aim of improving 
their photophysical and growth inhibitory properties. However, in contrast to the indolium 
rigid heptamethine cyanine dyes, the benzothiazole dyes (5 a-g) were inert to treatment with 
aniline under various experimental conditions. Therefore the synthesis of the functionalised 
benzothiazole dyes was discontinued. The synthesis of the linear heptamethine dyes is in 
itself significant, this in-situ cascade reaction is a modification of the Zincke reaction [218] 
and provides an elegant approach to the linear dyes which can be tailored to develop more 
structurally sophisticated cyanine dyes. The impact of the novel approach for the synthesis of 
the linear dyes (9 a-g, 10 a-g and 11 a-g) and linear substituted heptamethine cyanine dyes 
(12-21) is  timely,  highlighting the development  of cost  effective molecular probes  with 
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enhanced photo-physical and toxicity characteristics when compared against the current 
clinical standards ICG and IR-820 [265]. 
 
The synthesis of NIR benzothiazole heptamethine cyanine dye azide conjugates (25-27) using 
the Cu(I)-catalyzed azide-alkyne cycloaddition (CuAAC) provides a prototype for the design 
of future long-wavelength absorbing cyanine dyes conjugated to biomolecules. Also, this 
further illustrates the structural versatility and applicability of the dyes synthesised in this 
research project. 
 
With the increasing importance of NIR heptamethine cyanine dyes in biological imaging 
applications,  dyes  with  unique  structural  features  and  improved  spectral  properties  are 
desired. Several approaches have been attempted to improve the overall photophysical 
properties (absorption and emission wavelengths, fluorescence quantum yields, Stokes shifts 
and effect of solvent polarity) of heptamethine cyanine dyes [226]. To this end, the 
photophysical properties of the dyes synthesised in this research project were evaluated and 
compared against those of the standard fluorophores ICG and IR-820. Structures of the 
heptamethine cyanine dyes investigated were broadly categorised into nine main groups 
based on their heterocyclic ring system and the substitution pattern of their polymethine 
chain; indolium-based rigid heptamethine cyanine dyes (4 a-g), rigid benzothiazole 
heptamethine cyanine dyes (5 a-g), rigid benzo[e] heptamethine cyanine dyes (6 a-g), 
functionalised indolium-based rigid heptamethine cyanine dyes (7 a- g and 8 a-e), indolium- 
based linear heptamethine cyanine dyes (9 a-g), linear benzothiazole heptamethine cyanine 
dyes (10 a-g), linear benzo[e] heptamethine cyanine dyes (11 a-g), substituted linear 
heptamethine cyanine dyes (12-21), and heptamethine cyanine dye-azide conjugates (25-27). 
On evaluation it was discovered that all the dyes exhibited absorption wavelength in the NIR 
region (700 -900 nm) indicating their suitability for deep tissue imaging applications. The 
absorption and emission wavelengths, fluorescence quantum yields and Stokes shifts for the 
synthesised dyes showed no significant change in terms of the substituting group on the 
indolium nitrogen. These observations could be attributed to the fact that the N-donor and N- 
acceptor substituting groups are too far away from the chromophore and as such have very 
little influence on the spectroscopic properties of the dyes. However, the quantum yields 
studies showed that the dyes bearing the benzothiazole moiety had higher quantum yield 
values  when  compared  with  the  linear  dyes  bearing  the  3,3-dimethylindolenine  moiety. 
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Furthermore, it was also noted that the benzothaizole dyes in (5 a-g and 10 a-g) demonstrated 
an approximate 2.5 to 3-fold increase in quantum yield when compared with IR-820 and ICG. 
These excellent quantum yield values indicate the suitability of the benzothiazole dyes as 
potential candidates for molecular imaging applications in clinical research [266]. It was also 
discovered that rigidification of the polymethine chain reduces the quantum yields by 
approximately 50%, and this was confirmed by comparing the rigid heptamethine dyes with 
the linear dyes. Dyes (7 a-g, 8 a-e) bearing the aniline moiety on their polymethine chain 
gave the highest Stokes shift values. The observed increase could be as a result of the 
substitution of the meso-chlorine atom with an aromatic moiety, resulting in a large structural 
change between the ground and the excited singlet state of the dyes. The increase in Stokes 
shifts is desired for this type of research since it renders the amine-substituted cyanine dyes 
useful as NIR platforms for the development of a wide range of feature targeting and non- 
targeting fluorescent probes [203]. 
 
Apart from the photophysical characteristics of the dyes, the growth inhibition and LogP 
properties  are  important   characteristics   which   determine  the  practical   use  of  these 
fluorophores in living cells. The effect of the synthesised dyes on cell growth was compared 
to ICG, IR-820 and  AO. The results obtained in this research indicated that most of the dyes 
which exhibited no growth inhibition effects were dyes bearing the sulfonic acid group on 
their N-donor and N-acceptor system. Most of the dyes that exhibited growth inhibition were 
the dyes bearing the alkyl or benzyl group at their N-donor and N-acceptor system. It was 
therefore postulated that the growth inhibition effect of these dyes could be attributed to the 
nature of substituent on the N-donor and N-acceptor system. Further support for these 
observations was seen using a virtual method, the logP. The presence of the sulfonic acid 
group on the dyes tends to increase their aqueous solubility and reduce their growth inhibition 
characteristics, possibly through reduced membrane permeability and cellular uptake. The 
dyes  bearing the  sulfonic  acid  groups  are  structurally very similar to  ICG,  IR820.  The 
presence of the alkyl group tends to reduce the solubility and increase the growth inhibitory 
characteristic of the dyes due to their lipophilic characteristics. 
 
In conclusion, the results from this research work offer a strong platform for the development 
of a wide range of future targeting and non-targeting fluorescent probes. Also the dyes 
reported in this research show huge potential as new fluorescent probes for potential clinical 
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applications. In particular the benzothiazole dyes (10f, 10g, 16, 17, 18) (Figure 5.1) bearing 
the sulfonic acid group on their heterocyclic ring systems manifested the most promising 
potentials in terms of their photophysical and growth inhibition properties. Dyes 16 and 17 in 
particular offer the opportunity to carry out more synthetic modifications, which can be 
tailored to develop more structurally sophisticated dyes. 
 
 
 
 
 
 
 
 
10f 10g 
Na+ 
 
 
 
 
 
 
 
 
 
 
16 17 
 
 
 
 
 
 
 
 
 
18 
 
 
Figure 5.1: Promising benzothiazole heptamethine cyanine dyes. 
 
 
In the future, more detailed assays involving yeast cells should be performed to fully 
characterise  more  biological  properties  of  these  dyes.  This  could  be  extended  into 
mammalian cells lines. Furthermore, in vivo studies investigating potential targeting 
mechanisms such as aptamers and antibodies should be performed. Finally, the dyes should 
also be investigated as potential multifunctional agents for both molecular imaging and PDT 
applications. 
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  CHAPTER SIX  
 
 
Experimental 
 
 
 
1H and 13C NMR spectra were measured on either a Bruker DPX 250 MHz, Bruker Avance- 
III 300 MHz or a Bruker Avance 400 MHz spectrometer at ambient temperature with 
tetramethylsilane (TMS) as internal standard for 1H NMR and deuteriochloroform (CDCl3, δC 
77.23 ppm) and deuteriodimethylsulfoxide (d6-DMSO, δC  39.51 ppm) for 13C NMR unless 
 
otherwise stated. All chemical shifts are quoted in δ (ppm) and coupling constants in Hertz 
(Hz) using the high frequency positive convention. Coupling constants were rounded up into 
whole numbers. Low and high resolution mass spectra were obtained using electrospray 
ionization (ESI) mass spectrometry on a hybrid linear ion trap-fourier transform mass 
spectrometer. Accurate mass measurements were carried out for novel compounds by EPSRC 
National mass spectrometry service research group using the Thermofisher LTQ Orbitrap XL. 
Infrared spectra were recorded on a Specac ATR with a He Ne -633 nm laser. Stock solutions 
for  UV-Vis  spectroscopy  of  dyes  were  prepared  in  methanol.  The  absorbance  and 
fluorescence   spectra   of   each   of   the   dyes   were   measured   sequentially   to   reduce 
photobleaching and solubility issues. The fluorescence quantum yields of the dyes were 
calculated using the relative method i.e. integrated fluorescence peak area versus fraction of 
light absorbed at the excitation wavelength were plotted for both the standards and cyanine 
dyes [175]. Fluorescence quantum yields (φ) were measured using a fluorimeter based on an 
Innovative Photonic Solutions 785 nm diode laser, operating with a power output of 8 mW, 
an  Andor  Shamrock  SR-303i  spectrograph  and  an  Andor  iDus  CCD  detector  (model 
DU420A-BR-DD). Fluorescence was detected at right angles without any filters. The spectral 
response of the system was corrected following the method outlined by Kosch and coworkers 
[267]. Absorbance values (A) of solutions at 785 nm were measured using a Perkin Elmer 
Lambda 25 spectrophotometer. Corrected fluorescence spectra for a series of solutions of 
increasing concentration were rescaled in energy and the integrated intensity was plotted 
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versus 1-10-A, with A (785 nm) ≤ 0.1. The quantum yields were obtained from the relative 
slopes of such plots compared with that from solutions of ICG in dimethyl sulfoxide. For 
determinations in different solvents, the refractive index (n2) correction was applied. LogP 
values were obtained using the virtual method (the base 10 logarithm) [268]. Thin Layer 
Chromatography (TLC) was carried out on Machery-Nagel polygramSil/G/UV254 pre-coated 
plates. Melting point (m.p) analysis was carried out using a Griffin melting point apparatus. 
All   chemicals   were   purchased   from   commercial   sources   and   used   without   further 
purification. 
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1,2,3,3-Tetramethyl-3H-indol-1-ium iodide (1a) was synthesised according to a reported 
 
procedure [243]. 
 
 
 
 
 
 
 
 
 
2,3,3-Trimethylindolenine (1.00 g, 6.30 mmol) was dissolved in iodomethane (10.0 mL, 168 
mmol)  with  constant  stirring,  and  the  solution  was  heated  under  reflux  for  17  h.  The 
precipitate produced  was filtered under suction, washed with n-hexane and dried in vacuo to 
give the product 1a (1.12 g, 58%) as a pink solid; m.p. 257-259 °C, literature m.p. 258 °C 
[244]: 1H NMR (d6-DMSO, 250 MHz) δ 7.91-7.84 (m, 1H, Ar-H), 7.83-7.74 (m, 1H, Ar-H), 
7.62-7.53 (m, 2H, Ar-H), 3.92 (s, 3H, N-CH3), 2.71 (s, 3H, N-C-CH3), 1.47 (s, 6H, C- 
(CH3)2). 13C NMR (d6-DMSO, 62.8 MHz) δ 195.2, 142.3, 142.1, 122.9, 122.3, 121.9, 118.3, 
57.2, 38.4, 22.2, 15.1. IR (ATR) 2965, 1630, 1481, 938, 776, 588 cm-1. MS (ESI) m/z: 174 
[M]+. 
 
 
 
 
1-Ethyl-2,3,3-trimethyl-3H-indol-1-ium iodide (1b). 
 
 
 
 
 
 
 
 
 
 
 
1b  was  synthesised  as  for  1a  using  2,3,3-trimethylindolenine  (1.00  g,  6.30  mmol)  and 
iodoethane (13.0 mL, 168 mmol) to give the product 1b (1.70 g, 86%) as a pink solid; m.p. 
228-230 °C, literature m.p. 226-228 °C [245] : 1H NMR (d6-DMSO, 250 MHz) δ 7.69-7.65 
 
(m, 1H, Ar-H), 7.56- 7.53(m, 1H, Ar-H), 7.35-6.92 (m, 2H, Ar-H), 4.15 (q, J=8.0 Hz, 2H, N- 
CH2-CH3), 2.51 (s, 3H, N-C-CH3), 1.31 (s, 6H, C-(CH3)2), 1.12 (t, J=8.0 Hz, 3H, CH2-CH3). 
13C NMR (d6-DMSO, 62.8 MHz) δ 196.0, 141.9, 140.7, 129.37, 128.9, 123.5, 115.2, 54.1, 
43.0, 21.8, 13.7, 12.6. IR (ATR) 2969, 1630, 1459, 1364, 1129, 928, 772, 583 cm-1. MS (ESI) 
 
m/z: 188 [M]+. 
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2,3,3-Trimethyl-1-propyl-3H-indol-1-ium iodide (1c). 
 
 
 
 
 
 
 
 
 
 
 
 
1c was synthesised as for 1a using 2,3,3-trimethylindolenine (1.00 g, 6.30 mmol) and 
iodopropane (13.0 mL, 168 mmol) to give the product 1c (1.95 g, 94%) as a brown solid; 
m.p. 131-133 °C, literature m.p. 159 °C [246]: 1H NMR (d6-DMSO, 400 MHz) δ 8.02-7.99 
(m, 1H, Ar-H), 7.87-7.81 (m, 1H, Ar-H), 7.64-7.58 (m, 2H, Ar-H), 4.48 (t, J=6.0 Hz, 2H, N- 
CH2-CH2), 2.50 (s, 3H, N-C-CH3), 1.92 (sex, J=6.0 Hz, 2H, CH2-CH2-CH3), 1.55 (s, 6H, C- 
(CH3)2), 1.02 (t, J=6.0 Hz, 3H, CH2-CH3). 13C NMR (75.4 MHz, CDCl3): δ 195.7, 141.5, 
 
140.8, 130.2, 129.5, 123.5, 115.5, 54.7, 51.2, 23.3, 21.6, 17.1, 11.4. IR (ATR) 2970, 1641, 
 
1456, 1367, 1132, 920, 768, 572 cm-1. MS (ESI) m/z: 203 [M]+. 
 
 
 
 
 
1-Butyl-2,3,3-trimethyl-3H-indol-1-ium iodide (1d). 
 
 
 
 
 
 
 
 
 
 
 
 
1d  was  synthesised  as  for  1a  using  2,3,3-trimethylindolenine  (5.00  g,  31.4  mmol)  and 
iodobutane (20.0 mL,168 mmol) to give the product 1d (7.13 g, 67%) as a brown solid; m.p. 
139-141 °C, literature m.p. 136 °C [246]: 1H NMR (d6-DMSO, 300 MHz) δ 8.03 (d, J=9.0 
 
Hz, 1H, Ar-H), 7.88 (d, J=9.0 Hz, 1H, Ar-H), 7.63-7.60 (m, 2H, Ar-H), 4.50 (t, J=6.0 Hz, 
 
2H, N-CH2-CH2), 2.89 (s, 3H, N-C-CH3), 1.85 (quin, J=6.0 Hz, 2H, N-CH2-CH2-CH2), 1.55 
(s, 6H, C-(CH3)2), 1.47 (sex, J=6.0 Hz, 2H, CH2-CH2-CH3), 0.95 (t, J=6.0 Hz, 3H, CH2-CH3). 
13C NMR (75.4 MHz, CDCl3): δ 196.8, 144.1, 142.3, 141.5, 129.8, 129.4, 124.0, 116.0, 54.6, 
29.8, 22.5, 19.8, 14.9, 14.1. IR (ATR) 2862, 1593, 1458, 1371, 1296, 925, 776, 596 cm-1. MS 
(ESI) m/z: 216 [M]+. 
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1-Benzyl-2,3,3-trimethyl-3H-indol-1-ium  bromide  (1k)  was  synthesised  according  to  a 
 
reported procedure [247]. 
 
 
 
 
 
 
 
 
 
 
 
 
Benzyl bromide (0.80 mL, 6.80 mmol) dissolved in acetonitrile (20.0 mL) was stirred with 
constant heating under reflux. 2,3,3-trimethylindolenine (1.00 g, 6.30 mmol) was dissolved in 
acetonitrile (20.0 mL) and added drop wise to the reaction mixture from a dropping funnel. 
The reaction was stirred for 39 h with constant heating. The precipitate produced was filtered 
under suction, washed with n-hexane and dried in vacuo to give the product 1k (1.65 g, 77%) 
as a red hygroscopic solid; m.p. 226-228 °C. 1H NMR (d6-DMSO, 250 MHz) δ 7.89 (d, J=7.0 
 
Hz, 1H, Ar-H), 7.84 (d, J=7.0 Hz, 1H, Ar-H), 7.67-7.59 (m, 2H, Ar-H), 7.45-7.38 (m, 5H, 
Ar-H), 5.87 (s, 2H, N-CH2), 3.59 (s, 3H, N-C-CH3), 1.55 (s, 6H C-(CH3)2). 13C NMR (d6- 
DMSO, 62.8 MHz) δ 198.7, 142.5, 141.6, 132.7, 130.1, 129.5, 129.3, 128.1, 124.2, 116.5, 
55.1, 51.2, 22.7, 15.1, 9.8. IR (ATR) 2969, 1603, 1454, 931, 741, 701, 567 cm-1. MS (ESI) 
 
m/z: 250 [M]+. 
 
 
 
 
2,3,3-Trimethyl-1-(3-sulfonatopropyl)-3H-indol-1-ium (1l) was synthesised according to a 
reported procedure [248]. 
 
 
 
 
 
 
 
 
 
 
 
 
To a solution of 2,3,3-trimethylindolenine (9.92 g, 62.3 mmol) in toluene (50 mL) was added 
 
1,3-propanesultone (11.4 g, 93.5 mmol) with constant stirring, and the solution was heated 
under reflux for 18 h. The precipitate produced was filtered under suction, washed with 
toluene and dried in vacuo to give the product 1l (11.0 g, 63%) as a purple solid; m.p. 241- 
243 °C. 1H NMR (d6-DMSO, 400 MHz) δ 8.47 (d, J=7.0 Hz, 1H, Ar-H), 8.25 (d, J=8.0 Hz, 
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1H, Ar-H), 8.04-7.99 (m, 2H, Ar-H), 4.53 (t, J=7.0 Hz, 2H, N-CH2-CH2), 3.01-2.95 (m, 2H, 
CH2-SO3), 2.73 (s, 3H, N-C-CH3), 2.29-2.21 (m, 2H, CH2-CH2-CH2), 1.45 (s, 6H, C-(CH3)2). 
13C NMR (d6- DMSO, 75.4 MHz) δ 207.08, 177.75, 177.72, 141.35, 129.61, 128.51, 125.01, 
 
117.31, 47.80, 47.78, 31.17, 24.72, 17.21. IR (ATR) 2817, 1566, 1444, 1143, 1012, 770, 717, 
 
662 cm-1. MS (ESI) m/z: 282 [M+H]+. 
 
 
 
 
 
2,3,3-Trimethyl-1-(4-sulfonatobutyl)-3H-indol-1-ium (1m). 
 
 
 
 
 
 
 
 
 
 
 
 
 
1m was synthesised as for 1l using 2,3,3-trimethylindolenine (9.92 g, 62.3 mmol) and 1,4- 
butanesultone (12.7 g, 93.5 mmol)  to give the product 1m (9.33 g, 50%) as a white solid; 
m.p. 241-243 °C. 1H NMR (D2O, 400 MHz) δ 7.68 (d, J=6.0 Hz, 1H, Ar-H), 7.62 (d, J=6.0 
Hz, 1H, Ar-H), 7.52-7.41 (m, 2H, Ar-H), 4.40 (t, J=7.0 Hz, 2H, N-CH2), 2.85 (t, J=7.0 Hz, 
 
2H, -CH2-CH2-SO3), 2.70 (s, 3H, N-C-CH3), 2.00-1.97 (m, 2H, N-CH2-CH2-CH2), 1.77-1.69 
(m, 2H, CH2-CH2-CH2-SO3), 1.44 (s, 6H, C-(CH3)2). 13C NMR (D2O, 62.8 MHz) δ 196.4, 
141.7, 140.8, 129.8, 129.0, 123.3, 115.0, 54.4, 49.9, 47.3, 25.3, 21.6, 21.4, 1112. IR (ATR) 
 
2857, 1560, 1460, 1183, 1032, 780, 727, 666 cm-1. MS (ESI) m/z: 296 [M+H]+. 
 
 
 
 
2-Methyl-3-(methyl)-benzothiazolium iodide (2a) was synthesised according to a reported 
procedure [249]. 
 
 
 
 
 
 
To a solution of 2-methylbenzothiazole (0.94 g, 6.30 mmol) in toluene (50.0 mL), was added 
iodomethane (10.0 mL, 168 mmol) with constant stirring, and the solution was heated under 
reflux for 18 h. The precipitate produced was filtered under suction, washed with n-hexane 
and dried in vacuo to give the product 2a (1.64 g, 87%) as a white solid; m.p. 227-229 °C, 
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literature m.p. 225-226 °C [250]: 1H NMR (d6-DMSO, 250 MHz) δ 8.46 (d, J=8.0 Hz, 1H, 
Ar-H), 8.31 (d, J=9.0 Hz, 1H, Ar-H), 7.96 (t, J=9.0 Hz, 1H, Ar-H), 7.81 (t, J=8.0 Hz, 1H, Ar- 
H), 4.23 (s, 3H, N-CH3), 3.11 (s, 3H, N-C-CH3). 13C NMR (d6-DMSO, 62.8 MHz)  δ 177.2, 
141.5, 129.2, 128.6, 128.0,124.4, 116.7, 36.1, 17.1. IR (ATR) 2965, 1548, 1441, 1336, 1210, 
 
1131, 1011, 764, 717, 579 cm-1. MS (ESI) m/z: 164 [M]+. 
 
 
 
 
 
2-Methyl-3-(ethyl)-benzothiazolium iodide (2b). 
 
 
 
 
 
 
 
2b  was  synthesised  as  for  2a  using  2-methylbenzothiazole  (0.94  g,  6.30  mmol)  and 
iodoethane (13.5 mL, 168 mmol) to give the product 2b (0.84 g, 41%) as a white solid; m.p. 
196-200 °C, literature m.p. 198-200 °C [251]: 1H NMR (d6-DMSO, 250 MHz) δ 8.49 (d, 
 
J=7.0 Hz, 1H, Ar-H), 8.40 (d, J=7.0 Hz, 1H, Ar-H), 7.83 (t, J=8.0 Hz, 1H, Ar-H), 7.79 (t, 
J=7.0 Hz, 1H, Ar-H), 4.75 (t, J=7.0 Hz, 2H, N-CH2-CH3), 3.19 (s, 3H, N-C-CH3), 1.45 (t, 
J=7.0 Hz, 3H, C-CH3). 13C NMR (d6-DMSO, 62.8 MHz) δ 176.8, 140.4, 129.3, 129.1, 128.1, 
124.7, 116.6, 44.7, 16.7, 13.2. IR (ATR) 2912, 1613, 1513, 1445, 1329, 1270, 1203, 1100, 
 
777, 713, 670 cm-1. MS (ESI) m/z: 178 [M]+. 
 
 
 
 
 
2-Methyl-3-(propyl)-benzothiazolium iodide (2c). 
 
 
 
 
 
 
 
 
2c  was  synthesised  as  for  2a  using  2-methylbenzothiazole  (0.94  g,  6.30  mmol)  and 
iodopropane (13.5 mL, 168 mmol) to give the product 2c (1.62 g, 81%) as a white solid; m.p. 
199-201 °C: 1H NMR (d6-DMSO, 400 MHz) δ 8.51 (d, J=6.0 Hz, 1H, Ar-H), 8.42 (d, J=6.0 
 
Hz, 1H, Ar-H), 7.93 (t, J=9.0 Hz, 1H, Ar-H), 7.84 (t, J=6.0 Hz, 1H, Ar-H), 4.74 (t, J=6.0 Hz, 
 
2H, N-CH2- CH2), 3.25 (s, 3H, N-C-CH3), 1.93 (sex, J=6.0 Hz, 2H, CH2-CH2-CH3), 1.05 (t, 
J=6.0 Hz, 3H, CH2-CH3). 13C NMR (d6-DMSO, 75.4 MHz): δ 177.6, 141.3, 129.8, 129.5, 
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128.5, 125.1, 117.4, 50.8, 21.8, 17.3, 11.2. IR (ATR) 2919, 1607, 1518, 1449 cm-1. MS (ESI) 
 
m/z: 192.21 [M]+. 
 
 
 
 
 
2-Methyl-3-(butyl)-benzothiazolium iodide (2d). 
 
 
 
 
 
 
 
 
 
2d was synthesised as for 2a using 2-methylbenzothiazole (5.00 g, 33.5 mmol) and 1- 
iodobutane (20.0 mL, 175 mmol) to give the product 2d (3.63 g, 33%) as a cream solid; m.p. 
189-191 °C, literature m.p. 186-187 °C [252]: 1H NMR (d6-DMSO, 300 MHz) δ 8.48 (d, 
 
J=6.0 Hz, 1H, Ar-H), 8.37 (d, J=6.0 Hz, 1H, Ar-H), 7.92 (t, J=6.0 Hz, 1H, Ar-H), 7.83 (t, 
J=6.0 Hz, 1H, Ar-H),  4.74 (t, J=6.0 Hz, 2H, N-CH2-CH2), 3.23 (s, 3H, N-C-CH3), 1.86-1.71 
(m, 2H, N-CH2-CH2-CH2), 1.49-1.31 (m, 2H, N-CH2-CH2-CH2), 0.96 (t, J=9.0 Hz, 3H, CH2- 
CH3). 13C NMR (75.4 MHz, CDCl3): δ 177.5, 141.3, 129.8, 129.5, 128.5, 125.1, 117.3, 49.5, 
30.2, 19.7, 17.4, 14.0. IR (ATR) 2951, 1577, 1439, 1378, 1280, 948, 764 cm-1. MS (ESI) m/z: 
 
206.09 [M]+. 
 
 
 
 
 
 
 
2-Methyl-3-(2-benzyl)-benzothiazolium (2k) [245]. 
 
 
 
 
 
 
 
 
To a solution of 2-methylbenzothiazole (0.94 g, 6.30 mmol) in toluene (20.0 mL) was added 
benzyl bromide (1.16 g, 93.5 mmol) with constant stirring, and the solution was heated under 
reflux for 36 h. The precipitate produced was filtered under suction, washed with n-hexane 
and dried in vacuo to give the product 2k (0.12 g, 7%) as a pink solid; m.p. 94-96 °C, 
literature m.p. 93 °C [253]: 1H NMR (d6-DMSO, 250 MHz) δ 8.47 (d, J=7.0 Hz, 1H, Ar-H), 
8.12 (d, J=7.0 Hz, 1H, Ar-H), 7.45-7.40 (m, 2H, Ar-H), 7.32-7.11 (m, 5H, Ar-H), 6.12 (s, 2H, 
 
CH2-Ph), 3.21 (s, 3H, C-CH3). 13C NMR (d6-DMSO, 62.8 MHz) δ 186.4, 178.4, 140.9, 132.7, 
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129.5, 129.2, 128.1, 127.5, 126.9, 124.8, 117.0, 51.8, 17.2. IR (ATR) 2938, 1578, 1455, 
 
1339, 1021, 808, 748, 577 cm-1. MS (ESI) m/z: 240 [M]+. 
 
 
 
 
 
2-Methyl-3-(4-sulfopropyl)-benzothiazolium (2l). 
 
 
 
 
 
 
 
 
2l was synthesised as for 2a using 2-methylbenzothiazole (9.30 g, 62.3 mmol), and 1,3- 
propanesultone (11.4 g, 93.5 mmol) to give the product 2l (15.0 g, 91%) as a white solid; 
m.p. 258-260 °C, literature m.p. 276-278 °C [254]: 1H NMR (d6-DMSO, 250 MHz) δ 8.23- 
7.80 (m, 2H, Ar-H), 7.28 (t, J=7.0 Hz, 1H, Ar-H), 7.67 (t, J=7.0 Hz, 1H, Ar-H), 4.72 (t, J=7.0 
 
Hz, 2H, N-CH2), 3.08 (s, 3H, N-C-CH3), 3.02 (t, J=7.0 Hz, 2H, CH2-CH2-SO3), 2.28-2.20 (m, 
2H, N-CH2-CH2). 13C NMR (D2O, 75.4 MHz) δ 176.2, 140.7, 129.6, 128.8, 128.4, 123.6, 
116.1, 47.6, 47.2, 23.0, 16.1. IR (ATR) 2917, 1511, 1413, 1353, 1263, 1032, 756, 663 cm-1. 
MS (ESI) m/z: 272 [M+H]+. 
 
 
 
 
2-Methyl-3-(4-sulfobutyl)-benzothiazolium (2m). 
 
 
 
 
 
 
 
 
 
 
2m was synthesised as for 2a using 2-methylbenzothiazole (9.30 g, 62.3 mmol), and 1,4- 
butanesultone (12.7 g, 93.5 mmol) to give the product 2m (9.24 g, 51%) as a white solid; 
m.p. 258-260 °C, literature m.p. 294 °C [255]: 1H NMR (d6-DMSO, 300 MHz): δ 8.42 (d, 
J=9.0 Hz, 2H, Ar-H), 7.87 (t, J=9.0 Hz, 1H, Ar-H), 7.78 (t, J=9.0 Hz, 1H, Ar-H), 4.91 (t, 
J=9.0 Hz, 2H, N-CH2), 3.20 (s, 3H, N-C-CH3), 3.16  (br s, 2H, C-CH2), 2.67 (t, J=6.0 Hz, 
2H, C-CH2) 2.17 (q, J=9.0 Hz, 2H, C-CH2). 13C NMR (D2O, 62.8 MHz) δ 175.9, 140.9, 
 
129.6, 128.9, 128.4, 123.6, 116.4, 50.0, 48.9, 26.3, 21.4, 16.2. IR (ATR) 2947, 1523, 1443, 
 
1343, 1283, 1175, 1032, 796, 777, 714, 683 cm-1. MS (ESI) m/z: 286 [M+H]+. 
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1,1,2,3-Tetramethyl-1H-benzo[e]indol-3-ium iodide (3a) [243]. 
 
 
 
 
 
 
 
To a solution of 1,1,2-trimethyl-1H-benzo[e]indole (3.90 g, 18.6 mmol) in toluene (50.0 mL) 
was added iodomethane (20.0 mL, 481 mmol) with constant stirring, and the solution was 
heated under reflux for 18 h. The precipitate produced was filtered under suction, washed 
with n-hexane and dried in vacuo to give the product 3a (6.03 g, 91%) as a brown solid; m.p. 
230-232 °C, literature m.p. 221-223 °C [256]. 1H NMR (d6-DMSO, 300 MHz) δ 8.38 (d, 
 
J=9.0 Hz, 1H, Ar-H), 8.31 (d, J=9.0 Hz, 1H, Ar-H), 8.23 (d, J=9.0 Hz, 1H, Ar-H), 8.13 (d, 
 
J=9.0 Hz, 1H, Ar-H), 7.81-7.69 (m, 2H, Ar-H), 4.10 (s, 3H, N-CH3), 2.88 (s, 3H, N-C-CH3), 
1.75 (s, 6H, C-(CH3)2). 13C NMR (75.4 MHz, CDCl3): δ 196.1, 139.9, 137.8, 136.9, 133.4, 
 
130.9, 130.2, 129.3, 128.6, 127.5,113.6, 55.7, 21.7, 21.5, 14.5. IR (ATR) 3012, 1635, 1464, 
 
1391, 1225, 991, 895, 739 cm-1. MS (ESI) m/z: 224 [M]+. 
 
 
 
 
 
3-Ethyl-1,1,2-Trimethyl-1H-benzo[e]indol-3-ium iodide (3b). 
 
 
 
 
 
 
 
 
3b was synthesised as for 3a using 1,1,2-trimethyl-1H-benzo[e]indole (3.90 g, 18.6 mmol) 
and iodoethane (30.0 mL, 375 mmol) to give the product 3b (6.06 g, 89%) as a white solid; 
m.p. 215-217 °C, literature m.p. 213-218 °C [257]. 1H NMR (d6-DMSO, 300 MHz) δ 8.39 (d, 
J=6.0 Hz, 1H, Ar-H), 8.32 (d, J=9.0 Hz, 1H, Ar-H), 8.24 (d, J=9.0 Hz, 1H, Ar-H), 8.18 (d, 
J=9.0 Hz, 1H, Ar-H), 7.81-7.70 (m, 2H, Ar-H), 4.61 (q, J=7.0 Hz, 2H, N-CH2-CH3), 2.95 (s, 
3H, N-C-CH3), 1.76 (s, 6H, C-(CH3)2), 1.50 (t, J=7.0 Hz, 3H, CH2-CH3). 13C NMR (75.4 
 
MHz, CDCl3): δ 196.4, 138.6, 137.4, 133.4, 131.1, 130.1, 128.8, 127.7, 125.5, 123.9, 113.6, 
55.9, 43.8, 21.9, 14.1, 13.3. IR (ATR) 2978, 1583, 1461, 1388, 1215, 969, 874, 753 cm-1. MS 
(ESI) m/z: 238 [M]+. 
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1,1,2-Trimethyl-3-propyl-1H-benzo[e]indol-3-ium iodide (3c). 
 
 
 
 
 
 
 
 
 
3c was synthesised as for 3a using 1,1,2-trimethyl-1H-benzo[e]indole (3.90 g, 18.6 mmol) 
and iodopropane (30.0 mL, 309 mmol) to give the product 3c (5.74 g, 81%) as a brown solid; 
m.p. 165-167 °C. 1H NMR (d6-DMSO, 300 MHz) δ 8.39 (d, J=6.0 Hz, 1H, Ar-H), 8.31 (d, 
J=9.0 Hz, 1H, Ar-H), 8.23-8.17 (m, 2H, Ar-H), 7.85-7.70 (m, 2H, Ar-H), 4.60 (t, J=6.0 Hz, 
2H, N-CH2-CH2), 2.97 (s, 3H, N-C-CH3), 1.97 (sex, J=6.0 Hz, 2H, N-CH2-CH2), 1.77 (s, 6H, 
C-(CH3)2), 1.05 (t, J=6.0 Hz, 3H, CH2-CH3). 13C NMR (75.4 MHz, CDCl3): δ 196.9, 139.0, 
137.8, 133.4, 130.1, 129.3, 128.8, 127.7, 125.7, 123.9, 113.8, 55.9, 44.0, 22.1, 21.5, 14.4, 
 
11.2. IR (ATR) 2970, 2161, 2030, 1580, 1461, 1389, 1210, 1146, 993, 869, 742 cm-1. MS 
(ESI) m/z: 252 [M]+. 
 
 
 
 
3-Butyl-1,1,2-trimethyl-1H-benzo[e]indol-3-ium iodide (3d). 
 
 
 
 
 
 
 
 
 
 
3d was synthesised as for 3a using 1,1,2-trimethyl-1H-benzo[e]indole (3.90 g, 18.6 mmol) 
and iodobutane (30.0 mL, 263 mmol) to give the product 3d (4.82 g, 66%) as a yellow 
brownish solid; m.p. 166-168 °C, literature m.p. 165-168 °C [258]. 1H NMR (d6-DMSO, 300 
MHz) δ 8.25 (d, J=6.0 Hz, 1H, Ar-H), 8.17 (d, J=9.0 Hz, 1H, Ar-H), 8.09 (dd, J=6.0 Hz, 2H, 
 
Ar-H), 7.67-7.55 (m, 2H, Ar-H), 4.47 (t, J=6.0 Hz, 2H, N-CH2-CH2), 2.82 (s, 3H, N-C-CH3), 
 
1.76 (quin, J=6.0 Hz, 2H, N-CH2-CH2-CH2), 1.62 (s, 6H, C-(CH3)2), 1.36 (sex, J=6.0 Hz, 2H, 
CH2-CH3), 0.82 (t, J=6.0 Hz, 3H, CH2-CH3). 13C NMR (75.4 MHz, CDCl3): δ 196.7, 139.9, 
138.9, 137.4, 136.9, 133.4, 132.8, 131.1, 130.9, 130.1, 128.9, 55.9, 55.7, 48.2, 22.2, 21.7, 
 
21.5, 14.1. IR (ATR) 2866, 1577, 1460, 1387, 1206, 1131, 992, 870, 752 cm-1. MS (ESI) m/z: 
 
266 [M]+. 
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3-Benzyl-1,1,2-trimethyl-1H-benzo[e]indol-3-ium bromide (3e). 
 
 
 
 
 
 
 
 
 
 
3e was synthesised as for 3a using 1,1,2-trimethyl-1H-benzo[e]indole (3.90 g, 18.6 mmol) 
and benzyl bromide (3.10 mL, 25.2 mmol) to give the product 3e (4.63 g, 65%) as a light 
yellow solid; m.p. 236-238 °C. 1H NMR (d6-DMSO, 300 MHz) δ 8.42 (d, J=6.0 Hz, 1H, Ar- 
H), 8.25 (d, J=9.0 Hz, 1H, Ar-H), 8.19-8.11 (m, 3H, Ar-H), 7.99 (d, J=9.0 Hz, 1H, Ar-H), 
7.83-7.60 (m, 5H, Ar-H), 5.99 (s, 2H, N-CH2-Ph), 3.09 (s, 3H, N-C-CH3), 1.75 (s, 6H, C- 
(CH3)2). IR (ATR) 2965, 1609, 1459, 929, 748, 712, 560 cm-1. MS (ESI) m/z: 301.51[M]+. 
 
 
 
 
 
1,1,2-Trimethyl-3-(3-sulfonatopropyl)-1H-benzo[e]indol-3-ium (3f). 
 
 
 
 
 
 
 
 
 
 
3f was synthesised as for 3a using 1,1,2-trimethyl-1H-benzo[e]indole (3.25 g, 15.5 mmol) 
and 1,3-propanesultone (2.10 mL, 23.3 mmol) to give the product 3f (3.35 g, 65%) as a white 
solid; m.p. 268-270 °C. 1H NMR (d6-DMSO, 300 MHz) δ 8.37-8.20 (m, 4H, Ar-H), 7.70- 
7.71 (m, 2H, Ar-H), 4.77 (t, J=7.0 Hz, 2H, N-CH2-CH2), 2.93 (s, 3H, N-C-CH3), 2.69 (t, 
 
J=9.0 Hz, 2H, CH2-CH2-SO3), 2.23 (br s, 2H, CH2-CH2-SO3), 1.75 (s, 6H, C-CH3). IR (ATR) 
2978, 1582, 1463, 1389, 1181, 1030, 930, 874, 759 cm-1. MS (ESI) m/z: 332 [M+H]+. 
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1,1,2-Trimethyl-3-(4-sulfonatobutyl)-1H-benzo[e]indol-3-ium (3g). 
 
 
 
 
 
 
 
 
 
 
 
 
3g was synthesised as for 3a using 1,1,2-trimethyl-1H-benzo[e]indole (3.25 g, 15.5 mmol) 
and 1,4-bultanesultone (4.10 mL, 25.1 mmol) to give the product 3g (1.52 g, 28%) as a grey 
solid; m.p. 270-272 °C. 1H NMR (d6-DMSO, 300 MHz) δ 8.25 (d, J=8.0 Hz, 1H, Ar-H), 8.17 
(d, J=9.0 Hz, 1H, Ar-H), 8.10 (d, J=9.0 Hz, 2H, Ar-H), 7.66-7.59 (m, 2H, Ar-H), 4.36 (t, 
J=9.0 Hz, 2H, N-CH2-CH2), 2.95 (s, 3H, N-C-CH3), 2.08-2.02 (m, 6H, (CH2)3-SO3), 1.75 (s, 
6H, C-CH3). IR (ATR) 2964, 1582, 1468, 1350, 1152, 1032, 930, 874, 727 cm-1. MS (ESI) 
m/z: 346 [M+H]+. 
 
 
 
 
 
N-[5-Anilino-3-chloro-2,4-(propane-1,3-diyl)-2,4-pentadiene]anilinium  chloride  (VH1) 
 
was synthesised according to a reported procedure [259], [199]. 
 
 
 
 
 
 
 
 
At 0 ºC POCl3 (11.0 mL, 120 mmol) was added dropwise to anhydrous DMF (13.0 mL, 170 
mmol) with constant stirring. After 30 min, cyclohexanone (5.50 mL, 53.0 mmol) was added, 
and the mixture was heated under reflux for 1 h.  The reaction was cooled to 20 ºC and with 
constant stirring a mixture of aniline/EtOH [1:1 (v/v), 18.0 mL] was added dropwise. The 
reaction was continued for 30 min at 20 ºC with vigorous stirring, then the deep purple 
mixture was poured into H2O/HCl [10:1 (v/v), 110 mL]. Crystals were allowed to form for 2 
h in an ice bath; the reaction was filtered, washed with cold H2O and Et2O, and then dried in 
vacuo to give the product VH1 (15.4 g, 81%) as a dark purple solid; m.p. 226-228 °C, 
literature m.p. 220 °C [254]. 1H NMR (d6-DMSO, 250 MHz) δ 11.2 (br s, 2H, NH), 8.55 (d, 
J=14.0 Hz, 2H, CHalkene), 7.68 (d, J=7.0 Hz, 4H, Ar-H), 7.44 (t, J=7.0 Hz, 4H, Ar-H), 7.30- 
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7.28 (m, 2H, Ar-H), 3.03 (t, J=6.0 Hz, 4H, CH2-CH2), 2.05-1.98 (m, 2H, CH2-CH2). IR 
(ATR) 1609, 1562, 1457, 1267, 1179, 752, 683, 565 cm-1. MS (ESI) m/z: 323.22 [M]+. 
 
 
 
 
2-[(E)-2-[(3E)-2-Chloro-3-{2-[(2E)-3,3-dimethyl-1-(4-sulfonatobutyl)-2,3-dihydro-1H- 
indol-2-ylidene]ethylidene}cyclohex-1-en-1-yl]ethenyl]-3,3-dimethyl-1-(4- 
sulfonatobutyl)-3H-indol-1-ium (4g) was synthesised according to a reported procedure 
 
[260]. 
 
 
 
 
 
 
 
 
 
Na+ 
 
 
To a solution of 1l (1.77 g, 6.00 mmol) and anhydrous sodium acetate (0.60 g, 6.00 mmol) in 
EtOH (60.0 mL) was added VH1 (1.08 g, 3.00 mmol) with constant stirring, and the solution 
was heated under reflux for 4 h, cooled and then rotor evaporated to dryness. After removing 
the solvent, the crude product was purified by silica gel column chromatography (eluent 
solvent; chloroform:methanol = 7:3) to give the product 4g (1.01 g, 46%) as a shiny purple 
solid; m.p. 253-255 °C: 1H NMR (d6-DMSO, 400 MHz) δ 8.21 (d, J=14.0 Hz, 2H, CHalkene), 
7.67 (d, J=7.0 Hz, 2H, Ar-H), 7.39-7.31 (m, 4H, Ar-H), 7.12-7.06 (m, 2H, Ar-H), 6.31 (d, 
 
J=14.0 Hz, 2H, CHalkene), 4.89 (t, J=5.0 Hz, 4H, N-CH2-CH2), 3.01-2.96 (m, 4H, CH2-CH2), 
 
2.68-2.60 (m, 4H, CH2-CH2), 1.70-1.61 (m, 8H, (CH2)4-SO3), 1.50 (s, 12H, C-CH3), 1.30- 
1.09 (m, 2H, CH2-CH2). IR (ATR) 2921, 1541, 1240, 1004, 889, 707, 565 cm-1. MS (ESI) 
m/z: 727 [M+2H]+. UV abs λmax = 770 nm. 
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2-[(E)-2-[(3E)-2-Chloro-3-{2-[(2E)-1,3,3-trimethyl-2,3-dihydro-1H-indol-2- 
ylidene]ethylidene}cyclohex-1-en-1-yl]ethenyl]-1,3,3-trimethyl-3H-indol-1-ium iodide 
(4a). 
 
 
 
 
 
 
 
 
 
4a was synthesised as for 4g using 1a (0.602 g, 2.00 mmol) and anhydrous sodium acetate 
(0.16 g, 2.00 mmol) in EtOH (20.0 mL) and was added VH1 (0.36 g, 1.00 mmol) to give the 
crude product which was purified by silica gel column chromatography (solvent; chloroform: 
methanol=9:1) to obtain cyanine dye 4a (0.22 g, 36%) as a green solid; m.p. 253-255 °C: 1H 
NMR (d6-DMSO, 400 MHz) δ 8.27 (d, J=14.0 Hz, 2H, CHalkene), 7.64 (d, J=7.0 Hz, 2H, Ar- 
H), 7.46-7.40 (m, 4H, Ar-H), 7.32-7.29 (m, 2H, Ar-H), 6.32 (d, J=14.0 Hz, 2H, CHalkene), 
3.51 (s, 6H, N-CH3), 2.73 (t, J=6.0 Hz, 4H, CH2-CH2), 1.86-1.79 (m, 2H, CH2-CH2-CH2), 
 
1.67 (s, 12H, C-CH3). IR (ATR) 2922, 1556, 1508, 1486, 1437, 1363, 1301, 1244, 1151, 
1093, 924, 854, 788, 752 cm-1. MS (ESI) m/z: 483 [M]+. UV abs λmax = 766 nm. 
 
 
 
 
 
2-[(E)-2-[(3E)-2-Chloro-3-{2-[(2E)-1-ethyl-3,3-dimethyl-2,3-dihydro-1H-indol-2- 
ylidene]ethylidene}cyclohex-1-en-1-yl]ethenyl]-1-ethyl-3,3-dimethyl-3H-indol-1-ium 
iodide (4b). 
 
 
 
 
 
 
 
 
 
4b was synthesised as 4g using 1b (0.63 g, 2.00 mmol) and anhydrous sodium acetate (0.16 
g, 2.00 mmol) in EtOH (20.0 mL) and was added VH1 (0.36 g, 1.00 mmol) to give the crude 
product which  was purified by impregnation on silica and eluting with ethyl  acetate to 
remove the first band of impurities. The silica was then washed with methanol to remove the 
product and the solvent was rotor evaporated off to obtain cyanine dye 4b (0.41 g, 64%) as a 
green solid; m.p. 246-248 °C: 1H NMR (d6-DMSO, 400 MHz) δ 8.29 (d, J=14.0 Hz, 2H, 
 
CHalkene), 7.66 (d, J=8.0 Hz, 2H, Ar-H), 7.46-7.41 (m, 4H, Ar-H), 7.30-7.27 (m, 2H, Ar-H), 
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6.35 (d, J=14.0 Hz, 2H, CHalkene), 4.27 (q, J=7.0 Hz, 4H, N-CH2-CH3), 2.68 (t, J=6.0 Hz, 4H, 
CH2-CH2), 1.78-1.68 (m, 2H, CH2-CH2-CH2), 1.62 (s, 12H, C-CH3), 1.30 (t, J=7.0 Hz, 6H, 
CH2-CH3). IR (ATR) 2957, 1552, 1509, 1478, 1397, 1282, 1249, 1208, 1034, 913, 828, 742, 
579 cm-1. MS (ESI) m/z: 511 [M]+. UV abs λmax = 778 nm. 
 
 
 
 
 
2-[(E)-2-[(3E)-2-Chloro-3-{2-[(2E)-3,3-dimethyl-1-propylindol-2- 
ylidene]ethylidene}cyclohex-1-en-1-yl]ethenyl]-3,3-dimethyl-1-propylindol-1-ium iodide 
(4c). 
 
 
 
 
 
 
 
 
 
 
4c was synthesised as for 4g using 1c (1.31 g, 4.00 mmol) and anhydrous sodium acetate 
(0.33 g, 4.00 mmol) in EtOH (30.0 mL) and was added VH1 (0.72 g, 2.00 mmol) to give the 
crude product which was purified by silica gel column chromatography (solvent; 
chloroform:methanol=8:2) to obtain cyanine dye 4c (0.72 g, 54%) as a green solid; m.p. 246- 
248 °C: 1H NMR (d6-DMSO, 400 MHz) δ 8.17 (d, J=14.0 Hz, 2H, CHalkene), 7.50 (d, J=7.0 
 
Hz, 2H, Ar-H), 7.38-7.16 (m, 4H, Ar-H), 7.20 (t, J=7.0 Hz, 2H, Ar-H), 6.26 (d, J=14.0 Hz, 
 
2H, CHalkene), 4.12 (t, J=6.0 Hz, 4H, N-CH2-CH2), 2.61-2.57 (m, 4H, CH2-CH2-CH3), 1.75- 
 
1.64 (m, 6H, (CH2)3), 1.57 (s, 12H, C-CH3), 0.87 (t, J=7.0 Hz, 6H, CH2-CH3). IR (ATR) 
2925, 1549, 1397, 1241, 1159, 1041, 925, 750, 707 cm-1. MS (ESI) m/z: 539.29 [M]+. UV 
 
abs λmax = 781 nm. 
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Synthesis of 1-butyl-2-[(E)-2-[(3E)-3-{2-[(2E)-1-butyl-3,3-dimethylindol-2- 
ylidene]ethylidene}-2-chlorocyclohex-1-en-1-yl]ethenyl]-3,3-dimethylindol-1-ium iodide 
(4d). 
 
 
 
 
 
 
 
 
 
 
 
4d was synthesised as for 4g using 1d (1.37 g, 4.00 mmol) and anhydrous sodium acetate 
(0.33g, 4.00 mmol) in EtOH (30 mL) and was added VH1 (0.72 g, 2.00 mmol) to give the 
crude product which was purified by silica gel column chromatography (eluent solvent; 
chloroform:methanol=8:2) to obtain cyanine dye 4d (0.35 g, 25%) as a green solid; m.p. 219- 
221 °C: 1H NMR (d6-DMSO, 300 MHz) δ 8.28 (d, J=15.0 Hz, 2H, CHalkene), 7.66 (d, J=6.0 
 
Hz, 2H, Ar-H), 7.49 (dd, J=9.0 Hz, 4H, Ar-H), 7.31 (d, J=6.0 Hz, 2H, Ar-H), 6.36 (d, J=15.0 
 
Hz, 2H, CHalkene), 4.25 (t, J=6.0 Hz, 4H, N-CH2-CH2), 2.73 (quin, J=6.0 Hz, 4H, CH2-CH2- 
CH2), 1.88 (t, J=6.0 Hz, 2H, CH2-CH2), 1.76 (t, J=6.0 Hz, 4H, CH2-CH2), 1.67 (s, 12H, C- 
CH3), 1.44 (sex, J=9.0 Hz, 4H, CH2-CH3), 0.96 (t, J=9.0 Hz, 6H, CH2-CH3). IR (ATR) 2926, 
1548, 1394, 1227, 1149, 1088, 911, 751 cm-1. MS-EI: 567 [M]+. UV abs λmax = 780 nm. 
 
 
 
 
 
1-Benzyl-2-[(E)-2-[(3E)-3-{2-[(2E)-1-benzyl-3,3-dimethyl-2,3-dihydro-1H-indol-2- 
ylidene]ethylidene}-2-chlorocyclohex-1-en-1-yl]ethenyl]-3,3-dimethyl-3H-indol-1-ium 
bromide (4e). 
 
 
 
 
 
 
 
 
 
 
 
4e was synthesised as for 4g using 1k (0.66 g, 2.00 mmol) and anhydrous sodium acetate 
(0.16 g, 2.00 mmol) in EtOH (30.0 mL) and was added VH1 (0.36 g, 1.00 mmol) to give the 
crude product which was purified by silica gel column chromatography (solvent; 
chloroform:methanol=9:1) to obtain cyanine dye 4e (0.10 g, 14%) as a shiny purple solid; 
m.p. 254-256 °C: 1H NMR (d6-DMSO, 400 MHz) δ 8.25 (d, J=14.0 Hz, 2H, CHalkene), 7.41- 
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7.28 (m, 18H, Ar-H), 6.35 (d, J=14.0 Hz, 2H, CHalkene), 4.95 (br s, 4H, N-CH2-Ph), 2.50-2.45 
(m, 4H, CH2-CH2), 1.69 (s, 12H, C-CH3), 1.30-1.26 (m, 2H, CH2-CH2-CH2). IR (ATR) 1543, 
1363, 1225, 1099, 896, 784, 668, 597 cm-1. MS (ESI) m/z: 635 [M]+. UV abs λmax = 760 nm. 
 
 
 
 
 
2-[(E)-2-[(3E)-2-Chloro-3-{2-[(2E)-3,3-dimethyl-1-(3-sulfonatopropyl)-2,3-dihydro-1H- 
indol-2-ylidene]ethylidene}cyclohex-1-en-1-yl]ethenyl]-3,3-dimethyl-1-(3- 
sulfonatopropyl)-3H-indol-1-ium (4f). 
 
 
 
 
 
 
 
 
 
 
 
4f was synthesised as for 4g using 1l (1.69 g, 6.00 mmol) and anhydrous sodium acetate (0.49 
g, 6.00 mmol) in EtOH (60.0 mL) and was added VH1 (1.08 g, 3.00 mmol) to give the crude 
product which was purified by silica gel column chromatography (solvent; 
chloroform:methanol=9:1) to obtain cyanine dye 4f (1.44 g, 69%) as a green solid; m.p. 249- 
251 °C: 1H NMR (d6-DMSO, 250 MHz) δ 8.27 (d, J=15.0 Hz, 2H, CHalkene), 7.81 (d, J=7.0 
 
Hz, 2H, Ar-H), 7.74 (d, J=7.0 Hz, 2H, Ar-H), 7.38 (t, J=7.0 Hz, 2H, Ar-H), 7.12 (d, J=7.0 
 
Hz, 2H, Ar-H), 6.48 (d, J=15.0 Hz, 2H, CHalkene), 4.49 (t, J=5.0 Hz, 4H, N-CH2-CH2), 2.73 (t, 
J=5.0 Hz, 4H, CH2-CH2-SO3), 2.53-2.47 (m, 4H, CH2-CH2-CH2-SO3), 1.98-1.89 (m, 6H, 
(CH2)2), 1.66 (s, 12H, C-CH3). IR (ATR) 1542, 1390, 1454, 1390, 1003 cm-1. MS (ESI) m/z: 
699.20 [M+2H]+. UV abs λmax = 760 nm. 
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2-[(E)-2-[(3E)-2-Chloro-3-{2-[(2Z)-3-methyl-2,3-dihydro-1,3-benzothiazol-2- 
ylidene]ethylidene}cyclohex-1-en-1-yl]ethenyl]-3-methyl-1,3-benzothiazol-3-ium iodide 
(5a). 
 
 
 
 
 
 
 
 
 
5a was synthesised as for 4g using 2a (0.58 g, 2.00 mmol) and anhydrous sodium acetate 
(0.16 g, 2.00 mmol) in EtOH (20.0 mL) and was added VH1 (0.36 g, 1.00 mmol). The 
precipitate produced was filtered under suction, washed with n-hexane and dried in vacuo to 
give cyanine dye 5a (0.30 g, 51%) as a green solid; m.p. 255-257 °C: 1H NMR (d6-DMSO, 
400 MHz) δ 7.95 (d, J=7.0 Hz, 2H, Ar-H), 7.70 (d, J=13.0 Hz, 2H, CHalkene), 7.70 (d, J=8.0 
 
Hz, 2H, Ar-H), 7.52-7.48 (m, 2H, Ar-H), 7.34 (t, J=8.0 Hz, 2H, Ar-H), 6.47 (d, J=13.0 Hz, 
 
2H, CHalkene), 3.85 (s, 6H, N-CH3), 2.66 (t, J=6.0 Hz, 4H, CH2-CH2), 1.08-1.03 (m, 2H, CH2- 
CH2-CH2). IR (ATR) 2936, 1652 , 1506, 1423, 1384, 905, 849, 563 cm-1. MS (ESI) m/z: 463 
[M]+. UV abs λmax = 796 nm. 
 
 
 
 
2-[(E)-2-[(3E)-2-Chloro-3-{2-[(2Z)-3-ethyl-2,3-dihydro-1,3-benzothiazol-2- 
ylidene]ethylidene}cyclohex-1-en-1-yl]ethenyl]-3-ethyl-1,3-benzothiazol-3-ium iodide 
(5b). 
 
 
 
 
 
 
 
5b was synthesised as for 4g using 2b (0.62 g, 2.00 mmol) and anhydrous sodium acetate 
(0.16 g, 2.00 mmol) in EtOH (20.0 mL) and was added VH1 (0.36 g, 1.00 mmol). The 
precipitate produced was filtered under suction, washed with n-hexane and dried in vacuo to 
give cyanine dye 5b (0.37g, 60%) as a green solid; m.p. 246-248 °C: 1H NMR (d6-DMSO, 
400 MHz) δ 8.01 (d, J=14.0 Hz, 2H, CHalkene), 7.66 (d, J=7.0 Hz, 2H, Ar-H), 7.46-7.38 (m, 
 
4H, Ar-H), 7.30-7.25 (m, 2H, Ar-H), 6.35 (d, J=14.0 Hz, 2H, CHalkene), 4.28 (t, J=7.0 Hz, 4H, 
N-CH2-CH2), 2.63-2.59 (m, 4H, CH2-CH2), 2.51-2.48 (m, 2H, CH2-CH2-CH2), 1.51 (t, J=7.0 
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Hz, 6H, CH2-CH3). IR (ATR) 2957, 1552, 1509, 1478, 1397, 1282, 1249, 1208, 1034, 913, 
828, 742, 579 cm-1. MS (ESI) m/z: 491 [M]+. UV abs λmax = 796 nm. 
 
 
 
 
 
2-[(E)-2-[(3E)-2-Chloro-3-{2-[(2Z)-3-propyl-2,3-dihydro-1,3-benzothiazol-2- 
ylidene]ethylidene}cyclohex-1-en-1-yl]ethenyl]-3-propyl-1,3-benzothiazol-3-ium iodide 
(5c). 
 
 
 
 
 
 
 
 
 
5c was synthesised as for 4g using 2c (1.27 g, 4.00 mmol) and anhydrous sodium acetate 
(0.33 g, 4.00 mmol) in EtOH (30.0 mL) and was added VH1 (0.72 g, 2.00 mmol) to give the 
crude product which was purified by silica gel column chromatography (solvent; 
chloroform:methanol=8:2) to obtain cyanine dye 5c (0.81 g, 63%) as a green solid; m.p. 245- 
247 °C: 1H NMR (d6-DMSO, 400 MHz) δ 7.82 (d, J=8.0 Hz, 2H, Ar-H), 7.63 (d, J=13.0 Hz, 
 
2H, CHalkene), 7.58( brs, 2H, Ar-H), 7.39 (t, J=7.0 Hz, 2H, Ar-H), 7.20 (t, J=7.0 Hz, 2H, Ar- 
H), 6.38 (d, J=13.0 Hz, 2H, CHalkene), 4.25 (t, J=6.0 Hz, 4H, N-CH2-CH2), 2.51-2.47 (m, 4H, 
CH2-CH2), 1.63-1.57 (m, 6H, (CH2)2), 0.85 (t, J=7.0 Hz, 6H, CH2-CH3). IR (ATR) 2950, 
1528, 1496, 1387, 1274, 1216, 1055, 983, 844, 740 cm-1. MS (ESI) m/z: 519 [M]+. UV abs 
 
λmax = 797 nm. 
 
 
 
 
 
3-Butyl-2-[(E)-2-[(3E)-3-{2-[(2Z)-3-butyl-2,3-dihydro-1,3-benzothiazol-2- 
ylidene]ethylidene}-2-chlorocyclohex-1-en-1-yl]ethenyl]-1,3-benzothiazol-3-ium iodide 
(5d). 
 
 
 
 
 
 
 
 
 
5d was synthesised as for 4g using 2d (0.88 g, 3.00 mmol) and anhydrous sodium acetate 
 
(0.24 g, 3.00 mmol) in EtOH (30.0 mL) and was added VH1 (0.57 g, 1.50 mmol) to give the 
Experimental 
168 
 
 
 
 
crude   product   which   was   purified   by   silica   gel   column   chromatography   (solvent; 
 
chloroform:methanol=8:2) to obtain cyanine dye 5d (0.38g, 38%) as a green solid; m.p. 212- 
 
214 °C: 1H NMR (d6-DMSO, 400 MHz) δ 7.99 (d, J=6.0 Hz, 2H, Ar-H), 7.83 (d, J=15.0 Hz, 
 
2H, CHalkene), 7.77 (d, J=6.0 Hz, 2H, Ar-H), 7.59 (t, J=6.0 Hz, 2H, Ar-H), 7.43 (t, J=9.0 Hz, 
 
2H, Ar-H), 6.52 (d, J=15.0 Hz, 2H, CHalkene), 4.47 (t, J=6.0 Hz, 4H, N-CH2-CH2), 2.67-2.60 
(m, 4H, CH2-CH2), 1.84-1.80 (m, 2H, CH2-CH2-CH2), 1.74 (t, J=9.0 Hz, 4H, CH2-CH2), 1.44 
(sex, J=6.0 Hz, 4H, CH2-CH2-CH3), 0.95 (t, J=7.0 Hz, 6H, CH2-CH3). IR (ATR) 2937, 1578, 
1499, 1451, 1390, 1323, 1213, 1273, 1213, 1051, 902, 739 cm-1. MS (ESI) m/z: 547[M]+. UV 
 
abs λmax = 796 nm. 
 
 
 
 
 
3-Benzyl-2-[(E)-2-[(3E)-3-{2-[(2Z)-3-benzyl-2,3-dihydro-1,3-benzothiazol-2- 
ylidene]ethylidene}-2-chlorocyclohex-1-en-1-yl]ethenyl]-1,3-benzothiazol-3-ium 
bromide (5e). 
 
 
 
 
 
 
 
 
 
5e was synthesised as for 4g using 2k (2.56 g, 8.00 mmol) and anhydrous sodium acetate 
(0.66 g, 8.00 mmol) in EtOH (30.0 mL) and was added VH1 (1.44 g, 4.00 mmol) to give the 
crude product which was purified by silica gel column chromatography (solvent; 
chloroform:methanol=7:3) to obtain cyanine dye 5e (1.50 g, 54%) as a green solid; m.p. 254- 
256 °C: 1H NMR (d6-DMSO, 400 MHz) δ 7.94 (d, J=7.0 Hz, 2H, Ar-H), 7.74 (d, J=13.0 Hz, 
 
2H, CHalkene), 7.62 (d, J=8.0 Hz, 2H, Ar-H), 7.44 (t, J=7.0 Hz, 2H, Ar-H), 7.33 (d, J=6.0 Hz, 
 
4H, Ar-H), 7.27-7.13 (m, 8H, Ar-H), 6.52 (d, J=13.0 Hz, 2H, CHalkene), 5.70 (br s, 4H, N- 
CH2-Ph), 3.12 (brs, 2H, CH2), 2.57 (brs, 2H, CH2), 1.67 (br s, 2H, CH2). IR (ATR) 1543, 
1506, 1363, 1225, 1099, 896, 784, 668, 597 cm-1. MS (ESI) m/z: 615 [M]+. HRMS(ESI): 
 
Calcd for C38H32ClN2S2 [M]+615.1690, found 615.1682. UV abs λmax = 804 nm. 
Experimental 
169 
 
 
 
 
2-[(E)-2-[(3E)-2-Chloro-3-{2-[(2Z)-3-(3-sulfonatopropyl)-2,3-dihydro-1,3-benzothiazol- 
 
2-ylidene]ethylidene}cyclohex-1-en-1-yl]ethenyl]-3-(3-sulfonatopropyl)-1,3- 
benzothiazol-3-ium (5f). 
 
 
 
5f was synthesised as for 4g using 2l (0.66 g, 2.00 mmol) and anhydrous sodium acetate (0.16 
g, 2.00 mmol) in EtOH (30.0 mL) and was added VH1 (0.36 g, 1.00 mmol) to give the crude 
product which was purified by silica gel column chromatography (solvent; 
dichloromethane:methanol=9:1) to obtain cyanine dye 5f (0.10 g, 15%) as a green solid; m.p. 
240-242 °C: 1H NMR (d6-DMSO, 400 MHz) δ 7.88 (d, J=13.0 Hz, 2H, CHalkene), 7.69-7.60 
 
(m, 4H, Ar-H), 7.43 (t, J=7.0 Hz, 2H, Ar-H), 7.25 (t, J=7.0 Hz, 2H, Ar-H), 6.56 (d, J=13.0 
 
Hz, 2H, CHalkene), 4.51 (t, J=7.0 Hz, 4H, N-CH2-CH2), 2.55-2.45 (m, 8H, (CH2)4-SO3), 1.97 
(t, J=6.0 Hz, 4H, CH2-CH2), 1.76-1.70 (m, 2H, CH2-CH2-CH2). IR (ATR) 3050, 1527, 1499, 
1454, 1324, 1208, 983 cm-1. MS (ESI) m/z: 679 [M+2H]+. UV abs λmax = 775 nm. 
 
 
 
 
 
2-[(E)-2-[(3E)-2-Chloro-3-{2-[(2Z)-3-(4-sulfonatobutyl)-2,3-dihydro-1,3-benzothiazol-2- 
ylidene]ethylidene}cyclohex-1-en-1-yl]ethenyl]-3-(4-sulfonatobutyl)-1,3-benzothiazol-3- 
ium (5g). 
 
 
 
 
 
 
 
 
Na+ 
 
5g was synthesised as for 4g using 2m (0.58 g, 2.00 mmol) and anhydrous sodium acetate 
(0.16 g, 2.00 mmol) in EtOH (60.0 mL) and was added VH1 (0.36 g, 1.00 mmol) to give the 
crude product which was purified by silica gel column chromatography (solvent; 
chloroform:methanol=9:1) to obtain cyanine dye 5g (0.30 g, 42%) as a green solid; m.p. 247- 
249 °C: 1H NMR (d6-DMSO, 400 MHz) δ 7.98 (d, J=13.0 Hz, 2H, CHalkene), 7.83-7.68 (m, 
 
4H, Ar-H), 7.58-7.56 (m, 2H, Ar-H), 7.54-7.49 (m, 2H, Ar-H), 6.57 (d, J=13.0 Hz, 2H, 
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CHalkene), 4.46 (t, J=7.0 Hz, 4H, N-CH2-CH2), 3.34 (br s, 1H, CH2), 2.70-2.65 (m, 4H, CH2- 
CH2), 2.09 (br s, 1H, CH2), 1.76-1.50 (m, 12H, (CH2)6-SO3). IR (ATR) 3393, 1651, 1499, 
1392, 1324, 1276, 1217, 1127, 1011, 852, 796, 743, 564 cm-1. MS (ESI) m/z: 707 [M+2H]+. 
 
UV abs λmax = 800 nm. 
 
 
 
 
 
2-[(E)-2-[(3E)-2-Chloro-3-{2-[(2E)-1,1,3-trimethyl-1H,2H,3H-benzo[e]indol-2- 
ylidene]ethylidene}cyclohex-1-en-1-yl]ethenyl]-1,1,3-trimethyl-1H-benzo[e]indol-3-ium 
iodide (6a). 
 
 
 
 
 
 
 
 
 
6a was synthesised as for 4g using 3a (1.40 g, 4.00 mmol) and anhydrous sodium acetate 
(0.33 g, 4.00 mmol) in EtOH (30.0 mL) and was added VH1 (0.72 g, 2.00 mmol) to give the 
crude product which was purified by silica gel column chromatography (solvent; chloroform : 
methanol=8:2) to obtain cyanine dye 6a (0.41 g, 29%) as a green solid; m.p. 212-214 °C: 1H 
NMR (d6-DMSO, 300 MHz) δ 8.38 (d, J=15.0 Hz, 2H, CHalkene), 8.31 (d, J=9.0 Hz, 2H, Ar- 
H), 8.12-8.05 (m, 4H, Ar-H), 7.81 (d, J=9.0 Hz, 2H, Ar-H), 7.69 (t, J=9.0 Hz, 2H, Ar-H), 
7.52 (t, J=6.0 Hz, 2H, Ar-H), 6.37 (d, J=15.0 Hz, 2H, CHalkene), 3.82 (s, 6H, N-CH3), 2.78 (t, 
 
J=6.0 Hz, 4H, CH2-CH2), 1.95 (s, 12H, C-CH3), 1.91-1.86 (m, 2H, CH2-CH2-CH2). IR (ATR) 
2927, 1544, 1429, 1339, 1152, 997, 799 cm-1. MS (ESI) m/z: 583 [M]+. UV abs λmax = 813 
nm. 
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2-[(E)-2-[(3E)-2-Chloro-3-{2-[(2E)-3-ethyl-1,1-dimethyl-1H,2H,3H-benzo[e]indol-2- 
ylidene]ethylidene}cyclohex-1-en-1-yl]ethenyl]-3-ethyl-1,1-dimethyl-1H-benzo[e]indol-3- 
ium iodide (6b). 
 
 
 
 
 
 
 
 
 
6b was synthesised as for 4g using 3b (1.46 g, 4.00 mmol) and anhydrous sodium acetate 
(0.33 g, 4.00 mmol) in EtOH (30.0 mL) and was added VH1 (0.72 g, 2.00 mmol) to give the 
crude product which was purified by silica gel column chromatography (solvent; 
chloroform:methanol=8:2) to obtain cyanine dye 6b (0.85 g, 58%) as a green solid; m.p. 199- 
201 °C: 1H NMR (d6-DMSO, 300 MHz) δ 8.40 (d, J=14.0 Hz, 2H, CHalkene), 8.33 (d,  J=9.0 
 
Hz, 2H, Ar-H), 8.13-8.06 (m, 4H, Ar-H), 7.81 (d, J=9.0 Hz, 2H, Ar-H), 7.69 (t, J=9.0 Hz, 
 
2H, Ar-H), 7.55 (t, J=6.0 Hz, 2H, Ar-H), 6.40 (d, J=14.0 Hz, 2H, CHalkene), 4.43 (q, J=6.0 Hz, 
 
4H, N-CH2-CH3), 2.79 (t, J=6.0 Hz, 4H, CH2-CH2), 1.95 (s, 12H, C-CH3), 1.91-1.87 (m, 2H, 
CH2-CH2-CH2), 1.39 (t, J=6.0 Hz, 6H, CH2-CH3). IR (ATR) 2923, 1501, 1345, 1225, 1153, 
1082, 999, 898, 797, 708 cm-1. MS (ESI) m/z: 611 [M]+. UV abs λmax = 815 nm. 
 
 
 
 
 
2-[(E)-2-[(3E)-2-Chloro-3-{2-[(2E)-1,1-dimethyl-3-propyl-1H,2H,3H-benzo[e]indol-2- 
ylidene]ethylidene}cyclohex-1-en-1-yl]ethenyl]-1,1-dimethyl-3-propyl-1H-benzo[e]indol- 
3-ium iodide (6c). 
 
 
 
 
 
 
 
 
 
 
 
6c was synthesised as for 4g using 3c (1.52 g, 4.00 mmol) and anhydrous sodium acetate 
(0.33 g, 4.00 mmol) in EtOH (30.0 mL) and was added VH1 (0.72 g, 2.00 mmol) to give the 
crude product which was purified by silica gel column chromatography (solvent; chloroform : 
methanol=8:2) to obtain cyanine dye 6c (1.10 g, 72%) as a green solid; m.p. 198-200 °C: 1H 
NMR (d6-DMSO, 300 MHz) δ 8.40 (d, J=14.0 Hz, 2H, CHalkene), 8.33 (d, J=9.0 Hz, 2H, Ar- 
H), 8.12-8.06 (m, J=9.0 Hz, 4H, Ar-H), 7.83 (d, J=9.0 Hz, 2H, Ar-H), 7.69 (t, J=9.0 Hz, 2H, 
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Ar-H), 7.55 (t, J=6.0 Hz, 2H, Ar-H), 6.42 (d, J=14.0 Hz, 2H, CHalkene), 4.36 (t, J=6.0 Hz, 4H, 
N-CH2-CH2), 2.78 (sex, J=6.0 Hz, 4H, CH2-CH2-CH3), 1.96 (s, 12H, C-CH3), 1.91-1.80 (m, 
6H, (CH2)3), 1.02 (t, J=6.0 Hz, 6H, CH2-CH3). IR (ATR) 2922, 1543, 1384, 1266, 1050, 998, 
875, 784 cm-1. MS (ESI) m/z: 639[M]+. UV abs λmax = 818 nm. 
 
 
 
 
 
Synthesis of 3-butyl-2-[(E)-2-[(3E)-3-{2-[(2E)-3-butyl-1,1-dimethyl-1H,2H,3H- 
benzo[e]indol-2-ylidene]ethylidene}-2-chlorocyclohex-1-en-1-yl]ethenyl]-1,1-dimethyl- 
1H-benzo[e]indol-3-ium iodide (6d). 
 
 
 
 
 
 
 
 
 
 
 
 
 
6d was synthesised as for 4g using 3d (1.58 g, 4.00 mmol) and anhydrous sodium acetate 
(0.33 g, 4.00 mmol) in EtOH (30 mL) and was added VH1 (0.72 g, 2.00 mmol) to give the 
crude product which was purified by silica gel column chromatography (eluent solvent; 
chloroform:methanol=8:2) to obtain cyanine dye 6d (0.72 g, 45%) as a green solid; m.p. 167- 
169 °C: 1H NMR (d6-DMSO, 300 MHz) δ 8.39 (d, J=14.0 Hz, 2H, CHalkene), 8.32 (d, J=9.0 
 
Hz, 2H, Ar-H), 8.12-8.06 (m, 4H, Ar-H), 7.81 (d, J=9.0 Hz, 2H, Ar-H), 7.69 (t, J=9.0 Hz, 
 
2H, Ar-H), 7.56 (t, J=6.0 Hz, 2H, Ar-H), 6.40 (d, J=14.0 Hz, 2H, CHalkene), 4.39 (t, J=6.0 Hz, 
 
4H, N-CH2-CH2), 2.77 (t, J=6.0 Hz, 4H, CH2-CH2), 1.95 (s, 12H, C-CH3), 1.89 (br s, 2H, 
CH2-CH2), 1.80-1.74 (m, 4H, CH2-CH2), 1.46-1.40 (m, 4H, CH2-CH2-CH3), 0.98 (t, J=9.0 
Hz, 6H, CH2-CH3). IR (ATR) 2920, 1543, 1385, 1226, 1040, 998, 712 cm-1. MS (ESI) m/z: 
669 [M]+. UV abs λmax = 818 nm. 
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Synthesis of 3-benzyl-2-[(E)-2-[(3E)-3-{2-[(2E)-3-benzyl-1,1-dimethyl-1H,2H,3H- 
benzo[e]indol-2-ylidene]ethylidene}-2-chlorocyclohex-1-en-1-yl]ethenyl]-1,1-dimethyl- 
1H-benzo[e]indol-3-ium bromide (6e). 
 
 
 
 
 
 
 
 
 
 
 
 
6e was synthesised as for 4g using 3e (1.52 g, 4.00 mmol) and anhydrous sodium acetate 
(0.33 g, 4.00 mmol) in EtOH (30.0 mL) and was added VH1 (0.72 g, 2.00 mmol) to give the 
crude product which was purified by silica gel column chromatography (solvent; 
chloroform:methanol=8:2) to obtain cyanine dye 6e (0.32 g, 20%) as a green solid; m.p. 215- 
217 °C: 1H NMR (d6-DMSO, 300 MHz) δ 8.37-8.32 (m, 4H, Ar-H), 8.09-8.05 (m, 4H, Ar- 
 
H), 7.75 (d, J=9.0 Hz, 2H, Ar-H), 7.69 (d, J=9.0 Hz, 2H, Ar-H), 7.57 (t, J=15.0 Hz, 2H, 
CHalkene), 7.40-7.31 (m, 10H, Ar-H), 6.47 (d, J=15.0 Hz, 2H, CHalkene), 5.59 (br s, 4H, N- 
CH2-Ph), 2.61 (t, J=9.0 Hz, 4H, CH2-CH2), 2.01 (s, 12H, C-CH3), 1.89-1.74 (m, 2H, CH2- 
CH2-CH2). IR (ATR) 2932, 1623, 1431, 1347, 1227, 1081, 997, 806. 706 cm-1. MS (ESI) 
m/z: 735.26[M+]. HRMS(ESI): Calcd for C52H45CIN2   [M]+  735.3482, found 735.3484. UV 
 
abs λmax = 822 nm. 
 
 
 
 
 
2-[(E)-2-[(3E)-2-Chloro-3-{2-[(2E)-1,1-dimethyl-3-(3-sulfonatopropyl)-1H,2H,3H- 
benzo[e]indol-2-ylidene]ethylidene}cyclohex-1-en-1-yl]ethenyl]-1,1-dimethyl-3-(3- 
sulfonatopropyl)-1H-benzo[e]indol-3-ium (6f). 
 
 
 
 
 
 
 
 
 
 
 
 
6f was synthesised as for 4g using 3f (1.32 g, 4.00 mmol) and anhydrous sodium acetate 
 
(0.33 g, 4.00 mmol) in EtOH (30.0 mL) and was added VH1 (0.72 g, 2.00 mmol) to give the 
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crude product which was purified by silica gel column chromatography (solvent; chloroform : 
methanol=7:3) to obtain cyanine dye 6f (1.12 g, 70%) as a green solid; m.p. 235-237 °C: 1H 
NMR (d6-DMSO, 300 MHz) δ 8.39 (d, J=14.0 Hz, 2H, CHalkene), 8.31 (d, J=9.0 Hz, 2H, Ar- 
H), 8.10-8.04 (m, 4H, Ar-H), 7.88 (d, J=9.0 Hz, 2H, Ar-H), 7.68 (t, J=9.0 Hz, 2H, Ar-H), 
7.54 (t, J=6.0 Hz, 2H, Ar-H), 6.59 (d, J=14.0 Hz, 2H, CHalkene), 4.54 (t, J=6.0 Hz, 4H, N- 
CH2-CH2), 2.81 (t, J=6.0 Hz, 4H, CH2-CH2-SO3), 2.65 (quin, J=6.0 Hz, 4H, CH2-CH2-CH2), 
2.12-1.99 (m, 2H, CH2-CH2-CH2), 1.95 (s, 12H, C-CH3), 1.89 (t, J=6.0 Hz, 4H, CH2-CH2). 
IR (ATR) 2931, 1626, 1389, 1271, 1096, 1003, 921, 818, 710 cm-1. MS (ESI) m/z: 799 [M]+. 
UV abs λmax = 820 nm. 
 
 
 
 
2-[(E)-2-[(3E)-2-Chloro-3-{2-[(2E)-1,1-dimethyl-3-(4-sulfonatobutyl)-1H,2H,3H- 
benzo[e]indol-2-ylidene]ethylidene}cyclohex-1-en-1-yl]ethenyl]-1,1-dimethyl-3-(4- 
sulfonatobutyl)-1H-benzo[e]indol-3-ium (6g). 
 
 
 
 
 
 
 
 
 
 
Na+ 
 
6g was synthesised as for 4g using 3g (1.38 g, 4.00 mmol) and anhydrous sodium acetate 
(0.33 g, 4.00 mmol) in EtOH (30.0 mL) and was added VH1 (0.72 g, 2.00 mmol) to give the 
crude product which was purified by silica gel column chromatography (solvent; 
chloroform:methanol=7:3) to obtain cyanine dye 6g (1.30 g, 79%) as a green solid; m.p. 232- 
234 °C: 1H NMR (d6-DMSO, 300 MHz) δ 8.38 (d, J=14.0 Hz, 2H, CHalkene), 8.31 (d, J=9.0 
 
Hz, 2H, Ar-H), 8.05-8.00 (m, 4H, Ar-H), 7.83 (d, J=9.0 Hz, 2H, Ar-H), 7.68 (t, J=9.0 Hz, 
 
2H, Ar-H), 7.54 (t, J=9.0 Hz, 2H, Ar-H), 6.44 (d, J=14.0 Hz, 2H, CHalkene), 4.38 (t, J=9.0 Hz, 
 
4H, N-CH2-CH2), 2.79 (t, J=6.0 Hz, 4H, CH2-CH2-SO3), 2.54-2.49 (m, 6H, (CH2)4), 1.94 (s, 
 
12H, C-CH3), 1.89-1.76 (m, 8H, (CH2)4-CH2-SO3). IR (ATR) 2929, 1544, 1388, 1347, 1227, 
1035, 880 cm-1. MS (ESI) m/z: 827 [M]+. UV abs λmax = 820 nm. 
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1,3,3-Trimethyl-2-[(E)-2-[(3E)-2-(phenylamino)-3-{2-[(2E)-1,3,3-trimethyl- 2,3-dihydro- 
 
1H-indol-2-ylidene]ethylidene}cyclohex-1-en-1-yl]ethenyl]-3H-indol-1-ium iodide (7a) 
 
was synthesised according to a reported procedure [261]. 
 
 
 
 
 
 
 
Aniline (0.09 g, 1.00 mmol) was added by syringe to 4a (0.06 g, 0.10 mmol) dissolved in 
anhydrous  DMF  (10.0  mL)  under  nitrogen.  The  reaction  mixture  was  stirred  at  85  oC 
overnight  under  nitrogen.  The  solvent  was  removed  under  reduced  pressure,  the  crude 
product was purified by column chromatography on silica gel (dichloromethane:methanol = 
9:1) and treated with 2-propanol to afford a dark green solid 7a (20 mg, 30%); m.p. 213- 
 
215°C: 1H NMR (d6-DMSO, 250 MHz) δ 8.22 (br s, 1H, Ar-NH), 7.93 (d, J=14.0 Hz, 2H, 
CHalkene), 7.49 (d, J=6.0 Hz, 2H, Ar-H), 7.30-7.21 (m, 9H, Ar-H), 6.90 (d, J=6.0 Hz, 2H, Ar- 
H), 6.05 (d, J=14.0 Hz, 2H, CHalkene), 3.65 (s, 6H, N-CH3), 2.62 (t, J=6.0 Hz, 4H, CH2-CH2), 
1.85-1.79 (m, 2H, CH2-CH2-CH2), 1.03 (s, 12H, C-CH3). IR (ATR) 2928, 1555, 1484, 1436, 
1349, 1308, 1206, 1149, 915, 786 cm-1. MS (ESI) m/z: 540 [M]+. UV abs λmax = 734 nm. 
 
 
 
 
1-Ethyl-2-[(E)-2-[(3E)-3-{2-[(2E)-1-ethyl-3,3-dimethyl-2,3-dihydro-1H-indol-2- 
ylidene]ethylidene}-2-(phenylamino)cyclohex-1-en-1-yl]ethenyl]-3,3-dimethyl-3H-indol- 
1-ium iodide (7b). 
 
 
 
 
 
 
 
 
 
7b was synthesised as for 7a using 4b (0.06 g, 0.10 mmol), aniline (0.09 g, 1.00 mmol), and 
anhydrous DMF (10.0 mL). The solvent was removed under reduced pressure, the crude 
product was purified by column chromatography on silica gel (dichloromethane:methanol = 
9:1) to afford a shiny dark blue solid 7b (24 mg, 35%); m.p. 217-219 °C: 1H NMR (CDCl3, 
 
400 MHz) δ 9.05 (br s, 1H, Ar-NH), 8.16 (d, J=14.0 Hz, 2H, CHalkene), 7.41-7.35 (m, 5H, Ar- 
H), 7.22 (t, J=8.0 Hz, 4H, Ar-H), 7.09 (t, J=7.0 Hz, 2H, Ar-H), 6.92 (d, J=8.0 Hz, 2H, Ar-H), 
6.80 (t, J=7.0 Hz, 2H, Ar-H), 5.79 (d, J=14.0 Hz, 2H, CHalkene), 3.56 (q, J=9.0 Hz, 4H, N- 
CH2-CH3), 2.57 (t, J=6.0 Hz, 4H, CH2-CH2), 1.92-1.84 (m, J=6.0 Hz, 2H, CH2-CH2-CH2), 
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1.72 (t, J=6.0 Hz, 6H, CH2-CH3), 1.36 (s, 12H, C-CH3). IR (ATR) 2922, 1560, 1484, 1436, 
1342, 1318, 1206, 1129, 905, 783 cm-1. MS (ESI) m/z: 540 [M]+. UV abs λmax = 734 nm. 
 
 
 
 
 
2-[(E)-2-[(3E)-3-{2-[(2E)-3,3-Dimethyl-1-propyl-2,3-dihydro-1H-indol-2- 
ylidene]ethylidene}-2-(phenylamino)cyclohex-1-en-1-yl]ethenyl]-3,3-dimethyl-1-propyl- 
3H-indol-1-ium iodide (7c). 
 
 
 
 
 
 
 
 
 
 
7c was synthesised as for 7a using 4c (0.07 g, 0.10 mmol), aniline (0.09 g, 1.00 mmol), and 
anhydrous DMF (10.0 mL). The solvent was removed under reduced pressure, the crude 
product was purified by column chromatography on silica gel (dichloromethane : methanol = 
9:1) to afford a shiny dark blue solid 7c (31 mg, 43%); m.p. 215-217 °C: 1H NMR (CDCl3, 
 
400 MHz) δ 9.02 (br s, 1H, Ar-NH), 8.14 (d, J=14.0 Hz, 2H, CHalkene), 7.45-7.38 (m, 3H, Ar- 
H), 7.18-7.12 (m, 5H, Ar-H), 7.09 (t, J=7.0 Hz, 2H, Ar-H), 6.90 (d, J=8.0 Hz, 2H, Ar-H), 
6.78 (t, J=7.0 Hz, 1H, Ar-H), 5.79 (d, J=14.0 Hz, 2H, CHalkene), 3.88 (t, J=7.0 Hz, 4H, N- 
CH2-CH2), 2.56 (t, J=6.0 Hz, 4H, CH2-CH2), 1.93 (quin, J=6.0 Hz, 2H, CH2-CH2-CH2), 1.83- 
1.76 (m, 4H, CH2-CH2), 1.38 (s, 12H, C-CH3), 1.01 (t, J=7.0 Hz, 6H, CH2-CH3). IR (ATR) 
2920, 1549, 1431, 1344, 1232, 1151, 944, 787 cm-1. MS (ESI) m/z: 596 [M]+. UV abs λmax = 
 
746 nm. 
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1-Benzyl-2-[(E)-2-[(3E)-3-{2-[(2E)-1-benzyl-3,3-dimethyl-2,3-dihydro-1H-indol-2- 
ylidene]ethylidene}-2-(phenylamino)cyclohex-1-en-1-yl]ethenyl]-3,3-dimethyl-3H-indol- 
1-ium bromide (7d). 
 
 
 
 
 
 
 
 
 
 
7d was synthesised as for 7a using 4e (0.07 g, 0.10 mmol), aniline (0.09 g, 1.00 mmol), and 
anhydrous DMF (10.0 mL). The solvent was removed under reduced pressure, the crude 
product was purified by column chromatography on silica gel (chloroform:methanol =9:1)  to 
afford a dark shinny blue solid 7d (13 mg, 17%); m.p. 210-212 °C: 1H NMR (d6-DMSO, 400 
MHz) δ 8.87 (br s, 1H, Ar-NH), 7.95 (d, J=14.0 Hz, 2H, CHalkene), 7.48 (d, J=7.0 Hz, 2H, Ar- 
 
H), 7.33-7.32 (m, 4H, Ar-H), 7.31-7.28 (m, 6H, Ar-H), 7.22-7.19 (m, 6H, Ar-H), 7.14 (t, 
J=7.0 Hz, 2H, Ar-H), 6.95 (d, J=7.0 Hz, 2H, Ar-H), 6.78 (t, J=7.0 Hz, 1H, Ar-H), 6.07 (d, 
J=14.0 Hz, 2H, CHalkene), 5.36 (s, 4H, N-CH2-Ph), 2.43 (t, J=5.0 Hz, 4H, CH2-CH2), 1.73 
(quin, J=6.0 Hz, 2H, CH2-CH2-CH2), 1.33 (s, 12H, C-CH3). IR (ATR) 2921, 1504, 1436, 
1361, 1224, 1005, 897, 787 cm-1. MS (ESI) m/z: 692 [M]+. HRMS(ESI): Calcd for C50H50N3 
[M] + 692.3978, found 692.3980. UV abs λmax = 738 nm. 
 
 
 
 
 
2-[(E)-2-[(3E)-3-{2-[(2E)-3,3-Dimethyl-1-(3-sulfonatopropyl)-2,3-dihydro-1H-indol-2- 
ylidene]ethylidene}-2-(phenylamino)cyclohex-1-en-1-yl]ethenyl]-3,3-dimethyl-1-(3- 
sulfonatopropyl)-3H-indol-1-ium (7e). 
 
 
 
 
 
7e was synthesised as for 7a using 4f (0.07 g, 0.10 mmol), aniline (0.09 g, 1.00 mmol), and 
anhydrous DMF (10.0 mL). The solvent was removed under reduced pressure, the crude 
product was purified by column chromatography on silica gel (chloroform:methanol 8:2) to 
afford a dark green solid 7e (25 mg, 33%); m.p. 222-224 °C: 1H NMR (d6-DMSO, 400 MHz) 
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δ 8.62 (br s, 1H, Ar-NH), 7.92 (d, J=14.0 Hz, 2H, CHalkene), 7.36 (d, J=7.0 Hz, 2H, Ar-H), 
 
7.29-7.18 (m, 4H, Ar-H), 7.15 (t, J=8.0 Hz, 2H, Ar-H), 7.06 (t, J=7.0 Hz, 2H, Ar-H), 6.87 (d, 
J=8.0 Hz, 2H, Ar-H), 6.64 (t, J=7.0 Hz, 1H, Ar-H), 6.16 (d, J=14.0 Hz, 2H, CHalkene), 4.16 (t, 
J=7.0 Hz, 4H, N-CH2-CH2), 2.58 (t, J=6.0 Hz, 4H, CH2-CH2-SO3), 2.47 (t, J=7.0 Hz, 4H, 
CH2-CH2), 1.91 (quin, J=7.0 Hz, 4H, CH2-CH2-CH2), 1.78 (quin, J=6.0 Hz, 2H, CH2-CH2- 
CH2), 1.17 (s, 12H, C-CH3). IR (ATR) 2925, 1553, 1506, 1436, 1349, 1246, 1216, 1098, 903, 
743 cm-1. MS (ESI) m/z: 566 [M+2H]+. UV abs λmax = 745 nm. 
 
 
 
 
 
2-[(E)-2-[(3E)-3-{2-[(2E)-3,3-Dimethyl-1-(4-sulfonatobutyl)-2,3-dihydro-1H-indol-2- 
ylidene]ethylidene}-2-(phenylamino)cyclohex-1-en-1-yl]ethenyl]-3,3-dimethyl-1-(4- 
sulfonatobutyl)-3H-indol-1-ium (7f). 
 
 
 
 
 
 
 
 
 
Na+ 
 
 
7f was synthesised as for 7a using 4g (0.07 g, 0.10 mmol), aniline (0.09 g, 1.00 mmol), and 
anhydrous DMF (10.0 mL). The solvent was removed under reduced pressure, the crude 
product was purified by column chromatography on silica gel (chloroform:methanol = 8:2) 
to afford a dark green solid 7f (31 mg, 40%); m.p. 179-181 °C: 1H NMR (d6-DMSO, 400 
MHz) δ 8.65 (br s, 1H, Ar-NH), 7.98 (d, J=14.0 Hz, 2H, CHalkene), 7.43 (d, J=7.0 Hz, 2H, Ar- 
 
H), 7.33-7.28 (m, 4H, Ar-H), 7.22 (t, J=8.0 Hz, 2H, Ar-H), 7.13-6.99 (m, 2H, Ar-H), 6.93 (d, 
 
J=7.0 Hz, 2H, Ar-H), 6.71 (d, J=7.0 Hz, 1H, Ar-H), 6.10 (d, J=14.0 Hz, 2H, CHalkene), 4.05 (t, 
 
4H, J=7.0 Hz, N-CH2-CH2), 2.63 (t, J=6.0 Hz, 4H, CH2-CH2-SO3), 2.47 (t, J=7.0 Hz, 4H, 
CH2-CH2), 1.89 (br s,   2H, CH2-CH2-CH2), 1.71-1.63 (m, 8H, (CH2)4-CH2-SO3), 1.28 (s, 
12H, C-CH3). IR (ATR) 2928, 1508, 1437, 1366, 1097, 1101, 908, 790 cm-1. MS (ESI) m/z: 
784 [M+2H]+. UV abs λmax = 745 nm. 
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1,1,3-Trimethyl-2-[(E)-2-[(3E)-2-(phenylamino)-3-{2-[(2E)-1,1,3-trimethyl-1H,2H,3H- 
benzo[e]indol-2-ylidene]ethylidene}cyclohex-1-en-1-yl]ethenyl]-1H-benzo[e]indol-3-ium 
iodide (8a). 
 
 
 
 
 
 
 
 
 
 
8a was synthesised as for 7a using 6a (0.07 g, 0.10 mmol), aniline (0.09 g, 1.00 mmol), and 
anhydrous DMF (10.0 mL). The solvent was removed under reduced pressure, the crude 
product was purified by column chromatography on silica gel (dichloromethane:methanol = 
9:1) to afford a shiny dark blue solid 8a (34 mg, 44%); m.p. 188-190 °C: 1H NMR (d6- 
 
DMSO, 300 MHz) δ 8.76 (br s, 1H, NH), 8.37 (t, J=9.0 Hz, 2H, Ar-H), 8.16 (d, J=9.0 Hz, 
 
2H, Ar-H), 7.77-7.67 (m, 4H, Ar-H), 7.66-7.63 (m, 5H, Ar-H), 7.46 (t, J=9.0 Hz, 2H, Ar-H), 
 
7.32 (t, J=9.0 Hz, 1H, Ar-H), 7.25 (t, J=9.0 Hz, 2H, Ar-H), 6.59 (d, J=12.0 Hz, 2H, CHalkene), 
 
5.42 (d, J=12.0 Hz, 2H, CHalkene), 2.83-2.66 (m, 2H, CH2-CH2-CH2), 2.28 (t, J=6.0 Hz, 4H, 
CH2-CH2), 1.90 (s, 6H, N-CH3), 1.20 (s, 12H, C-CH3). IR (ATR) 2992, 1515, 1441, 1350, 
1228, 1011, 929, 747 cm-1. MS (ESI) m/z: 638 [M]+. HRMS(ESI): Calcd for C46H46N3 [M]+ 
 
638.3530, found 638.3529. UV abs λmax = 780 nm. 
 
 
 
 
 
3-Ethyl-2-[(E)-2-[(3E)-3-{2-[(2E)-3-ethyl-1,1-dimethyl-1H,2H,3H-benzo[e]indol-2- 
ylidene]ethylidene}-2-(phenylamino)cyclohex-1-en-1-yl]ethenyl]-1,1-dimethyl-1H- 
benzo[e]indol-3-ium iodide (8b). 
 
 
 
 
 
 
 
 
 
 
 
8b was synthesised as for 7a using 6b (0.07 g, 0.10 mmol), aniline (0.09 g, 1.00 mmol), and 
anhydrous DMF (10.0 mL). The solvent was removed under reduced pressure, the crude 
product was purified by column chromatography on silica gel (dichloromethane:methanol = 
9:1) to afford a shiny dark blue solid 8b (27 mg, 34%); m.p. 188-190 °C: 1H NMR (d6- 
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DMSO, 300 MHz) δ 8.74 (br s, 1H, NH), 8.14-8.01 (m, 8H, Ar-H), 7.67 (d, J=9.0 Hz, 2H, 
Ar-H), 7.60 (t, J=9.0 Hz, 2H, Ar-H), 7.47 (t, J=9.0 Hz, 2H, Ar-H), 7.31 (d, J=15.0 Hz, 2H, 
CHalkene), 7.03 (d, J=9.0 Hz, 2H, Ar-H), 6.79 (t, J=6.0 Hz, 1H, Ar-H), 6.14 (d, J= 15.0 Hz, 
2H, CHalkene), 4.25 (q, J=6.0 Hz, 4H, N-CH2-CH3), 2.70 (t, J=6.0 Hz, 4H, CH2-CH2), 1.96- 
 
1.87 (m, 2H, CH2-CH2-CH2), 1.62 (s, 12H, C-CH3), 1.32 (t, J=9.0 Hz, 6H, CH2-CH3). IR 
(ATR)  2921,  1546,  1430,  1346,  1226,  1001,  901,  cm-1.  MS  (ESI)  m/z:  668  [M]+. 
HRMS(ESI): Calcd for C48H50N3[M]+ 668.3999, found 668.3993. UV abs λmax = 776 nm. 
 
 
 
 
2-[(E)-2-[(3E)-3-{2-[(2E)-1,1-Dimethyl-3-propyl-1H,2H,3H-benzo[e]indol-2- 
ylidene]ethylidene}-2-(phenylamino)cyclohex-1-en-1-yl]ethenyl]-1,1-dimethyl-3-propyl- 
1H-benzo[e]indol-3-iumiodide (8c). 
 
 
 
 
 
 
 
 
 
 
 
8c was synthesised as for 7a using 6c (0.08 g, 0.10 mmol), aniline (0.09 g, 1.00 mmol), and 
anhydrous DMF (10.0 mL). The solvent was removed under reduced pressure, the crude 
product was purified by column chromatography on silica gel (dichloromethane:methanol = 
9:1) to afford a shiny dark blue solid 8c (31 mg, 38%); m.p. 188-190 °C: 1H NMR (d6- 
 
DMSO, 300 MHz) δ 8.76 (br s, 1H, NH), 8.13-8.07 (m, 4H, Ar-H), 8.02-7.98 (m, 4H, Ar-H), 
 
7.68 (d, J=9.0 Hz, 2H, Ar-H), 7.57 (t, J=9.0 Hz, 2H, Ar-H), 7.46 (t, J=9.0 Hz, 2H, Ar-H), 
 
7.31 (d, J=15.0 Hz, 2H, CHalkene), 7.03 (d, J=9.0 Hz, 2H, Ar-H), 6.78 (t, J=6.0 Hz, 1H, Ar-H), 
 
6.14 (d, J= 15.0 Hz, 2H, CHalkene), 4.20 (t, J=9.0 Hz, 4H, N-CH2-CH2), 2.68 (t, J=6.0 Hz, 4H, 
CH2-CH2), 1.92-180 (m, 2H, CH2-CH2-CH2), 1.78-1.61 (m, 4H, N-CH2-CH2-CH3), 0.97 (s, 
12H, C-CH3), 0.97 (t, J=9.0 Hz, 6H, CH2-CH3). IR (ATR) 2922, 1547, 1430, 1342, 1225, 
1001,  897,  711  cm-1. MS  (ESI)  m/z:  696  [M]+.  HRMS(FAB):  Calcd  for  C50H54N3[M]+ 
 
696.4312, found 696.4304. UV abs λmax = 778 nm. 
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3-Benzyl-2-[(E)-2-[(3E)-3-{2-[(2E)-3-benzyl-1,1-dimethyl-1H,2H,3H-benzo[e]indol-2- 
ylidene]ethylidene}-2-(phenylamino)cyclohex-1-en-1-yl]ethenyl]-1,1-dimethyl-1H- 
benzo[e]indol-3-ium bromide (8d). 
 
 
 
 
 
 
 
 
 
 
 
8d was synthesised as for 7a using 6e (0.06 g, 0.10 mmol), aniline (0.09 g, 1.00 mmol), and 
anhydrous DMF (10.0 mL). The solvent was removed under reduced pressure, the crude 
product was purified by column chromatography on silica gel (dichloromethane:methanol = 
9:1) to afford a shiny dark blue solid 8d (31 mg, 38%); m.p. 214-216 °C: 1H NMR (d6- 
 
DMSO, 300 MHz) δ 8.93 (brs, 1H, NH), 8.32 (s, 1H, Ar-H), 8.16 (d, J=9.0 Hz, 2H, Ar-H), 
 
8.08 (d, J=15.0 Hz, 2H, CHalkene), 7.99-7.90 (m, 4H, Ar-H), 7.62-7.33 (m, 4H, Ar-H), 7.46 (t, 
 
J=9.0 Hz, 2H, Ar-H), 7.31-7.23 (m, 11H, Ar-H), 7.03 (d, J=9.0 Hz, 2H, Ar-H), 6.83 (t, J=6.0 
 
Hz, 1H, Ar-H), 6.11 (d, J= 15.0 Hz, 2H, CHalkene), 5.50 (br s, 4H, N-CH2-Ph), 2.64-2.56 (m, 
 
4H, CH2-CH2), 1.78 (quin, J=6.0 Hz, 2H, CH2-CH2-CH2), 1.65 (s, 12H, C-CH3). IR (ATR) 
2924, 1592, 1433, 1345, 1271, 1093, 886, 664 cm-1. MS (ESI) m/z: 792 [M]+. HRMS(FAB): 
Calcd for C58H54N3[M]+ 792.4312, found 792.4307. UV abs λmax = 769 nm. 
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2-[(E)-2-[(3E)-3-{2-[(2E)-1,1-Dimethyl-3-(4-sulfonatobutyl)-1H,2H,3H-benzo[e]indol-2- 
ylidene]ethylidene}-2-(phenylamino)cyclohex-1-en-1-yl]ethenyl]-1,1-dimethyl-3-(4- 
sulfonatobutyl)-1H-benzo[e]indol-3-ium (8e). 
 
 
 
 
 
 
 
 
 
 
Na+ 
 
 
 
8e was synthesised as for 7a using 6g (0.08 g, 0.10 mmol), aniline (0.09 g, 1.00 mmol), and 
anhydrous DMF (10.0 mL). The solvent was removed under reduced pressure, the crude 
product was purified by column chromatography on silica gel (dichloromethane:methanol = 
9:1) to afford a green solid 8e (35 mg, 40%); m.p. 230-232 °C: 1H NMR (d6-DMSO, 300 
 
MHz) δ 8.75 (brs, 1H, NH), 8.12-8.08 (m, 4H, Ar-H), 8.00 (d, J=6.0 Hz, 4H, Ar-H), 7.69 (d, 
J=9.0 Hz, 2H, Ar-H), 7.58 (t, J=15.0 Hz, 2H, CHalkene), 7.45 (t, J=9.0 Hz, 2H, Ar-H), 7.30 (t, 
J=6.0 Hz, 2H, Ar-H), 7.03 (d, J=9.0 Hz, 2H, Ar-H), 6.77 (t, J=6.0 Hz, 1H, Ar-H), 6.16 (d, J= 
15.0 Hz, 2H, CHalkene), 4.19 (t, J=6.0 Hz, 4H, N-CH2-CH2), 2.73 (t, J=6.0 Hz, 4H, CH2-CH2- 
SO3), 2.48-2.35 (m, 4H, CH2-CH2), 1.93-187 (m, 2H, CH2-CH2-CH2), 1.76-1.65 (m, 8H, 
CH2-(CH2)4-SO3), 1.60 (s, 12H, C-CH3). IR (ATR) 2928, 1594, 1433, 1349, 1227, 1004, 886, 
714 cm-1. MS (ESI) m/z: 884 [M]+. UV abs λmax = 779 nm. 
 
 
 
 
N-(2,4-Dinitrophenyl) pyridinium chloride (PY1) was synthesised according to a reported 
procedure [262]. 
 
 
 
 
 
 
 
 
 
 
 
Pyridine (3.00 mL, 37.9 mmol) was dissolved in acetone (17.0 mL) and stirred, while 2,4- 
dinitrochlorobenzene (7.67 g, 37.9 mmol) was added to the reaction mixture. The mixture 
was heated under reflux overnight and then cooled to room temperature. The precipitate 
Experimental 
183 
 
 
 
 
produced was filtered under suction and washed with n-hexane to obtain PY1 (8.10 g, 76%) 
as a pale yellow powder; m.p. 197-199 °C, literature m.p. 197-200 °C [262]: 1H NMR (d6- 
DMSO, 250 MHz) δ 9.43 (d, J=6.0 Hz, 2H, Ar-H), 9.21 (s, 1H, Ar-H), 8.95 (t, J=7.0 Hz, 2H, 
Ar-H), 8.50-8.41 (m, 3H, Ar-H). 13C NMR (d6-DMSO, 68.2 MHz) δ 149.1, 148.9, 146.1, 
143.1, 138.8, 132.0, 130.3, 128.1, 121.4. IR (ATR) 2971, 1540, 1474, 1341, 1266, 1154, 943, 
 
855, 739 cm-1. MS (ESI) m/z: 246 [M]+. 
 
 
 
 
 
N-(2,4-Dinitrophenyl)-3-methylpyridinium chloride (PY2). 
 
 
 
 
 
 
 
 
 
 
 
PY2 was synthesised as for PY1 using 3-picoline (2.00 mL, 21.0 mmol) and 2,4- 
dinitrochlorobenzene (4.00 g, 19.7 mmol) to give the product PY2 (4.00 g, 69%) as a pale 
purple powder; m.p. 206-208 °C, literature m.p. 206-207 °C [263] : 1H NMR (d6-DMSO, 250 
MHz) δ 9.44 (s, 1H, Ar-H), 9.35 (d, J=6.0 Hz, 1H, Ar-H), 9.12 (d, J=3.0 Hz, 1H, Ar-H), 
 
9.01-8.97 (m, 1H, Ar-H), 8.83 (d, J=8.0 Hz, 1H, Ar-H), 8.49 (d, J=8.0 Hz, 1H, Ar-H), 8.38- 
 
8.33 (m, 1H, Ar-H), 2.59 (s, 3H, CH3). 13C NMR (d6-DMSO, 62.8 MHz) δ 149.6, 145.9, 
 
143.9, 143.5, 139.3, 139.2, 132.5, 130.8, 127.8, 122.0, 41.0. IR (ATR) 2959, 1570, 1455, 
 
1356, 1274, 1134, 952, 867, 726 cm-1. MS (ESI) m/z: 260 [M]+. 
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N-(2,4-Dinitrophenyl)-4-phenylpyridinium chloride (PY5). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PY5 was synthesised as for PY1 using 4-phenylpyridrine (2.74 g, 17.7 mmol)  and 2,4- 
dinitrochlorobenzene (3.57 g, 17.7 mmol) to give the product PY5 (5.12 g, 81%) as a pale 
yellow powder; m.p. 185-187 °C, literature m.p. 186-187 °C [264]: 1H NMR (d6-DMSO, 400 
MHz) δ 9.43 (d, J=7.0 Hz, 2H, Ar-H), 9.08 (s, J=6.0 Hz, 1H, Ar-H), 8.95-8.92 (m, 1H, Ar- 
 
H), 8.82 (d, J=7.0 Hz, 2H, Ar-H), 8.45 (d, J=8.0 Hz, 1H, Ar-H), 8.23-8.20 (m, 2H, Ar-H), 
 
7.71-7.64 (m, 3H, Ar-H). IR (ATR) 2960, 1557, 1462, 1367, 1258, 1151, 949, 850, 754 cm-1. 
MS (ESI) m/z: 322 [M]+. 
 
 
 
 
3-Bromo-1-(2,4-dinitrophenyl) pyridinium chloride (PY3). 
 
 
 
 
 
 
 
 
 
 
 
PY3 was synthesised as for PY1 using 3-bromopyridrine (2.00 mL, 21.0 mmol) and 2,4- 
dinitrochlorobenzene (4.00 g, 19.7 mmol) to give the product PY3 (5.60 g, 79%) as a  yellow 
solid; m.p. 143-145 °C: 1H NMR (d6-DMSO, 300 MHz) δ 8.88 (d, J=3.0 Hz, 1H, Ar-H), 8.66 
(s, 1H, Ar-H), 8.54 (d, J=6.0 Hz, 1H, Ar-H), 8.52-8.49 (m, 1H, Ar-H), 8.06-7.99 (m, 2H, Ar- 
H), 7.38-7.34 (m, 1H, Ar-H). 13C NMR (d6-DMSO, 75.4 MHz) δ 150.7, 148.5, 147.8, 146.7, 
139.2, 132.2, 128.4, 127.8, 126.0, 121.2, 120.9. IR (ATR) 2949, 1570, 1485, 1355, 1271, 
 
1162, 965, 873, 767 cm-1. MS (ESI) m/z: 325 [M]+. 
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3-Chloro-1-(2,4-dinitrophenyl) pyridinium chloride (PY4). 
 
 
 
 
 
 
 
 
 
 
PY4 was synthesised as for PY1 using 3-chloropyridrine (2.00 mL, 21.0 mmol) and 2,4- 
dinitrochlorobenzene (4.00 g, 19.7 mmol) to give the product PY4 (4.93 g, 79%) as a  yellow 
solid; m.p. 146-148 °C: 1H NMR (d6-DMSO, 300 MHz) δ 8.92 (d, J=3.0 Hz, 1H, Ar-H), 8.59 
(s, 1H, Ar-H), 8.55-8.52 (m, 2H, Ar-H), 7.92-7,89 (m, 2H, Ar-H),  7.48-7.43 (m, 1H, Ar-H). 
13C NMR (d6-DMSO, 75.4 MHz) δ 148.5, 148.1, 147.7, 146.6, 136.3, 133.5, 132.2, 131.6, 
128.3, 125.3, 121.4. IR (ATR) 2988, 1523, 1469, 1256, 1124, 968, 852, 748 cm-1. MS (ESI) 
 
m/z: 280 [M]+. 
 
 
 
 
1,3,3-Trimethyl-2-[(1E,3E,5E)-7-[(2E)-1,3,3-trimethyl-2,3-dihydro-1H-indol-;2- 
ylidene]hepta-1,3,5-trien-1-yl]-3H-indol-1-ium iodide (9a). 
 
 
 
 
 
 
 
 
To a solution of N-(2,4-dinitrophenyl) pyridinium chloride (0.22 g, 0.80 mmol) in EtOH 
(10.0 mL) was added 1a (0.60 g, 2.00 mmol). The reaction mixture was stirred for 5 mins, 
and then followed by the addition of sodium acetate (0.41 g, 5.00 mmol). The reaction was 
stirred at room temperature overnight and 20.0 mL n-hexane added. The precipitate produced 
was filtered under suction and washed with n-hexane. The crude product was purified by 
silica gel column chromatography (solvent; chloroform:methanol = 9:1) to obtain cyanine 
dye 9a (0.12 g, 28%) as a green solid; m.p. 178-180 °C: 1H NMR (d6-DMSO, 400 MHz) δ 
 
7.89 (t, J=13.0 Hz, 2H, CHalkene), 7.79 (t, J=13.0 Hz, 1H, CHalkene), 7.58 (d, J=7.0 Hz, 2H, Ar- 
H), 7.41-7.35 (m, 4H, Ar-H), 7.24 (t, J=6.0 Hz, 2H, Ar-H), 6.51 (t, J=13.0 Hz, 2H, CHalkene), 
6.32 (d, J=13.0 Hz, 2H, CHalkene), 3.62 (s, 6H, N-CH3), 1.63 (s, 12H, C-CH3). IR (ATR) 
2924, 1597, 1438, 1384, 1308, 1141, 987, 887, 740 cm-1. MS (ESI) m/z: 409 [M]+. UV abs 
 
λmax = 740 nm. 
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1-Ethyl-2-[(1E,3E,5E)-7-[(2E)-1-ethyl-3,3-dimethyl-2,3-dihydro-1H-indol-2- 
 
ylidene]hepta-1,3,5-trien-1-yl]-3,3-dimethyl-3H-indol-1-ium iodide (9b). 
 
 
 
 
 
 
 
 
 
9b was synthesised as for 9a using PY1 (0.22 g, 0.80 mmol) and anhydrous sodium acetate 
(0.41 g, 5.00 mmol) in EtOH (10.0 mL) with 1b (0.58 g, 2.00 mmol) to give the crude 
product which was purified by silica gel column chromatography (solvent; chloroform: 
methanol=9:1) to obtain cyanine dye 9b (0.21 g, 47%) as a shiny green solid; m.p. 188-190 
°C: 1H NMR (d6-DMSO, 400 MHz) δ 7.91 (t, J=13.0 Hz, 2H, CHalkene), 7.79 (t, J=13.0 Hz, 
 
1H, CHalkene), 7.59 (d, J=7.0 Hz, 2H, Ar-H), 7.42-7.36 (m, 4H, Ar-H), 7.24 (t, J=6.0 Hz, 2H, 
Ar-H), 6.56 (t, J=13.0 Hz, 2H, CHalkene), 6.38 (d, J=13.0 Hz, 2H, CHalkene), 4.14 (q, J=6.0 Hz, 
4H, N-CH2-CH3), 1.62 (s, 12H, C-CH3), 1.34 (t, J=7.0 Hz, 6H, CH2-CH3). IR (ATR) 2962, 
1595, 1509, 1394, 1192, 1089, 882, 739 cm-1. MS (ESI) m/z: 437 [M]+. UV abs λmax = 742 
nm. 
 
 
 
 
2-[(1E,3E,5E)-7-[(2E)-3,3-Dimethyl-1-propyl-2,3-dihydro-1H-indol-2-ylidene]hepta- 
 
1,3,5-trien-1-yl]-3,3-dimethyl-1-propyl-3H-indol-1-ium iodide (9c). 
 
 
 
 
 
 
 
 
 
 
9c was synthesised as for 9a using PY1 (0.22 g, 0.80 mmol) and anhydrous sodium acetate 
(0.41 g, 5.00 mmol) in EtOH (10.0 mL) with 1c (0.66 g, 2.00 mmol) to give the crude 
product which was purified by silica gel column chromatography (solvent; chloroform: 
methanol=9:1) to obtain cyanine dye 9c (0.31 g, 66%) as a shiny green solid; m.p. 166-168 
°C: 1H NMR (d6-DMSO, 400 MHz) δ 7.91 (t, J=13.0 Hz, 2H, CHalkene), 7.75 (d, J=14.0 Hz, 
 
1H, CHalkene), 7.59 (d, J=7.0 Hz, 2H, Ar-H), 7.39-7.38 (m, 4H, Ar-H), 7.24-7.20 (m, 2H, Ar- 
H), 6.57 (d, J=13.0 Hz, 2H, CHalkene), 6.40 (t, J=14.0 Hz, 2H, CHalkene), 4.06 (t, J=7.0 Hz, 4H, 
N-CH2-CH2), 1.74 (quin, J=7.0 Hz, 4H, CH2-CH2-CH3), 1.63 (s, 12H, C-CH3), 0.97 (t, J=7.0 
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Hz, 6H, CH2-CH3). IR (ATR) 2957, 1601, 1508, 1397, 1312, 1191, 1144, 960, 877, 783 cm-1. 
MS (ESI) m/z: 465 [M]+. UV abs λmax = 746 nm. 
 
 
 
 
1-Butyl-2-[(1E,3E,5E)-7-[(2E)-1-butyl-3,3-dimethyl-2,3-dihydro-1H-indol-2- 
ylidene]hepta-1,3,5-trien-1-yl]-3,3-dimethyl-3H-indol-1-ium iodide (9d). 
 
 
 
 
 
 
 
 
 
 
9d was synthesised as for 9a using PY1 (0.22 g, 0.80 mmol) and anhydrous sodium acetate 
(0.41 g, 5.00 mmol) in EtOH (10.0 mL) with 1d (0.69 g, 2.00 mmol) to give the crude 
product which was purified by silica gel column chromatography (solvent; chloroform: 
methanol=9:1) to obtain cyanine dye 9d (0.15 g, 31%) as a green solid; m.p. 169-171 °C: 1H 
NMR (d6-DMSO, 300 MHz) δ 7.92 (t, J=13.0 Hz, 2H, CHalkene), 7.80 (d, J=13.0 Hz, 1H, 
CHalkene), 7.60 (d, J=6.0 Hz, 2H, Ar-H), 7.39-7.35 (m, 4H, Ar-H), 7.25-7.20 (m, 2H, Ar-H), 
6.58 (t, J=13.0 Hz, 2H, CHalkene), 6.40 (d, J=13.0 Hz, 2H, CHalkene), 4.10 (t, J=9.0 Hz, 4H, N- 
 
CH2-CH2), 1.69 (quin, J=9.0 Hz, 4H, CH2-CH2-CH2), 1.63 (s, 12H, C-CH3), 1.43 (sex, J=9.0 
 
Hz, 4H, CH2-CH2-CH3), 0.95 (t, J=6.0 Hz, 6H, CH2-CH3). IR (ATR) 2920, 1595, 1508, 1401, 
1316, 1217, 1144, 985, 893, 783 cm-1. MS (ESI) m/z: 493 [M]+. UV abs λmax = 746 nm. 
 
 
 
 
1-Benzyl-2-[(1E,3E,5E)-7-[(2E)-1-benzyl-3,3-dimethyl-2,3-dihydro-1H-indol-2- 
ylidene]hepta-1,3,5-trien-1-yl]-3,3-dimethyl-3H-indol-1-ium bromide (9e). 
 
 
 
 
 
 
 
 
 
 
 
9e was synthesised as for 9a using PY1 (0.22 g, 0.80 mmol) and anhydrous sodium acetate 
(0.41 g, 5.00 mmol) in EtOH (10.0 mL) with 1k (0.66 g, 2.00 mmol) to give the crude 
product  which  was  purified  by  silica  gel  column  chromatography  (solvent;  chloroform: 
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methanol=9:1) to obtain cyanine dye 9e (0.11 g, 21%) as a shiny purple solid; m.p. 170-172 
 
°C: 1H NMR (d6-DMSO, 400 MHz) δ 8.34 (t, J=13.0 Hz, 2H, CHalkene), 7.61 (d, J=7.0 Hz, 
 
2H, Ar-H), 7.32-7.25 (m, 8H, Ar-H), 7.23-6.99 (m, 10H, Ar-H), 6.90 (d, J=9.0 Hz, 1H, Ar- 
H), 6.40 (d, J=13.0 Hz, 2H, CHalkene), 5.34 (s, 4H, Ph-CH2), 1.67 (s, 12H, C-CH3). IR (ATR) 
2971, 1598, 1507, 1397, 1060, 983, 893, 738 cm-1. MS (ESI) m/z: 561 [M]+. UV abs λmax = 
 
748 nm. 
 
 
 
 
2-[(1E,3E,5E)-7-[(2E)-3,3-Dimethyl-1-(3-sulfonatopropyl)-2,3-dihydro-1H-indol-2- 
ylidene]hepta-1,3,5-trien-1-yl]-3,3-dimethyl-1-(3-sulfonatopropyl)-3H-indol-1-ium (9f). 
 
 
 
 
 
 
 
 
 
 
9f was synthesised as for 9a using PY1 (0.22 g, 0.80 mmol) and anhydrous sodium acetate 
(0.41 g, 5.00 mmol) in EtOH (10.0 mL) with 1l (0.56 g, 2.00 mmol) to give the crude product 
which  was  purified  by  silica  gel  column  chromatography  (solvent;  chloroform: 
methanol=7:3) to obtain cyanine dye 9f (0.30 g, 60%) as a green solid; m.p. 220-222 °C: 1H 
NMR (d6-DMSO, 400 MHz) δ 8.26 (t, J=13.0 Hz, 2H, CHalkene), 7.51-7.42 (m, 2H, Ar-H), 
7.39 (t, J=7.0 Hz, 2H, Ar-H), 7.27-7.18 (t, J=7.0 Hz, 3H, Ar-H), 7.11 (t, J=7.0 Hz, 2H, Ar- 
 
H), 6.44 (t, J=13.0 Hz, 2H, CHalkene), 6.29 (d, J=13.0 Hz, 2H, CHalkene), 4.12-3.87 (m,  4H, N- 
CH2), 2.46-2.32 (m, 4H, CH2-SO3), 1.85-1.72 (m, 4H, CH2-CH2-SO3), 1.56 (s, 12H, C-CH3). 
IR (ATR) 2975, 2361, 1600, 1451, 1381, 1336, 1033, 924, 749 cm-1. MS (ESI) m/z: 623 
[M+2H]+. UV abs λmax = 747 nm. 
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2-[(1E,3E,5E)-7-[(2E)-3,3-Dimethyl-1-(4-sulfonatobutyl)-2,3-dihydro-1H-indol-2- 
ylidene]hepta-1,3,5-trien-1-yl]-3,3-dimethyl-1-(4-sulfonatobutyl)-3H-indol-1-ium (9g). 
 
 
 
 
 
 
 
 
 
Na+ 
 
 
9g was synthesised as for 9a using PY1 (0.22 g, 0.80 mmol) and anhydrous sodium acetate 
(0.41 g, 5.00 mmol) in EtOH (10.0 mL) with 1m (0.59 g, 2.00 mmol) to give the crude 
product which was purified by silica gel column chromatography (solvent; chloroform: 
methanol=7:3) to obtain cyanine dye 9g (0.38 g, 73%) as a green solid; m.p. 221-223 °C: 1H 
NMR (d6-DMSO, 400 MHz) δ 7.90 (t, J=13.0 Hz, 2H, CHalkene), 7.80-7.44 (m, 1H, Ar-H), 
7.57 (d, J=7.0 Hz, 2H, Ar-H), 7.41-7.35 (m, 4H, Ar-H), 7.23 (t, J=8.0 Hz, 2H, Ar-H), 6.58 (t, 
 
J=13.0 Hz, 2H, CHalkene), 6.44 (d, J=13.0 Hz, 2H, CHalkene), 4.06 (t, J=7.0 Hz, 4H, N-CH2- 
CH2), 2.47 (t, J=7.0 Hz, 4H, CH2-CH2-SO3), 1.74-1.66 (m, 8H, (CH2)4-CH2-SO3) 1.62 (s, 
12H, C-CH3). IR (ATR) 2924, 1597, 1509, 1317, 1158, 966, 741 cm-1. MS (ESI) m/z: 653 
[M+2H]+. UV abs λmax = 747 nm. 
 
 
 
 
 
3-Methyl-2-[(1E,3E,5E)-7-[(2Z)-3-methyl-2,3-dihydro-1,3-benzothiazol-2-ylidene]hepta- 
 
1,3,5-trien-1-yl]-1,3-benzothiazol-3-ium iodide (10a). 
 
 
 
 
 
 
 
10a was synthesised as for 9a using PY1 (0.22 g, 0.80 mmol) and anhydrous sodium acetate 
(0.41 g, 5.00 mmol) in EtOH (10.0 mL) with 2a (0.58 g, 2.00 mmol) to give the crude 
product which was purified by silica gel column chromatography (solvent; chloroform: 
methanol=9:1) to obtain cyanine dye 10a (0.32 g, 78%) as a green solid; m.p. 210-212 °C: 1H 
NMR (d6-DMSO, 400 MHz) δ 7.95 (d, J=7.0 Hz, 2H, Ar-H), 7.67 (d, J=8.0 Hz, 2H, Ar-H), 
7.53 (t, J=7.0 Hz, 2H, Ar-H), 7.43-7.35 (m, 5H, Ar-H), 6.54 (d, J=13.0 Hz, 2H, CHalkene), 
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6.48 (t, J=13.0 Hz, 2H, CHalkene), 3.77 (s, 6H, N-CH3). IR (ATR) 1543, 1518, 1356, 1232, 
1081, 887, 764, 615 cm-1. MS (ESI) m/z: 389 [M]+. UV abs λmax = 756 nm. 
 
 
 
 
 
3-Ethyl-2-[(1E,3E,5E)-7-[(2Z)-3-ethyl-2,3-dihydro-1,3-benzothiazol-2-ylidene]hepta- 
 
1,3,5-trien-1-yl]-1,3-benzothiazol-3-ium iodide (10b). 
 
 
 
 
 
 
 
 
 
10b was synthesised as for 9a using PY1 (0.22 g, 0.80 mmol) and anhydrous sodium acetate 
(0.41 g, 5.00 mmol) in EtOH (10.0 mL) with 2b (0.61 g, 2.00 mmol) to give the crude 
product which was purified by silica gel column chromatography (solvent; chloroform: 
methanol=9:1) to obtain cyanine dye 10b (0.20 g, 46%) as a green solid; m.p. 216-218 °C: 1H 
NMR (d6-DMSO, 400 MHz) δ 7.95 (d, J=7.0 Hz, 2H, Ar-H), 7.68 (d, J=6.0 Hz, 2H, Ar-H), 
7.54 (t, J=6.0 Hz, 2H, Ar-H), 7.43-7.32 (m, 5H, Ar-H), 6.58 (d, J=13.0 Hz, 2H, CHalkene), 
 
6.45 (t, J=13.0 Hz, 2H, CHalkene), 4.36 (q, J=6.0 Hz, 4H, N-CH2-CH3), 1.30 (t, J=7.0 Hz, 6H, 
CH2-CH3). IR (ATR) 2971, 1579, 1507, 1396, 1059, 983, 830, 738 cm-1. MS (ESI) m/z: 417 
[M]+. UV abs λmax = 759 nm. 
 
 
 
 
3-Propyl-2-[(1E,3E,5E)-7-[(2Z)-3-propyl-2,3-dihydro-1,3-benzothiazol-2-ylidene]hepta- 
 
1,3,5-trien-1-yl]-1,3-benzothiazol-3-ium iodide (10c). 
 
 
 
 
 
 
 
 
 
 
10c was synthesised as for 10a using PY1 (0.22 g, 0.80 mmol) and anhydrous sodium acetate 
(0.41 g, 5.00 mmol) in EtOH (10.0 mL) with 2c (0.64 g, 2.00 mmol) to give the crude 
product which was purified by silica gel column chromatography (solvent; chloroform: 
methanol=9:1) to obtain cyanine dye 10c (0.30 g, 66%) as a green solid; m.p. 193-195 °C: 1H 
NMR (d6-DMSO, 400 MHz) δ 7.95 (d, J=7.0 Hz, 2H, Ar-H), 7.71 (d, J=8.0 Hz, 2H, Ar-H), 
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7.53 (d, J=7.0 Hz, 2H, Ar-H), 7.44 (d, J=13.0 Hz, 2H, CHalkene), 7.37-733 (m, 3H, Ar-H), 
 
6.60 (d, J=13.0 Hz, 2H, CHalkene), 6.40 (t, J=13.0 Hz, 2H, CHalkene), 4.27 (t, J=7.0 Hz, 4H, N- 
CH2-CH2), 1.75 (quin, J=7.0 Hz, 4H, CH2-CH2-CH3), 0.97 (t, J=7.0 Hz, 6H, CH2-CH3). IR 
(ATR) 2960, 1579, 1500, 1393, 1324, 970, 805, 743 cm-1. MS (ESI) m/z: 445 [M]+. 
HRMS(FAB): Calcd for C27H29N2S2 [M]+ 445.1766, found 445.1758. UV abs λmax = 761 nm. 
 
 
 
 
3-Butyl-2-[(1E,3E,5E)-7-[(2Z)-3-butyl-2,3-dihydro-1,3-benzothiazol-2-ylidene]hepta- 
 
1,3,5-trien-1-yl]-1,3-benzothiazol-3-ium iodide (10d). 
 
 
 
 
 
 
 
 
 
 
 
10d was synthesised as for 9a using PY1 (0.22 g, 0.80 mmol) and anhydrous sodium acetate 
(0.41 g, 5.00 mmol) in EtOH (10.0 mL) with 2d (0.67 g, 2.00 mmol) to give the crude 
product which was purified by silica gel column chromatography (solvent; chloroform: 
methanol=9:1) to obtain cyanine dye 10d (0.21 g, 44%) as a green solid; m.p. 176-178 °C: 1H 
NMR (d6-DMSO, 300 MHz) δ 7.98 (d, J=9.0 Hz, 2H, Ar-H), 7.71 (d, J=9.0 Hz, 2H, Ar-H), 
7.57 (t, J=12.0 Hz, 2H, CHalkene), 7.47-7.35 (m, 5H, Ar-H), 6.60 (d, J=12.0 Hz, 2H, CHalkene), 
 
6.49 (t, J=12.0 Hz, 2H, CHalkene), 4.33 (t, J=6.0 Hz, 4H, N-CH2-CH2), 1.71 (quin, J=6.0 Hz, 
 
4H, CH2-CH2-CH2), 1.47-1.37 (m, 4H, CH2-CH2-CH3), 0.95 (t, J=6.0 Hz, 6H, CH2-CH3). IR 
(ATR) 2951, 1501, 1451, 1391, 1320, 1051, 918, 821, 737 cm-1. MS (ESI) m/z: 473 [M]+. 
UV abs λmax = 761 nm. 
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3-Benzyl-2-[(1E,3E,5E)-7-[(2Z)-3-benzyl-2,3-dihydro-1,3-benzothiazol-2-ylidene]hepta- 
 
1,3,5-trien-1-yl]-1,3-benzothiazol-3-ium bromide (10e). 
 
 
 
 
 
 
 
 
 
 
 
10e was synthesised as for 9a using PY1 (0.22 g, 0.80 mmol) and anhydrous sodium acetate 
(0.41 g, 5.00 mmol) in EtOH (10.0 mL) with 2k (0.64 g, 2.00 mmol) to give the crude 
product which was purified by silica gel column chromatography (solvent; chloroform: 
methanol=8:2) to obtain cyanine dye 10e (0.30 g, 60%) as a green solid; m.p. 209-211 °C: 1H 
NMR (d6-DMSO, 400 MHz) δ 8.02 (d, J=7.0 Hz, 2H, Ar-H), 7.65 (d, J=8.0 Hz, 2H, Ar-H), 
7.52-7.36 (m, 11H, Ar-H), 7.33 (t, J=8.0 Hz, 2H, Ar-H), 7.26 (d, J=7.0 Hz, 4H, Ar-H), 6.64 
(d, J=13.0 Hz, 2H, CHalkene), 6.31 (t, J=13.0 Hz, 2H, CHalkene), 5.64 (br s, 4H, Ph-CH2). IR 
(ATR) 2979, 1582, 1504, 1459, 1328, 1114, 994, 814, 732 cm-1. MS (ESI) m/z: 541 [M]+. 
HRMS(ESI): Calcd for C35H29N2S2 [M]+. 541.1766, found 541.1756. UV abs λmax = 765 nm. 
 
 
 
 
3-(3-Sulfonatopropyl)-2-[(1E,3E,5E)-7-[(2Z)-3-(3-sulfonatopropyl)-2,3-dihydro-1,3- 
benzothiazol-2-ylidene]hepta-1,3,5-trien-1-yl]-1,3-benzothiazol-3-ium (10f). 
 
 
 
 
 
10f was synthesised as for 9a using PY1 (0.22 g, 0.80 mmol) and anhydrous sodium acetate 
(0.41 g, 5.00 mmol) in EtOH (10.0 mL) with 2l (0.54 g, 2.00 mmol) to give the crude product 
which  was  purified  by  silica  gel  column  chromatography  (solvent;  chloroform: 
methanol=7:3) to obtain cyanine dye 10f (0.22 g, 46%) as a green solid; m.p. 225-227 °C: 1H 
NMR (d6-DMSO, 400 MHz) δ 7.95 (d, J=7.0 Hz, 2H, Ar-H), 7.79 (d, J=8.0 Hz, 2H, Ar-H), 
7.55 (t, J=8.0 Hz, 2H, Ar-H), 7.44-7.34 (m, 5H, Ar-H), 6.69 (d, J=13.0 Hz, 2H, CHalkene), 
 
6.44 (t, J=13.0 Hz, 2H, CHalkene), 4.48 (t, J=8.0 Hz, 4H, N-CH2-CH2), 2.58 (t, J=7.0 Hz, 4H, 
CH2-CH2-SO3), 2.03 (quin, J=8.0 Hz, 4H, CH2 CH2-CH2). IR (ATR) 3398, 2361, 1581, 1504, 
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1405, 1329, 1091, 993, 749 cm-1. MS (ESI) m/z: 603 [M+2H]+. HRMS(ESI): Calcd for 
 
C27H27N2O6S4 [M+2H]+. 603.0757, found 603.0742. UV abs λmax = 762 nm. 
 
 
 
 
 
3-(4-Sulfonatobutyl)-2-[(1E,3E,5E)-7-[(2Z)-3-(4-sulfonatobutyl)-2,3-dihydro-1,3- 
benzothiazol-2-ylidene]hepta-1,3,5-trien-1-yl]-1,3-benzothiazol-3-ium (10g). 
 
 
 
 
 
 
 
 
 
Na+ 
 
 
10g was synthesised as for 9a using PY1 (0.22 g, 0.80 mmol) and anhydrous sodium acetate 
(0.41 g, 5.00 mmol) in EtOH (10.0 mL) with 2m (0.57 g, 2.00 mmol) to give the crude 
product which was purified by silica gel column chromatography (solvent; chloroform: 
methanol=7:3) to obtain cyanine dye 10g (0.23 g, 47%) as a green solid; m.p. 228-230 °C: 1H 
NMR (d6-DMSO, 400 MHz) δ 7.94 (d, J=8.0 Hz, 2H, Ar-H), 7.78 (d, J=8.0 Hz, 2H, Ar-H), 
7.53 (t, J=8.0 Hz, 2H, Ar-H), 7.43-7.33 (m, 5H, Ar-H), 6.68 (d, J=13.0 Hz, 2H, CHalkene), 
 
6.42 (d, J=13.0 Hz, 2H, CHalkene), 4.06-3.87 (m, 4H, N-CH2-CH2), 2.56 (t, J=8.0 Hz 4H, CH2- 
CH2-SO3), 2.41-2.06 (m, 4H, N-CH2-CH2), 1.91-1.65 (m, 4H, CH2-CH2-SO3-). IR (ATR) 
3405, 2361, 1683, 1505, 1400, 1328, 1074, 978, 742 cm-1. MS (ESI) m/z: 631 [M+2H]+. UV 
 
abs λmax = 762 nm. 
 
 
 
 
1,1,3-Trimethyl-2-[(1E,3E,5E)-7-[(2E)-1,1,3-trimethyl-1H,2H,3H-benzo[e]indol-2- 
ylidene]hepta-1,3,5-trien-1-yl]-1H-benzo[e]indol-3-ium iodide (11a). 
 
 
 
 
 
 
 
 
 
11a was synthesised as for 9a using PY1 (0.22 g, 0.80 mmol) and anhydrous sodium acetate 
(0.41 g, 5.00 mmol) in EtOH (10.0 mL) with 3a (0.70 g, 2.00 mmol) to give the crude 
product  which  was  purified  by  silica  gel  column  chromatography  (solvent;  chloroform: 
Experimental 
194 
 
 
 
 
methanol=9:1) to obtain cyanine dye 11a (0.19 g, 37%) as a green solid; m.p. 176-178 °C: 1H 
NMR (d6-DMSO, 300 MHz) δ 8.27 (d, J=9.0 Hz, 2H Ar-H), 8.09-8.02 (m, 5H, Ar-H), 7.98 
(t, J=13.0 Hz, 1H, CHalkene), 7.83 (t, J=13.0 Hz, 1H, CHalkene), 7.74 (d, J=9.0 Hz, 2H, Ar-H), 
7.67 (t, J=6.0 Hz, 2H, Ar-H), 7.52 (t, J=6.0 Hz, 2H, Ar-H), 6.61 (t, J=13.0 Hz, 2H, CHalkene), 
 
6.44 (d, J=14.0 Hz, 2H, CHalkene), 3.70 (br s, 6H, N-CH2), 1.91 (s, 12H, C-CH3). IR (ATR) 
2925, 1626, 1508, 1390, 1322, 1055, 916, 817, 716 cm-1. MS (ESI) m/z: 509 [M]+. UV abs 
 
λmax = 778 nm. 
 
 
 
 
3-Ethyl-2-[(1E,3E,5E)-7-[(2E)-3-ethyl-1,1-dimethyl-1H,2H,3H-benzo[e]indol-2- 
ylidene]hepta-1,3,5-trien-1-yl]-1,1-dimethyl-1H-benzo[e]indol-3-ium iodide (11b). 
 
 
 
 
 
 
 
 
 
 
 
11b was synthesised as for 9a using PY1 (0.22 g, 0.80 mmol) and anhydrous sodium acetate 
(0.41 g, 5.00 mmol) in EtOH (10.0 mL) with 3b (0.73 g, 2.00 mmol) to give the crude 
product which was purified by silica gel column chromatography (solvent; chloroform: 
methanol=9:1) to obtain cyanine dye 11b (0.10 g, 19%) as a green solid; m.p. 198-200 °C: 1H 
NMR (d6-DMSO, 300 MHz) δ 8.27 (d, J=9.0 Hz, 2H Ar-H), 8.09-8.03 (m, 5H, Ar-H), 7.99 
(t, J=13.0 Hz, 1H, CHalkene), 7.85 (t, J=13.0 Hz, 2H, CHalkene), 7.74 (d, J=9.0 Hz, 2H, Ar-H), 
7.68 (t, J=6.0 Hz, 2H, Ar-H), 7.52 (t, J=7.0 Hz, 2H, Ar-H), 6.63 (t, J=13.0 Hz, 2H, CHalkene), 
 
6.46 (d, J=14.0 Hz, 2H, CHalkene), 4.29 (q, J=6.0 Hz,  4H, N-CH2-CH3), 1.91 (s, 12H, C-CH3), 
 
1.35 (t, J=6.0 Hz,  6H, CH2-CH3). IR (ATR) 2969, 1620, 1507, 1471, 1396, 1192, 1082, 952, 
859, 706 cm-1. MS (ESI) m/z: 537 [M]+. UV abs λmax = 781 nm. 
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2-[(1E,3E,5E)-7-[(2E)-1,1-Dimethyl-3-propyl-1H,2H,3H-benzo[e]indol-2-ylidene]hepta- 
 
1,3,5-trien-1-yl]-1,1-dimethyl-3-propyl-1H-benzo[e]indol-3-ium iodide (11c). 
 
 
 
 
 
 
 
 
 
 
 
 
11c was synthesised as for 9a using PY1 (0.22 g, 0.80 mmol) and anhydrous sodium acetate 
(0.41 g, 5.00 mmol) in EtOH (10.0 mL) with 3c (0.76 g, 2.00 mmol) to give the crude 
product which was purified by silica gel column chromatography (solvent; chloroform: 
methanol=9:1) to obtain cyanine dye 11c (0.11 g, 20%) as a green solid; m.p. 195-197 °C: 1H 
NMR (d6-DMSO, 300 MHz) δ 8.27 (d, J=8.0 Hz, 2H Ar-H), 8.08-8.03 (m, 5H, Ar-H), 7.80 
(t, J=13.0 Hz, 2H, CHalkene), 7.75 (t, J=13.0 Hz, 2H, Ar-H), 7.67 (t, J=8.0 Hz, 2H, Ar-H), 
7.52 (t, J=8.0 Hz, 2H, Ar-H), 6.59 (t, J=13.0 Hz, 2H, CHalkene), 6.48 (d, J=14.0 Hz, 2H, 
 
CHalkene), 4.21 (t, J=9.0 Hz, 4H, N-CH2-CH2), 1.91 (s, 12H, C-CH3), 1.82 (sex, J=6.0 Hz, 4H, 
N-CH2-CH2-CH3), 1.01 (t, J=6.0 Hz,   6H, CH2-CH3). IR (ATR) 2922, 1600, 1504, 1467, 
1346, 1191, 1052, 915, 871, 711 cm-1. MS (ESI) m/z: 565.31 [M]+. UV abs λmax = 782 nm. 
 
 
 
 
3-Butyl-2-[(1E,3E,5E)-7-[(2E)-3-butyl-1,1-dimethyl-1H,2H,3H-benzo[e]indol-2- 
ylidene]hepta-1,3,5-trien-1-yl]-1,1-dimethyl-1H-benzo[e]indol-3-ium iodide (11d). 
 
 
 
 
 
 
 
 
 
 
 
 
 
11d was synthesised as for 9a using PY1 (0.22 g, 0.80 mmol) and anhydrous sodium acetate 
(0.41 g, 5.00 mmol) in EtOH (10.0 mL) with 3d (0.63 g, 2.00 mmol) to give the crude 
product which was purified by silica gel column chromatography (solvent; chloroform: 
methanol=9:1) to obtain cyanine dye 11d (0.16 g, 28%) as a green solid; m.p. 196-198 °C: 1H 
NMR (d6-DMSO, 300 MHz) δ 8.27 (d, J=9.0 Hz, 2H Ar-H), 8.08-8.03 (m, 5H, Ar-H), 7.99 
Experimental 
196 
 
 
 
 
(t, J=12.0 Hz, 2H, CHalkene), 7.74 (d, J=9.0 Hz, 2H, Ar-H), 7.67 (t, J=13.0 Hz, 2H, CHalkene), 
 
7.52 (t, J=8.0 Hz, 2H, Ar-H), 6.63 (t, J=13.0 Hz, 2H, CHalkene), 6.46 (d, J=14.0 Hz, 2H, 
CHalkene), 4.23 (t, J=6.0 Hz, 4H, N-CH2-CH2), 1.91 (s, 12H, C-CH3), 1.77 (quin, J=6.0 Hz, 
4H, N-CH2-CH2-CH2), 1.47 (sex, J=9.0 Hz, 4H, N-CH2-CH2-CH3), 0.97 (t, J=9.0 Hz,  6H, 
CH2-CH3). IR (ATR) 2924, 1601, 1504, 1400, 1346, 1181, 1053, 881, 713 cm-1. MS (ESI) 
m/z: 593[M]+. UV abs λmax = 783 nm. 
 
 
 
 
3-Benzyl-2-[(1E,3E,5E)-7-[(2E)-3-benzyl-1,1-dimethyl-1H,2H,3H-benzo[e]indol-2- 
ylidene]hepta-1,3,5-trien-1-yl]-1,1-dimethyl-1H-benzo[e]indol-3-ium bromide (11e). 
 
 
 
 
 
 
 
 
 
 
 
 
 
11e was synthesised as for 9a using PY1 (0.22 g, 0.80 mmol) and anhydrous sodium acetate 
(0.41 g, 5.00 mmol) in EtOH (10.0 mL) with 3e (0.76 g, 2.00 mmol) to give the crude 
product which was purified by silica gel column chromatography (eluent solvent; chloroform: 
methanol=9:1) to obtain cyanine dye 11e (0.10 g, 17%) as a light green solid; m.p. 157-159 
°C: 1H NMR (d6-DMSO, 300 MHz) δ 8.63 (d, J=8.0 Hz, 2H, Ar-H), 8.04-7.98 (m, 6H, Ar- 
 
H), 7.69-7.60 (m, 4H, Ar-H), 7.54 (t, J=12.0 Hz, 2H, CHalkene), 7.41-7.33 (m, 4H, Ar-H), 
 
7.31-7.27 (m, 6H, Ar-H), 6.65 (d, J=12.0 Hz, 1H, CHalkene), 6.53 (t, J=12.0 Hz, 4H, CHalkene), 
 
5.54 (s, 4H, N-CH2-Ph), 1.98 (s, 12H, C-CH3). IR (ATR) 2923, 1601, 1501, 1462, 1393, 
1346, 1051, 991, 876, 716 cm-1. MS (ESI) m/z: 661 [M]+. UV abs λmax = 786 nm. 
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2-[(1E,3E,5E)-7-[(2E)-1,1-Dimethyl-3-(3-sulfonatopropyl)-1H,2H,3H-benzo[e]indol-2- 
ylidene]hepta-1,3,5-trien-1-yl]-1,1-dimethyl-3-(3-sulfonatopropyl)-1H-benzo[e]indol-3- 
ium (11f). 
 
 
 
 
 
 
 
 
 
 
 
 
 
11f was synthesised as for 9a using PY1 (0.22 g, 0.80 mmol) and anhydrous sodium acetate 
(0.41 g, 5.00 mmol) in EtOH (10.0 mL) with 3f (0.66 g, 2.00 mmol) to give the crude product 
which  was  purified  by  silica  gel  column  chromatography  (solvent;  chloroform: 
methanol=8:2) to obtain cyanine dye 11f (0.18 g, 32%) as a green solid; m.p. 240-242 °C: 1H 
NMR (d6-DMSO, 300 MHz) δ 8.26 (d, J=9.0 Hz, 2H Ar-H), 8.03-8.01 (m, 6H, Ar-H), 7.83 
(d, J=9.0 Hz, 3H, Ar-H), 7.67 (t, J=12.0 Hz, 2H, CHalkene), 7.52 (t, J=8.0 Hz, 2H, Ar-H), 6.60 
(t, J=12.0 Hz, 4H, CHalkene), 4.39 (t, J=6.0 Hz, 4H, N-CH2-CH2), 2.66 (t, J=9.0 Hz, 4H, CH2- 
CH2-SO3), 2.08 (quin, J=6.0 Hz, 4H, N-CH2-CH2-CH2), 1.91 (s, 12H, C-CH3). IR (ATR) 
2286, 1504, 1471, 1355, 1073, 913, 806, 716 cm-1. MS (ESI) m/z: 723 [M+2H]+. UV abs λmax 
 
= 784 nm. 
 
 
 
 
 
2-[(1E,3E,5E)-7-[(2E)-1,1-Dimethyl-3-(4-sulfonatobutyl)-1H,2H,3H-benzo[e]indol-2- 
ylidene]hepta-1,3,5-trien-1-yl]-1,1-dimethyl-3-(4-sulfonatobutyl)-1H-benzo[e]indol-3- 
ium (11g). 
 
 
 
 
 
 
 
 
 
 
Na+ 
 
 
11g was synthesised as for 9a using PY1 (0.22 g, 0.80 mmol) and anhydrous sodium acetate 
 
(0.41 g, 5.00 mmol) in EtOH (10.0 mL) with 3g (0.69 g, 2.00 mmol) to give the crude 
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product which was purified by silica gel column chromatography (solvent; chloroform: 
methanol=8:2) to obtain cyanine dye 11g (0.17 g, 28%) as a green solid; m.p. 247-249 °C: 1H 
NMR (d6-DMSO, 300 MHz) δ 8.26 (t, J=9.0 Hz, 2H Ar-H), 8.06-7.88 (m, 6H, Ar-H), 7.71 
(d, J=8.0 Hz, 3H, Ar-H), 7.76 (t, J=8.0 Hz, 2H, Ar-H), 7.45 (t, J=8.0 Hz, 2H, Ar-H), 6.63 (d, 
J=13.0 Hz, 2H, CHalkene), 6.51 (t, J=13.0 Hz, 2H, CHalkene), 4.20 (t, J=6.0 Hz, 4H, N-CH2- 
CH2), 2.55 (quin, J=6.0 Hz, 4H, N-CH2-CH2-CH2), 1.91 (s, 12H, C-CH3), 1.83 (br s, 8H, 
SO3-(CH2)4-CH2). IR (ATR) 2927, 1620, 1405, 1352, 1042, 997, 881, 715 cm-1. MS (ESI) 
m/z: 753 [M+2H]+. UV abs λmax = 784 nm. 
 
 
 
 
1,1,3-Trimethyl-2-[(1E,3E,5E)-5-methyl-7-[(2E)-1,1,3-trimethyl-1H,2H,3H- 
benzo[e]indol-2-ylidene]hepta-1,3,5-trien-1-yl]-1H-benzo[e]indol-3-ium iodide (OA188). 
 
 
 
 
 
 
 
 
 
 
OA188 was synthesised as for 9a using PY2 (0.24 g, 0.80 mmol) and anhydrous sodium 
acetate (0.41 g, 5.00 mmol) in EtOH (10.0 mL) with 3a (0.70 g, 2.00 mmol) to give the crude 
product which was purified by silica gel column chromatography (solvent; chloroform: 
methanol=9:1) to obtain cyanine dye OA188 (0.11 g, 21%) as a green solid; m.p. 206-208 
°C: 1H NMR (d6-DMSO, 300 MHz) δ 8.27 (d, J=9.0 Hz, 2H, Ar-H), 8.09 (t, J=9.0 Hz, 5H, 
 
Ar-H), 7.91 (d, J=15.0 Hz, 1H, CHalkene), 7.80-7.70 (m, 3H, Ar-H), 7.68 (t, J=15.0 Hz, 2H, 
CHalkene), 7.52 (t, J=8.0 Hz, 2H, Ar-H), 6.74 (t, J=15.0 Hz, 1H, CHalkene), 6.46 (d, J=15.0 Hz, 
1H, CHalkene), 6.23 (d, J=15.0 Hz, 1H, CHalkene), 3.75 (s, 3H, N-CH3), 3.71 (s, 3H, N-CH3), 
 
2.06 (s, 3H, C-CH3), 1.93 (s, 6H, C-CH3), 1.92 (s, 6H, C-CH3). IR (ATR) 2919, 1598, 1512, 
1435,  1387,  1217,  1151,  982  cm-1.  MS  (ESI)  m/z:  523  [M]+.  HRMS(ESI):  Calcd  for 
 
C38H39N2 [M]+. 523.3107, found 523.3101. UV abs λmax = 759 nm. 
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1 1,3,3-Trimethyl-2-[(1E,3Z,5E)-4-phenyl-7-[(2E)-1,3,3-trimethyl-2,3-dihydro-1H-indol- 
 
2-ylidene]hepta-1,3,5-trien-1-yl]-3H-indol-1-ium iodide (21). 
 
 
 
 
 
 
 
 
21 was synthesised as for 9a using PY5 (0.30 g, 0.80 mmol) and anhydrous sodium acetate 
(0.41 g, 5.00 mmol) in EtOH (10.0 mL) with 1a (0.63 g, 2.00 mmol) to give the crude 
product which was purified by silica gel column chromatography (solvent; chloroform: 
methanol=9:1) to obtain cyanine dye 21 (0.10 g, 21%) as a green solid; m.p. 145-147 °C: 1H 
NMR (d6-DMSO, 300 MHz) δ 7.63-7.52 (m, 3H, Ar-H), 7.47 (d, J=7.0 Hz, 2H, Ar-H), 7.36- 
7.27 (m, 8H, Ar-H), 7.20 (t, J=7.0 Hz, 2H, Ar-H), 6.75 (d, J=14.0 Hz, 2H, CHalkene), 6.40 (d, 
 
J=14.0 Hz, 2H, CHalkene), 3.50 (s, 6H, N-CH3), 1.25 (s, 12H, C-CH3). IR (ATR) 3333, 2291, 
1585, 1507, 1439, 1325, 1262, 1141, 907, 741 cm-1. MS (ESI) m/z: 485 [M]+. UV abs λmax = 
 
750 nm. 
 
 
 
 
 
2-[(1E,3E,5Z)-5-Bromo-7-[(2E)-1,3,3-trimethyl-2,3-dihydro-1H-indol-2-ylidene]hepta- 
 
1,3,5-trien-1-yl]-1,3,3-trimethyl-3H-indol-1-ium iodide (19). 
 
 
 
 
 
 
 
 
19 was synthesised as for 9a using PY3 (0.30 g, 0.80 mmol) and anhydrous sodium acetate 
(0.41 g, 5.00 mmol) in EtOH (10.0 mL) with 1a (0.60 g, 2.00 mmol) to give the crude 
product which was purified by silica gel column chromatography (eluent solvent; chloroform: 
methanol=9:1) to obtain cyanine dye 19 (0.12 g, 24%) as a shiny green solid; m.p. 209-211 
°C: 1H NMR (d6-DMSO, 300 MHz) δ 8.12-8.04 (m, 2H, Ar-H), 7.96 (d, J=12.0 Hz, 1H, 
 
CHalkene), 7.70 (d, J=6.0 Hz, 1H, Ar-H), 7.58-7.55 (m, 2H, Ar-H), 7.51 (t, J=12.0 Hz, 1H, 
CHalkene), 7.39-7.33 (m, 3H, Ar-H), 7.23 (t, J=12.0 Hz, 1H, CHalkene), 6.79-6.68 (m, 2H, Ar- 
H), 6.08 (d, J=12.0 Hz, 1H, CHalkene), 3.75 (s, 3H, N-CH3), 3.56 (s, 3H, N-CH3), 1.67 (s, 6H, 
C-CH3), 1.64 (s, 6H, C-CH3). IR (ATR) 2918, 1590, 1400, 1354, 1270, 980, 740 cm-1. MS 
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(ESI) m/z: 487 [M]+. HRMS(ESI): Calcd for C29H32BrN2[M]+ 487.1743, found 487.1742. UV 
 
abs λmax = 732 nm. 
 
 
 
 
 
2-[(1E,3E,5Z)-5-Chloro-7-[(2Z)-3-methyl-2,3-dihydro-1,3-benzothiazol-2-ylidene]hepta- 
 
1,3,5-trien-1-yl]-3-methyl-1,3-benzothiazol-3-ium iodide (20). 
 
 
 
 
 
 
 
 
20 was synthesised as for 9a using PY4 (0.25 g, 0.80 mmol) and anhydrous sodium acetate 
(0.41 g, 5.00 mmol) in EtOH (10.0 mL) with 2a (0.58 g, 2.00 mmol) to give the crude 
product which was purified by silica gel column chromatography (solvent; chloroform: 
methanol=9:1) to obtain cyanine dye 20 (0.16 g, 36%) as a green solid; m.p. 196-198 °C: 1H 
NMR (d6-DMSO, 300 MHz) δ 8.10 (d, J=7.0 Hz, 1H, Ar-H), 7.91 (d, J=7.0 Hz, 1H, Ar-H), 
7.86 (d, J=8.0 Hz, 1H, Ar-H), 7.68-7.55 (m, 4H, Ar-H), 7.50 (t, J=8.0 Hz, 2H, Ar-H), 7.41 (d, 
 
J=13.0 Hz, 1H, CHalkene), 7.32 (t, J=7.0 Hz, 1H, Ar-H), 6.97 (d, J=13.0 Hz, 1H, CHalkene), 
 
6.63 (d, J=13.0 Hz, 1H, CHalkene), 6.18 (d, J=13.0 Hz, 1H, CHalkene), 3.93 (s, 3H, N-CH3), 
3.73 (s, 3H, N-CH3). IR (ATR) 3396, 2357, 1579, 1439, 1371, 1267, 1194, 999, 813 cm-1. 
MS  (ESI)  m/z:  423  [M]+.  HRMS(ESI):  Calcd  for  C23H20BrN2S2[M]+   423.0751,  found 
423.0748. UV abs λmax = 752 nm. 
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2-[(1E,3E,5E)-7-[(2E)-3,3-Dimethyl-1-(4-sulfonatobutyl)-2,3-dihydro-1H-indol-2- 
ylidene]-5-methylhepta-1,3,5-trien-1-yl]-3,3-dimethyl-1-(4-sulfonatobutyl)-3H-indol-1- 
ium (12). 
 
 
 
 
 
 
 
 
Na+ 
 
 
12 was synthesised as for 9a using PY2 (0.23 g, 0.80 mmol) and anhydrous sodium acetate 
(0.41 g, 5.00 mmol) in EtOH (10.0 mL) with 1m (0.59 g, 2.00 mmol) to give the crude 
product which was purified by silica gel column chromatography (solvent; chloroform: 
methanol=7:3) to obtain cyanine dye 12 (0.10 g, 19%) as a shiny purple solid; m.p. 160-162 
°C: 1H NMR (d6-DMSO, 400 MHz) δ 7.88 (t, J=13.0 Hz, 1H, CHalkene), 7.71-7.65 (m, 2H, 
 
Ar-H), 7.51 (d, J=7.0 Hz, 2H, Ar-H), 7.34-7.28 (m, 4H, Ar-H), 7.16 (t, J=7.0 Hz, 2H, Ar-H), 
 
6.64 (t, J=13.0 Hz, 1H, CHalkene), 6.43 (d, J=14.0 Hz, 1H, CHalkene), 6.16 (d, J=14.0 Hz, 1H, 
CHalkene), 4.07 (t, J=7.0 Hz, 2H, N-CH2-CH2), 3.99 (t, J=7.0 Hz, 2H, N-CH2-CH2), 2.43-2.40 
(m, 4H, CH2-SO3), 1.95 (s, 3H, C-CH3), 1.75-1.66 (m, 8H, CH2), 1.18 (br s, 12H, (CH3)4). IR 
(ATR) 2928, 1585, 1511, 1404, 1318, 974, 744 cm-1. MS (ESI) m/z: 665 [M+2H]+. 
HRMS(ESI): Calcd for C36H45N2O6S2.[M+2H]+  665.2725, found 665.2710. UV abs λmax  = 
784 nm. 
 
 
 
 
 
2-[(1E,3E,5Z)-5-Bromo-7-[(2E)-3,3-dimethyl-1-(4-sulfonatobutyl)-2,3-dihydro-1H-indol- 
 
2-ylidene]hepta-1,3,5-trien-1-yl]-3,3-dimethyl-1-(4-sulfonatobutyl)-3H-indol-1-ium (13). 
 
 
 
 
 
 
 
 
 
Na+ 
 
 
13 was synthesised as for 9a using PY3 (0.28 g, 0.80 mmol) and anhydrous sodium acetate 
(0.41 g, 5.00 mmol) in EtOH (10.0 mL) with 1m (0.59 g, 2.00 mmol) to give the crude 
product  which  was  purified  by  silica  gel  column  chromatography  (solvent;  chloroform: 
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methanol=7:3) to obtain cyanine dye 13 (0.11 g, 19%) as a green solid; m.p. 231-233 °C: 1H 
NMR (d6-DMSO, 400 MHz) δ 8.14-8.03 (m, 2H, Ar-H), 7.96 (d, J=15.0 Hz, 1H, CHalkene), 
7.69 (d, J=6.0 Hz, 1H, Ar-H), 7.63 (d, J=6.0 Hz, 1H, Ar-H), 7.57 (d, J=6.0 Hz, 1H, Ar-H), 
 
7.50 (t, J=9.0 Hz, 1H, Ar-H), 7.39-7.33 (m, 3H, Ar-H), 7.22 (t, J=9.0 Hz, 1H, Ar-H), 6.92 (d, 
 
J=15.0 Hz, 1H, CHalkene), 6.81 (t, J=15.0 Hz, 1H, CHalkene), 6.13 (d, J=15.0 Hz, 1H, CHalkene), 
 
4.27 (t, J=6.0 Hz, 2H, N-CH2-CH2), 4.07 (t, J=6.0 Hz, 2H, N-CH2-CH2), 1.78-1.69 (m, 12H, 
CH2-SO3), 1.67 (s, 6H, C-CH3), 1.63 (s, 6H, C-CH3). IR (ATR) 2925, 1588, 1405, 1366, 
1289, 977, 746 cm-1. MS (ESI) m/z: 731 [M+2H]+. HRMS(ESI): Calcd for 
 
C35H44BrN2O6S2.[M+2H]+ 731.1819, found 731.1813. UV abs λmax = 753 nm. 
 
 
 
 
 
2-[(1E,3E,5Z)-5-chloro-7-[(2E)-3,3-dimethyl-1-(4-sulfobutyl)-2,3-dihydro-1H-indol-2- 
ylidene]hepta-1,3,5-trien-1-yl]-3,3-dimethyl-1-(4-sulfinatobutyl)-3H-indol-1-ium (14). 
 
 
 
 
 
 
 
 
 
Na+ 
 
 
14 was synthesised as for 9a using PY4 (0.25 g, 0.80 mmol) and anhydrous sodium acetate 
(0.41 g, 5.00 mmol) in EtOH (10.0 mL) with 1m (0.59 g, 2.00 mmol) to give the crude 
product which was purified by silica gel column chromatography (solvent; chloroform: 
methanol=7:3) to obtain cyanine dye 14 (0.10 g, 18%) as a green solid; m.p. 233-235 °C: 1H 
NMR (d6-DMSO, 300 MHz) δ 8.13 (d, J=12.0 Hz, 1H, CHalkene), 8.04 (d, J=12.0 Hz, 1H, 
CHalkene), 7.62 (d, J=9.0 Hz, 1H, Ar-H), 7.56 (d, J=9.0 Hz, 1H, Ar-H), 7.48 (t, J=15.0 Hz, 1H, 
CHalkene), 7.40-7.30 (m, 3H, Ar-H), 7.20-7.15 (m, 1H, Ar-H), 6.90 (d, J=15.0 Hz, 1H, 
CHalkene), 6.81 (t, J=12.0 Hz, 1H, CHalkene), 6.12 (d, J=12.0 Hz, 1H, CHalkene), 4.25 (t, J=6.0 
Hz, 2H, N-CH2-CH2), 4.07 (t, J=6.0 Hz, 2H, N-CH2-CH2), 1.79-1.71 (m, 12H, CH2-SO3), 
 
1.65 (s, 6H, C-CH3), 1.62 (s, 6H, C-CH3). IR (ATR) 2921, 1511, 1405, 1366, 1290, 980, 746 
cm-1.  MS  (ESI)  m/z:  687  [M+2H]+.  HRMS(ESI):  Calcd  for  C35H44ClN2O6S2.[M+2H]+ 
687.2324, found 687.2318. UV abs λmax = 774 nm. 
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2-[(1E,3Z,5E)-7-[(2E)-3,3-dimethyl-1-(4-sulfonatobutyl)-2,3-dihydro-1H-indol-2- 
ylidene]-4-phenylhepta-1,3,5-trien-1-yl]-3,3-dimethyl-1-(4-sulfonatobutyl)-3H-indol-1- 
ium (15). 
 
 
 
 
 
 
 
 
 
Na+ 
 
 
15 was synthesised as for 9a using PY5 (0.30 g, 0.80 mmol) and anhydrous sodium acetate 
(0.41 g, 5.00 mmol) in EtOH (10.0 mL) with 1m (0.59 g, 2.00 mmol) to give the crude 
product which was purified by silica gel column chromatography (solvent; chloroform: 
methanol=7:3) to obtain cyanine dye 15 (0.12 g, 20%) as a green solid; m.p. 259-261 °C: 1H 
NMR (d6-DMSO, 300 MHz) δ 7.65-7.59 (m, 3H, Ar-H), 7.49 (d, J=9.0 Hz, 2H, Ar-H), 7.40- 
7.33 (m, 6H, Ar-H), 7.27 (d, J=8.0 Hz, 2H, Ar-H), 7.20 (t, J=12.0 Hz, 2H, CHalkene), 6.78 (d, 
 
J=12.0 Hz, 2H, CHalkene), 6.53 (d, J=12.0 Hz, 2H, CHalkene), 4.07 (t, J=9.0 Hz, 4H, N-CH2- 
CH2), 2.46 (br s, 4H, CH2-SO3), 1.76-1.69 (m, 8H, CH2), 1.24 (s, 12H, C-CH3). IR (ATR) 
2968, 1561, 1445, 1368, 1209, 1006, 756 cm-1. MS (ESI) m/z: 729 [M+2H]+. HRMS(ESI): 
 
Calcd for C41H49N2O6S2.[M+2H]+ 729.3027, found 729.3023. UV abs λmax = 758 nm. 
 
 
 
 
2-[(1E,3E,5Z)-5-bromo-7-[(2Z)-3-(3-sulfonatopropyl)-2,3-dihydro-1,3-benzothiazol-2- 
ylidene]hepta-1,3,5-trien-1-yl]-3-(3-sulfonatopropyl)-1,3-benzothiazol-3-ium (16). 
 
 
 
 
 
16 was synthesised as for 9a using PY3 (0.28 g, 0.80 mmol)  and anhydrous sodium acetate 
(0.41 g, 5.00 mmol) in EtOH (10.0 mL) with 2l (0.54 g, 2.00 mmol)   to give the crude 
product which was purified by silica gel column chromatography (solvent; chloroform: 
methanol=7:3) to obtain cyanine dye 16 (0.10 g, 18%) as a green solid; m.p. 232-234 °C: 1H 
NMR (d6-DMSO, 300 MHz) δ 8.13 (d, J=9.0 Hz, 1H, Ar-H), 8.02 (d, J=9.0 Hz, 1H, Ar-H), 
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7.93 (d, J=9.0 Hz, 1H, Ar-H), 7.78 (d, J=9.0 Hz, 1H, Ar-H), 7.70-7.65 (m, 3H, Ar-H), 7.55- 
 
7.51 (m, 3H, Ar-H), 7.35 (t, J=15.0 Hz, 1H, CHalkene), 7.15 (d, J=12.0 Hz, 1H, CHalkene), 6.63 
(t, J=12.0 Hz, 1H, CHalkene), 6.29 (d, J=12.0 Hz, 1H, CHalkene), 4.67 (t, J=9.0 Hz, 2H, N-CH2- 
CH2), 4.47 (t, J=9.0 Hz, 2H, N-CH2-CH2), 2.63 (t, J=9.0 Hz, 4H, CH2-CH2-SO3), 2.09 (quin, 
J=9.0 Hz, 4H, CH2-CH2-SO3). IR (ATR) 2966, 1458, 1402, 1327, 1270, 810, 746 cm-1. MS 
(ESI) m/z: 682 [M+2H]+. HRMS(ESI): Not successful. UV abs λmax = 753 nm. 
 
 
 
 
2-[(1E,3E,5Z)-5-chloro-7-[(2Z)-3-(3-sulfonatopropyl)-2,3-dihydro-1,3-benzothiazol-2- 
ylidene]hepta-1,3,5-trien-1-yl]-3-(3-sulfonatopropyl)-1,3-benzothiazol-3-ium (17). 
 
 
 
 
17 was synthesised as for 9a using PY4 (0.25 g, 0.80 mmol) and anhydrous sodium acetate 
(0.41 g, 5.00 mmol) in EtOH (10.0 mL) with 2l (0.54 g, 2.00 mmol) to give the crude product 
which  was  purified  by  silica  gel  column  chromatography  (solvent;  chloroform: 
methanol=7:3) to obtain cyanine dye 17 (0.11 g, 22%) as a green solid; m.p. 242-244 °C: 1H 
NMR (d6-DMSO, 300 MHz) δ 8.11 (d, J=6.0 Hz, 1H, Ar-H), 8.00 (d, J=9.0 Hz, 1H, Ar-H ), 
7.91 (d, J=6.0 Hz, 1H, Ar-H), 7.76 (d, J=9.0 Hz, 1H, Ar-H), 7.66-7.60 (m, 3H, Ar-H), 7.51- 
 
7.46 (m, 2H, Ar-H), 7.43 (d, J=15.0 Hz, 1H, CHalkene), 7.34 (t, J=15.0 Hz, 1H, CHalkene), 7.13 
(d, J=15.0 Hz, 1H, CHalkene), 6.63 (t, J=15.0 Hz, 1H, CHalkene), 6.32 (d, J=15.0 Hz, 1H, 
CHalkene), 4.65 (t, J=6.0 Hz, 2H, N-CH2-CH2), 4.47 (t, J=6.0 Hz, 2H, N-CH2-CH2), 2.63-2.55 
(m, 4H, CH2-CH2-SO3), 2.08 (quin, J=9.0 Hz, 4H, CH2-CH2-CH2-SO3). IR (ATR) 2939, 
1578, 1401, 1269, 811, 741 cm-1. MS (ESI) m/z: 637 [M+2H]+. HRMS(ESI): Calcd for 
 
C27H28ClN2O6S4 [M+2H]+ 637.0367, found 637.0346. UV abs λmax = 758 nm. 
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2-[(1E,3E,5E)-5-methyl-7-[(2Z)-3-(3-sulfonatopropyl)-2,3-dihydro-1,3-benzothiazol-2- 
 
ylidene]hepta-1,3,5-trien-1-yl]-3-(3-sulfonatopropyl)-1,3-benzothiazol-3-ium (18). 
 
 
 
 
 
18 was synthesised as for 9a using PY2 (0.23 g, 0.80 mmol) and anhydrous sodium acetate 
(0.41 g, 5.00 mmol) in EtOH (10.0 mL) with 2m (0.54 g, 2.00 mmol) to give the crude 
product which was purified by silica gel column chromatography (solvent; chloroform: 
methanol=7:3) to obtain cyanine dye 18 (0.10 g, 20%) as a green solid; m.p. 245-247 °C: 1H 
NMR (d6-DMSO, 300 MHz) δ 7.96 (d, J=6.0 Hz, 2H, Ar-H), 7.80 (d, J=9.0 Hz, 2H, Ar-H), 
7.56 (t, J=9.0 Hz, 2H, Ar-H), 7.44-7.28 (m, 5H, Ar-H), 6.75 (d, J=15.0 Hz, 1H, CHalkene), 
 
6.67 (t, J=15.0 Hz, 1H, CHalkene), 6.55 (t, J=15.0 Hz, 1H, CHalkene), 4.60 (t, J=9.0 Hz, 2H, N- 
CH2-CH2), 4.49 (t, J=9.0 Hz, 2H, N-CH2-CH2), 2.59 (s, 3H, CH3), 2.02 (br s, 8H, CH2-SO3), 
IR (ATR) 2925, 1506, 1400, 1329, 1273, 868, 741 cm-1. MS(ESI) m/z: 617 [M+2H]+. 
HRMS(ESI): Calcd for C28H31N2O6S4.[M+2H]+ 617.0896, found 617.0889. UV abs λmax  = 
784 nm. 
 
 
 
 
 
2-Methyl-3-(prop-2-yn-1-yl)-1,3-benzothiazol-3-ium bromide (2n). 
 
 
 
 
 
 
 
2n  was  synthesised  as  for  1a  using  2-methylbenzothiazole  (15.0  mL,  100  mmol)  and 
propargyl bromide (4.00 mL, 34.0 mmol) to give the product 2n (0.84 g, 9%) as a grey solid; 
m.p. 201-204 °C: 1H NMR (d6-DMSO, 300 MHz) δ 8.55 (d, J=8.0 Hz, 1H, Ar-H), 8.40 (d, 
J=8.0 Hz, 1H, Ar-H), 7.96 (t, J=7.0 Hz, 1H, Ar-H), 7.85 (t, J=8.0 Hz, 1H, Ar-H), 5.80 (s, 2H, 
N-CH2), 3.87 (s, 1H, CH), 3.29 (s, 3H, C-CH3). 13C NMR (d6-DMSO, 75.4 MHz) δ 178.9, 
140.7, 130.0, 129.4, 128.7, 125.4, 117.1, 79.5, 79.4, 75.1, 17.7. IR (ATR) 2946, 1578, 1513, 
 
1434, 1329, 1195, 1091, 804, 756, 629 cm-1. MS (ESI) m/z: 188 [M]+. 
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3-(Prop-2-yn-1-yl)-2-[(1E,3E,5E)-7-[(2Z)-3-(prop-2-yn-1-yl)-2,3-dihydro-1,3- 
 
benzothiazol-2-ylidene]hepta-1,3,5-trien-1-yl]-1,3-benzothiazol-3-ium bromide (22). 
 
 
 
 
 
 
 
 
 
22 was synthesised as for 9a using PY1 (0.22 g, 0.80 mmol) and anhydrous sodium acetate 
(0.41 g, 5.00 mmol) in EtOH (10.0 mL) with 2n1 (0.54 g, 2.00 mmol) to give the crude 
product which was purified by silica gel column chromatography (eluent solvent; chloroform: 
methanol=9:1) to obtain cyanine dye (22, 0.20 g, 48%) as a green solid; m.p. 168-170 °C: 1H 
NMR (d6-DMSO, 300 MHz) δ 8.00 (d, J=6.0 Hz, 2H, Ar-H), 7.74 (d, J=6.0 Hz, 2H, Ar-H), 
7.59-7.43 (m, 3H, Ar-H), 7.42-7.37 (m, 4H, Ar-H), 6.67 (d, J=12.0 Hz, 2H, CHalkene), 6.54 (t, 
 
J=12.0 Hz, 2H, CHalkene), 5.28 (s, 4H, N-CH2), 3.60 (s, 2H, CH). IR (ATR) 2982, 1613, 1504, 
1397, 1324, 1063, 990, 803, 737 cm-1. MS (ESI) m/z: 436.98 [M]+. HRMS(ESI): Calcd for 
 
C27H21N2S2 [M]+ 437.1140, found 437.1131. UV abs λmax = 758 nm. 
 
 
 
 
 
2-[(E)-2-[(3E)-2-Chloro-3-{2-[(2Z)-3-(prop-2-yn-1-yl)-2,3-dihydro-1,3-benzothiazol-2- 
ylidene]ethylidene}cyclohex-1-en-1-yl]ethenyl]-3-(prop-2-yn-1-yl)-1,3-benzothiazol-3- 
ium bromide (23). 
 
 
 
 
 
 
 
 
 
 
23 was synthesised as for 4a using 2n (2.16 g, 8.00 mmol) and anhydrous sodium acetate 
(0.66 g, 8.00 mmol) in EtOH (40.0 mL) and was added VH1 (1.44 g, 4.00 mmol) to give the 
crude product which was purified by silica gel column chromatography (solvent; chloroform : 
methanol=8:2) to obtain cyanine dye 23 (1.11 g, 47%) as a green solid; m.p. 191-193 °C: 1H 
NMR (d6-DMSO, 300 MHz) δ 7.95 (d, J=7.0 Hz, 2H, Ar-H), 7.78-771 (m, 4H, Ar-H), 7.55 
(t, J=8.0 Hz, 2H, Ar-H), 7.32 (t, J=8.0 Hz, 2H, Ar-H), 6.59 (d, J=14.0 Hz, 2H, CHalkene), 5.38 
(s, 4H, N-CH2), 3.61 (s, 2H, CH), 2.50 (t, J=3.0 Hz, 4H, CH2-CH2), 1.98-1.88 (m, 2H, CH2- 
CH2-CH2). IR (ATR) 3283, 1659, 1580, 1498, 1382, 1321, 1092, 991, 851, 738 cm-1. MS 
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(ESI) m/z: 510 [M]+. HRMS(ESI): Calcd for C30H24ClN2S2 [M] + 511.1063, found 511.1054. 
 
UV abs λmax = 800 nm. 
 
 
 
 
2-[(1E,3E,5E)-5-Methyl-7-[(2Z)-3-(prop-2-yn-1-yl)-2,3-dihydro-1,3-benzothiazol-2- 
ylidene]hepta-1,3,5-trien-1-yl]-3-(prop-2-yn-1-yl)-1,3-benzothiazol-3-ium bromide (24). 
 
 
 
 
 
 
 
 
 
24 was synthesised as for 9a using PY2 (0.24 g, 0.80 mmol) and anhydrous sodium acetate 
(0.41 g, 5.00 mmol) in EtOH (10.0 mL) with 2n (0.54 g, 2.00 mmol) to give the crude 
product which was purified by silica gel column chromatography (solvent; chloroform: 
methanol=9:1) to obtain cyanine dye 24 (0.11 g, 26%) as a dark green solid; m.p. 171-173 
°C: 1H NMR (d6-DMSO, 300 MHz) δ 8.00 (d, J=6.0 Hz, 2H, Ar-H), 7.74 (d, J=6.0 Hz, 2H, 
 
Ar-H), 7.59 (t, J=15.0 Hz, 2H, CHalkene), 7.50-7.32 (m, 5H, Ar-H), 6.72 (d, J=15.0 Hz, 1H, 
CHalkene), 6.61 (t, J=15.0 Hz, 2H, CHalkene), 5.39 (s, 2H, N-CH2), 5.27 (s, 2H, N-CH2),  3.60 
(s, 2H, CH), 2.02 (s, 3H, C-CH3). IR (ATR) 3177, 1574, 1506, 1402, 1269, 1124, 1010, 801, 
737 cm-1. MS (ESI) m/z: 450 [M]+. HRMS(ESI): Calcd for C28H23N2S2 [M]+ 451.1297, found 
 
451.1294. UV abs λmax = 759 nm. 
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3-[(1-Benzyl-1H-1,2,3-triazol-4-yl)methyl]-2-[(1E,3E,5E)-7-[(2Z)-3-[(1-benzyl-1H-1,2,3- 
triazol-4-yl)methyl]-2,3-dihydro-1,3-benzothiazol-2-ylidene]hepta-1,3,5-trien-1-yl]-1,3- 
benzothiazol-3-ium bromide (25). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
22 (0.17 g, 0.34 mmol), benzylazide (0.09 g, 0.68 mmol), copper(II)sulfhate (0.03 g, 0.16 
mmol) and sodium ascorbate (0.13 g, 0.68 mmol) were dissolved in a 75% acetone/water 
solution (20.0 mL) and stirred at room temperature overnight. The reaction was stopped and 
the crude product was purified by silica gel column chromatography (solvent; chloroform: 
methanol = 8:2) to afford the desired cyanine dye azide conjugate 25 (70 mg, 26%) as a green 
solid; m.p. 158-160 °C: 1H NMR (d6-DMSO, 300 MHz) δ 8.34 (s, 2H, N-CHalkene), 7.97 (d, 
 
J=6.0 Hz, 2H, Ar-H), 7.84 (d, J=6.0 Hz, 2H, Ar-H), 7.54 (t, J=9.0 Hz, 2H, Ar-H), 7.49-7.26 
(m, 15H, Ar-H), 6.79 (d, J=15.0 Hz, 2H, CHalkene), 6.48 (t, J=15.0 Hz, 2H, CHalkene), 5.63 (s, 
4H, N-CH2), 5.59 (s, 4H, N-CH2-Ph). IR (ATR) 3389, 2286, 1503, 1455, 1322, 1068, 982, 
806, 717 cm-1. MS (ESI) m/z: 703 [M]+. HRMS (ESI): Calcd for C41H35N8S2 [M]+ 703.2420, 
 
found 703.2414. UV abs λmax = 764 nm. 
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3-[(1-Benzyl-1H-1,2,3-triazol-4-yl)methyl]-2-[(E)-2-[(3E)-3-{2-[(2Z)-3-[(1-benzyl-1H- 
 
 
1,2,3-triazol-4-yl)methyl]-2,3-dihydro-1,3-benzothiazol-2-ylidene]ethylidene}-2- 
 
chlorocyclohex-1-en-1-yl]ethenyl]-1,3-benzothiazol-3-ium bromide (26). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
26 was synthesised as for 25 using 23 (0.201 g, 0.34 mmol), benzylazide (0.09 g, 0.68 mmol), 
copper(II)sulfate (0.03 g, 0.16 mmol) and sodium ascorbate (0.13 g, 0.68 mmol) to give the 
crude product which was purified by silica gel column chromatography (solvent; chloroform: 
methanol = 8:2) to afford the desired cyanine dye azide conjugate 26 (89 mg, 31%) as a green 
solid; m.p. 214-216 °C: 1H NMR (d6-DMSO, 300 MHz) δ 8.34 (s, 2H, N-CHalkene), 7.98 (d, 
 
J=6.0 Hz, 2H, Ar-H), 7.91 (d, J=9.0 Hz, 2H, Ar-H), 7.82 (d, J=15.0 Hz, 2H, CHalkene), 7.59 (t, 
 
J=8.0 Hz, 2H, Ar-H), 7.42-7.27 (m, 13H, Ar-H), 6.76 (d, J=15.0 Hz, 2H, CHalkene), 5.77 (s, 
 
4H, N-CH2), 5.60 (s, 4H, N-CH2-Ph), 2.60-2.55 (m, 4H, CH2-CH2), 1.80-1.75 (m, 2H, CH2- 
CH2-CH2). IR (ATR) 2182, 1499, 1390, 1278, 1104, 998, 848, 714 cm-1. MS (ESI) m/z: 777 
[M]+. HRMS(FAB): Calcd for C44H38ClN8S2 [M+] 777.2343, found 777.2342. UV abs λmax = 
804 nm. 
Experimental 
3-[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]-2-[(1E,3E,5E)-7-[(2Z)-3-[(1-benzyl-1H-1,2,3- 
210 
 
 
triazol-4-yl)methyl]-2,3-dihydro-1,3-benzothiazol-2-ylidene]-5-methylhepta-1,3,5-trien- 
 
1-yl]-1,3-benzothiazol-3-ium bromide (27). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
27 was synthesised as for 25 using 24 (0.18 g, 0.34 mmol), benzylazide (0.09 g, 0.68 mmol), 
copper(ll)sulphate (0.03 g, 0.16 mmol) and sodium ascorbate (0.13 g, 0.68 mmol) to give the 
crude product which was purified by silica gel column chromatography (eluent solvent; 
chloroform: methanol = 8:2) to produce the desired cyanine dye azide conjugate 27 (64 mg, 
24%) as a dark green solid; m.p. 175-177 °C: 1H NMR (d6-DMSO, 300 MHz) δ 8.37 (d, 
 
J=6.0 Hz, 2H, N-CHalkene), 7.98 (d, J=6.0 Hz, 2H, Ar-H), 7.87 (d, J=8.0 Hz, 2H, Ar-H), 7.39 
(t, J=9.0 Hz, 2H, Ar-H), 7.35-7.27 (m, 15H, Ar-H), 6.84 (d, J=12.0 Hz, 1H, CHalkene), 6.66 (d, 
J=12.0 Hz, 1H, CHalkene), 6.56 (d, J=12.0 Hz, 1H, CHalkene), 5.73 (s, 2H, N-CH2), 5.64 (s, 2H, 
N-CH2), 5.60 (s, 4H,-CH2-Ph), 1.96 (s, 3H, C-CH3). IR (ATR) 3276, 2285, 1512, 1330, 1123, 
1010, 807, 722 cm-1. MS (ESI) m/z: 717.11 [M]+. HRMS (FAB): Calcd for C42H37N8S2 [M]+ 
 
717.2577, found 777.2591. UV abs λmax = 770 nm. 
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